Same review, same sources, same scoring — the summary and the reasoning open together on each row.
4. bmiMD
$89/mo — per month on the 6-month plan — the 1-month plan is $129/mo
Summary, strengths and trade-offs5 points
bmiMD, operated by Medccm Inc., is a mainstream telehealth weight-loss clinic that also sells compounded sermorelin in both an injectable and a sublingual-tablet format, across all 50 states.
Strengths
- A public Trustpilot profile backs up its review claims
- Sells sermorelin in two delivery formats — injection and sublingual tablet — rather than just one
- Operates in all 50 states
Trade-offs
- The lowest advertised sermorelin rate requires a longer commitment; the plain monthly rate runs higher
- The compounding pharmacy that fills prescriptions is not named on the site
5. Embody
$99/mo — printed as "In Stock · Fixed price of $99/month" for "Sermorelin Injection" and "Your price stays locked: $99/month flat, no increases, ever"; the page states that "Treatment plans are provided on a subscription basis and can be canceled at any time"
Summary, strengths and trade-offs9 points
Embody sells compounded semaglutide and tirzepatide from a store that prices every supply length, and runs separate offer pages for sermorelin, NAD+ and glutathione at one flat monthly figure each, though its offer page, its store and its terms print three different prices for the same GLP-1.
Strengths
- Names four dispensing pharmacies with their addresses and phone numbers on every page
- Prints a total and a per-month rate for every supply length of both GLP-1s, and the two agree
- Prices sermorelin, NAD+ and glutathione each on its own page, with the period printed beside the figure
- Names its operating company, its street address and its governing law
Trade-offs
- Its GLP-1 offer page, its store and its terms print three different prices for the same injection
- The offer-page figure matches the store's twelve-month rate, and the offer page never says so
- Every payment is final; a multi-month plan is not refunded even for months never shipped
- Its own pages disagree on which states it serves
- Names no clinician; care is attributed to a network
6. HealthRX.com
$179/mo — per month on the monthly subscription, "$179 billed monthly"; longer prepaid cadences lower the rate to $143 a month on a 12-month term billed at $1,719, and a one-time 1-month supply is $199
Summary, strengths and trade-offs10 points
HealthRX.com runs one of the widest priced peptide catalogs on this roster, publishing a figure for ten tracked compounds, per vial on its guide pages and as monthly subscriptions in its shop — including semax, epitalon and MOTS-c, which almost nobody prices — and answering its own service-area question with all 50 states.
Strengths
- Prices ten tracked compounds, four of which almost nothing else on this roster prices at all
- Answers its own service-area question with a plain "All 50 US states" rather than a pharmacy licensure claim
- States the vial size and strength beside every guide-page figure, so the unit is never left to inference
- Offers a monthly subscription and a one-time supply side by side on each shop product page
- Publishes a LegitScript certificate number on the page rather than only a seal image
Trade-offs
- Its guide page and its shop page publish different glutathione prices on the same day, and neither cites the other
- The shop page prints a "$122/month equivalent" that is a twelve-month total resolved to a month
- Describes the pharmacy only as "a US-licensed 503A compounding pharmacy" and never names one
- Several compound guide pages send their eligibility button to the weight-loss program rather than to the compound
- Publishes no operating company under a corporate suffix on any page read
7. Shed
$199/mo — the pricing block reads "Injections / Sermorelin / $199/month / Taken 5 times weekly / 1-month supply"; the "$149" elsewhere on the same page is a Wegovy Pill comparison figure, not this compound’s
Summary, strengths and trade-offs8 points
Shed prices four of the compounds compared here, states the supply period on every one, and is the clearest case on this roster of a seller whose own page prints three different figures for a single product.
Strengths
- Prices four of the compounds compared here, more than all but a handful of sellers on this roster
- States the supply period and the dosing frequency beside every figure
- Prices three separate NAD+ preparations rather than quoting one figure for all of them
- Names its operating company, its street address and its governing law in its own terms
Trade-offs
- Prints three different figures for its GHK-Cu product, two of which are divisions of a quarterly total
- Puts a GLP-1 comparison price on the sermorelin page, where a careless reader will take it for sermorelin’s
- Names no compounding pharmacy on any page read
- Makes no statement about which states it serves
8. Direct Meds
$249/mo — per month on the 90-day plan, free shipping
Summary, strengths and trade-offs10 points
Direct Meds is a Utah telehealth company that received an FDA warning letter in September 2025 for marketing compounded GLP-1s as equivalent to Ozempic and Wegovy; its sermorelin line sits in the same catalog, priced lower per month on the 90-day plan than on a single 30-day supply.
Strengths
- Carries a LegitScript certification seal
- Publishes both the 30-day and the 90-day sermorelin rate side by side on the same card, so the trade-off is visible before checkout
- Shipping is free on the 90-day plan rather than billed as a separate line
- Offers both injectable and sublingual formats on its GLP-1 line, disclosed alongside its warning letter
Trade-offs
- Received an FDA warning letter in September 2025 for marketing compounded GLP-1 drugs as equivalent to FDA-approved products
- BBB customer reviews average 1.12 out of 5 across 226 reviews, many describing unexpected multi-month charges
- As of a mid-July 2026 site check, it had removed its previously named 503A pharmacy partners from public view in favor of generic wording
- Staying flexible costs more: a single 30-day supply is the most expensive way to buy sermorelin here, and it adds a shipping charge the 90-day plan waives
- Its sermorelin marketing page publishes no price at all; the figures appear only on the shop page reached through Add To Cart
- Not available in Mississippi, Louisiana or California, and its full state list is not published
9. Pallas Health
$597 — A TWELVE-week CHARGE, not a month — "$89 for your first month, then $597 every 12 weeks ($199/mo average). Cancel anytime." The $199 is the seller's own arithmetic on the $597 charge and it labels it "average"; a reader who records $199/mo drops the word the seller put there and hides a $597 billing event
Summary, strengths and trade-offs8 points
Pallas deliberately does not sell the peptides this market is built on, publishes an essay explaining why, and corrects the category error the whole vertical makes: "NAD+ — a coenzyme, not a peptide."
Strengths
- Explains in its own words why it does not sell the peptides most of this market advertises
- Corrects the category error the vertical repeats, saying plainly that the coenzyme is not a peptide
- Prints the twelve-week charge and its own derived monthly average as two separate numbers
- Publishes per-state pages, which most of this roster does not
Trade-offs
- Publishes no ongoing rate for its coenzyme line — only a first-month floor
- The advertised monthly figure is arithmetic on a quarterly charge, and the word "average" is easy to lose
- Names no dispensing pharmacy, describing them by license class only
- Its catalog is two compounds, which is the point but is still a narrow menu
10. System Labs
$219/mo — per month after a $109 first month, as the page's billing answer states: "First month is $109. After that, $219 per month." Some visitors see the listing above it as a "Quarterly Supply (9mg)" at $175 after an $89 first month
Summary, strengths and trade-offs6 points
System Labs is a peptide-only storefront with no GLP-1 line, selling NAD+, glutathione, sermorelin and a topical GHK-Cu cream, LegitScript-verified but without a named pharmacy partner or a published state list.
Strengths
- Carries a LegitScript verification seal
- Sells a genuinely peptide-focused menu rather than treating peptides as a GLP-1 add-on
- Its GHK-Cu cream is priced flat, with no strikethrough figure or first-month teaser
Trade-offs
- The compounding pharmacy is described only as "US-based," never named
- Which states it ships to is not published anywhere on the site
- Most of its other peptide prices are shown as a struck-through renewal rate beside a first-month promo, so the ongoing cost takes a second look to find
11. CoreAge Rx
$99 — starting at
Summary, strengths and trade-offs5 points
CoreAge Rx runs a flat-price compounded model — one dose, one price, no ladder that climbs as you titrate up — and ships to all 50 states with a LegitScript seal on its NAD+ and sermorelin lines.
Strengths
- LegitScript-verified pharmacy standards, applied across its peptide catalog as well as its GLP-1 line
- One price per compound regardless of dose, so titrating up does not raise the monthly cost
- Ships to all 50 states with 24/7 support
Trade-offs
- The compounding pharmacy that fills prescriptions is not named on the site
- A newer brand with a thinner independent-review history than longer-running competitors
12. Oak
$133 — printed per month against a stated 4 week supply; the panel prints a struck-through $200 beside it
Summary, strengths and trade-offs8 points
Oak prices four tracked peptides once a reader follows its own home-page links into its checkout, where each carries a struck-through former figure and a live one.
Strengths
- Prices four tracked compounds, tesamorelin and glutathione among them, rather than the growth-hormone line alone
- States the supply length on the two compounds where it differs from a month
- Says its longevity billing is monthly and non-recurring rather than a subscription
- Shows the former figure alongside the current one instead of quietly replacing it
Trade-offs
- Publishes no peptide figure on its marketing site; every price sits inside the checkout
- Its checkout answers 200 at a nonsense path, so a status check alone would not catch a bad address
- Names no dispensing pharmacy on either of its hosts
- Publishes no state list and no corporate entity
13. Lttl
$99/mo — plans start at, per month
Summary, strengths and trade-offs8 points
Lttl prices four NAD+ formats at the same figure and undercuts most of this roster on glutathione, but every number it prints is a plan floor rather than a rate.
Strengths
- Prices the injectable, nasal and oral NAD+ formats identically
- Attaches a month to every figure on the homepage
- Says its medications are "compounded by certified U.S. pharmacies"
- Publishes its glutathione figure rather than folding it into a bundle
Trade-offs
- Every figure is a floor — "plans start at" — with no ceiling published
- Publishes no operating company on any page read
- Describes an "FDA-Registered Pharmacy" without naming one
- Its first-month discount is advertised as a code with no stated expiry
14. RNK Health
$129/mo — from, per month
Summary, strengths and trade-offs8 points
RNK Health names its own professional corporations in its terms and charges the same figure for injectable, nasal and liposomal NAD+.
Strengths
- Names RNK Health LLC and the professional entities its clinicians work for
- Prices injectable, nasal and liposomal NAD+ at one figure
- States a monthly period on every treatment tile
- Publishes a one-price summary — "One Price. Zero Hassle." — with what it includes
Trade-offs
- Describes "independent, licensed third-party pharmacies" without naming one
- Publishes no state list
- No certificate of analysis is reachable
- Its lab-panel and peptide prices sit in the same list, which makes the peptide figure easy to misread
15. MyDrHank
$137/mo — "SermorelinRx... From / $137 / /mo", read from the printed page; the served HTML for this address contains none of it
Summary, strengths and trade-offs8 points
MyDrHank prices five preparations of three compounds compared here at flat monthly rates, and publishes every one of them only after its scripts run — the address alone serves the same short shell for a real product and for a path that does not exist.
Strengths
- Prices five preparations of three compounds at flat monthly rates on their own pages
- Prices both a needle and a needle-free form of two compounds separately
- Says on its own NAD+ pages that the clinical evidence for those routes is limited
- Falls back to the homepage for an unknown product rather than rendering an empty product page
Trade-offs
- Publishes nothing in the page itself — every figure exists only after its scripts run
- Serves the identical document for a real product and for a path that does not exist
- Prefixes every figure with "From", so none of the five is a settled charge
- Names no compounding pharmacy on a product page or in its terms
16. Bodybuilding Health+
$159/mo — per month on the one-month plan as the seller's own sermorelin page prices it; that page advertises "Starting at $129/mo (first month)" while the home-page card prints $129/mo with no such qualifier, and its three-month lane is $165.67/mo — more per month than the one-month lane — billed once at $497; the page says the compound is available in injection or tablet
Summary, strengths and trade-offs9 points
Bodybuilding Health+ prices seven compounds compared here on plan ladders, and two of those ladders cost more per month the longer you commit — including the tirzepatide lane the seller itself badges "Best Value".
Strengths
- Prices seven compounds compared here, the widest priced menu among the sellers added in this pass
- Publishes a full plan ladder for both GLP-1 lines with the per-month figure and the total saving printed on each lane
- Names its operating company and a street address in its footer and terms, and names the governing law
- Its sermorelin product page states that the headline figure is a first-month rate, which the home-page card does not
Trade-offs
- Its own tirzepatide ladder charges more per month on the twelve-month lane than on the six-month lane, while badging the twelve-month lane "Best Value"
- The home page and the sermorelin product page disagree about whether the advertised figure is a first-month rate or a plan rate
- The FAQ says all fifty states and the terms say the service is available in certain states and to contact customer service for the list
- No compounding pharmacy is named and no lab work is described as included
- A Florida address in the footer and Georgia named as the governing law, which are two different states to keep track of
17. MangoRx
$185/mo — the treatment block prints "Starting at" above "$185 Monthly"
Summary, strengths and trade-offs8 points
MangoRx prints one figure per peptide on the compound’s own page — sermorelin and NAD+ each carry a starting monthly rate in the treatment block — and its FAQ describes the compounder by state and accreditation without ever naming it.
Strengths
- Each peptide has its own page, and the figure sits in the treatment block under the compound name rather than behind an intake
- One starting rate per compound, stated with the word Monthly beside it
- Free provider visits and shipping are stated sitewide rather than added at checkout
- The FAQ answers its own state question directly instead of implying nationwide coverage
Trade-offs
- The compounding pharmacy is described by state and accreditation but never named
- Neither figure appears in the served HTML — both live in a hydration payload until the page renders
- No list of the states served is published anywhere on the site
- The bloodwork answers all describe a different product line, so nothing says whether labs matter here
18. Strut Health
$99 — A 30-DAY SUPPLY, which is what the card says — "SERMORELIN ORAL $99 30-day supply" — not a billing month; the seller's own comparison table separately calls it "$99/mo", so the two halves of its own page disagree on the unit and the card is what is recorded here. Dosing is one lozenge daily
Summary, strengths and trade-offs8 points
Strut labels its own sermorelin, in its own comparison table, as a "Compounded prescription (off-label use)" — and carries a 2026 federal warning letter over misleading claims about its compounded weight-loss line.
Strengths
- Labels its own product "Compounded prescription (off-label use)" inside its comparison table, as a row a reader can check
- Publishes two routes at two prices with the dosing frequency printed beside each
- Names both the platform company and the separate medical group that employs the prescribers
- Says outright that its providers are not employed by the platform
Trade-offs
- Carries a February 2026 federal warning letter naming its own website over misleading compounded-drug claims
- Its own page gives the oral form two different units — "30-day supply" on the card and "$99/mo" in the table
- The homepage publishes no price at all, so only the product page carries one
- Declines to say where the service is available and names no dispensing pharmacy
19. Gala GLP-1
$118 — the effective rate on a twelve-month plan billed up front
Summary, strengths and trade-offs8 points
Gala GLP-1 prices NAD+ and sermorelin by the twenty-eight-day supply and says so, and charges at checkout before a clinician has seen the intake — refunding in full if nothing can be prescribed.
Strengths
- Prints the supply length — twenty-eight days — rather than letting the reader assume a month
- Says its compounded GLP-1 is not FDA-approved, in its own footnote
- States its charging model plainly, including the full refund if nothing is prescribed
- Prices NAD+ and sermorelin individually rather than behind a longevity floor
Trade-offs
- Its weight-loss figures cover both molecules at once, so neither drug has a price
- Its own FAQ and its product pages give different GLP-1 entry prices on different plan terms
- Names no dispensing pharmacy
- Its efficacy counters render as zeroes, so those pages state no readable figure
20. Luvo Health
$199 — read from a pricing grid headed "4 WEEKS" whose rows print two figures each: "Sermorelin $199 $10 /week". The header says four weeks and the unit label says per week, and the page contains no sentence reconciling them. Four weeks is thirteen charges a year, not twelve. What the second figure covers was not established and is not guessed here
Summary, strengths and trade-offs8 points
Luvo Health prices everything in a grid headed "4 WEEKS" whose unit label reads "per week", with two figures on every row and no sentence anywhere explaining what the second one is.
Strengths
- Puts its entire catalog on one pricing page with a figure against every line, including lines it does not otherwise advertise
- Carries a wider peptide list than most sellers on this roster, including a tissue-repair peptide and a gonadotropin-releasing analogue
- Names the operating company in the first line of its terms and again in the page heading
- States the period in the grid header rather than leaving it out entirely
Trade-offs
- The header says four weeks and the unit label says per week — the page contradicts itself about its own billing period
- Two figures per row with nothing on the page saying what the second one buys
- Four-week billing means thirteen charges a year, which no comparison table with a monthly column will show
- No pharmacy named, no certificate of analysis, no state coverage list
21. PeterMD
$211.65 — the price of a 4-Week Supply, in the seller's own words — four weeks is not a calendar month. The same page lists a 12-Week Supply at $585.00 against a stated regular price of $634.95, and this site makes no claim about what that regular price was ever charged at.
Summary, strengths and trade-offs7 points
PeterMD is the only seller compared here that publishes a state exclusion list per compound rather than a single coverage claim, and it names no operating company at all.
Strengths
- Prints a per-compound state exclusion sentence in each product page header, which no other seller compared here does
- Names the supply length beside each figure, in weeks, rather than implying a calendar month
- Names Oklahoma as the governing law and states that the arbitration agreement is governed by the Federal Arbitration Act
Trade-offs
- No operating company is named on the home page, in the terms, in either privacy policy or on the about page
- The NAD+ supply length is published as a range of eight to ten weeks, so no honest per-month figure exists for it
- The longer sermorelin lane is advertised as a reduction against a stated former price, and nothing on the page establishes what that former price was charged at
- The compounding pharmacy that fills an order is not named
22. Idgie Health
$125/mo — per month for the 300 mcg troche on the 3-month plan, charged as $377 every 3 months; the 500 mcg troche is $437 every 3 months
Summary, strengths and trade-offs11 points
Idgie Health prices NAD+, glutathione, sermorelin, GHK-Cu and both GLP-1s by plan length, prints the full charge for every multi-month plan, and names its prescribing physician and its pharmacy.
Strengths
- Each priced product page shows the checkout total for its quarterly and six-month plans beside the per-month rate
- Sells NAD+ as an injection and a nasal spray, and prices sermorelin as an injection and as a troche with a per-strength table
- Discloses who prescribes (Dr. Sean Arora of Arora Health & Aesthetics, with an NPI number) and who dispenses (VialsRX, with a Houston address)
- States that no membership fee applies, and lists what the plan price covers
- Renewals can be stopped from the patient account or through the care team
Trade-offs
- The NAD+ injection page prints two different monthly rates for its six-month plan: the per-month figure and the amount charged do not agree
- Money paid for a quarterly or six-month term is not refundable under a policy that calls every sale final
- Its shipping policy contradicts the product pages on both cost and delivery time
- Template text has leaked between products: the NAD+ injection page's compounding note is about tirzepatide
- No strength is published for the NAD+, glutathione or sermorelin injections
- A state page claims every state, while the older terms of service restrict some services to unnamed states
23. Precision Telemed
$149.99/mo — a starting rate, read as "Explore Sermorelin From $149.99/mo" in the cross-sell block of the NAD+ page — this figure was not read on a sermorelin product page, so it is the lowest advertised rate for the line and not a price for any particular dose
Summary, strengths and trade-offs8 points
Precision Telemed names the pharmacy that fills its orders, names the prescribing medical group separately from the platform company, and prints a first-month rate and an ongoing rate as two different numbers.
Strengths
- Names the filling pharmacy, its license class and its accreditations, which almost nothing else on this roster does
- Separates the platform company from the prescribing medical group and names both
- Prints the first-month rate and the ongoing rate as two distinct numbers rather than one blended figure
- States a fifty-state footprint three times, including as a direct answer in its own FAQ
Trade-offs
- Says "every batch tested for potency, sterility, and purity" and publishes no certificate for any batch
- The sermorelin figure appears only as a cross-sell line on the coenzyme page, with no product page behind it in this pass
- The $400–$600 per-session figures on the page describe IV clinics generally, not this seller, and a reader skimming will mix them up
- No state-by-state detail sits behind the fifty-state claim
24. Auren Rx
$159/mo — per month, auto-refill membership (vs. $199/mo with no commitment)
Summary, strengths and trade-offs7 points
Auren Rx names both its prescribing group, Wasef Health, and its dispensing pharmacy, VialsRX in Houston, with street addresses and phone numbers, and lets a subscriber pause an auto-refill plan on NAD+, sermorelin, glutathione or GHK-Cu instead of forcing a full cancellation.
Strengths
- Names its prescribing group and pharmacy with full street addresses and phone numbers, rare in this category
- Carries a verifiable LegitScript seal
- The first visit is free and nothing is charged until a clinician reviews and approves the order
- An auto-refill plan can be paused rather than fully canceled
Trade-offs
- Its homepage headline price applies to a microdose track; the standard compounded dose costs more
- Its homepage teasers disagree with its own product pages on two of four peptides: NAD+ and glutathione are each advertised lower in the nav than the product page charges
- The listed New York address is a mail-forwarding suite, not a clinic
25. Lavender Sky Health
$125 — for 60 rapid-dissolve tablets from the named pharmacy, with no billing period stated; the same combination is $189 for 60 tablets from BPI/The Pharmacy Hub, a sermorelin ODT is $199 for 40 tablets from Empower, and a sermorelin/NAD+/B12 capsule is $275 for 60 from Hallandale; medication pricing shown excludes the consultation fee, which is priced separately
Summary, strengths and trade-offs10 points
Lavender Sky Health publishes a price for every peptide it sells against the specific pharmacy that would fill it — nine pharmacies named, quantity by quantity — and states plainly that none of those figures includes the consultation fee it prices separately.
Strengths
- Names the pharmacy that would fill every single price it publishes, across nine pharmacies, which no other seller compared here does
- Prints the quantity beside every figure — milliliters, milligrams, grams or tablet count — so each number describes a stated amount
- States sitewide that the medication figures exclude the consultation fee, and then publishes what that consultation costs on a page of its own
- Publishes a per-pharmacy and per-formulation shipping-exclusion list rather than a single coverage sentence, which is the most detailed footprint disclosure compared here
- Names its operating company and a street address in its own privacy and HIPAA notices
Trade-offs
- Not one peptide figure on the pricing page states a billing period, so none of them is a monthly cost
- Almost every peptide price is hidden until a toggle is clicked: the pricing page renders about a fifth of its text closed, and a reader who does not operate the control sees no peptide price at all
- Its governing-law clause names no state — it reads "the laws of the state applicable to the patient's care" — so there is no forum a reader can identify in advance
- The all-fifty-states claim and the shipping-exclusion matrix have to be read together, and several products are unavailable in a dozen or more states depending on which pharmacy fills them
- Several published lines are marked temporarily unavailable or out of stock, including the cheapest nasal-spray option
26. RestorLife Med
$99/mo — per month billed quarterly, after the same discount; the list rate on the same tile is $166/mo
Summary, strengths and trade-offs8 points
RestorLife Med prices sermorelin four ways on one page — monthly, quarterly, discounted and list — and every one of the four carries a month.
Strengths
- Prints the discounted and undiscounted rate for both billing cycles on one tile
- Says it is "available in all 50 states" and warns that some require a video visit first
- States that the card charge will not process until the prescription is approved
- Attaches a billing cycle — monthly or quarterly — to every figure
Trade-offs
- Sells only one tracked compound
- Publishes no operating company on any page read
- Describes a "Partner Pharmacy" without naming it
- Its discount is tied to a promotional code with no stated expiry
27. He & She MD
$149/mo — per month on the twelve-month plan; the same table prices one month at $229
Summary, strengths and trade-offs8 points
He & She MD is one of the few sellers on this roster that names its dispensing pharmacies outright, and one whose plans page and product pages publish different prices for the same shorter plans.
Strengths
- Names both dispensing pharmacies, one with a street address and a telephone number
- Publishes a full plan ladder — one, three, six and twelve months — beside every peptide
- Says what the plan price includes: medication, supplies, shipping and provider support
- Prices glutathione and MOTS-C, which most sellers on this roster do not price at all
Trade-offs
- Its plans page and its product pages price the same shorter GLP-1 plans differently
- Its oral tirzepatide price table is labeled as sermorelin pricing
- Its cheapest rate on every ladder requires committing to twelve months
- The forty-four-state number belongs to its pharmacy, not to its own service, and no state list is published
28. Sermorelin.com
$149/mo — per month on the seller's own "6-Month Plan", the cheapest of three tiers and the only one carrying the "180-day money-back guarantee on our 6-Month Plan"
Summary, strengths and trade-offs8 points
Sermorelin.com sells one compound under a domain named after it, on a three-tier subscription with the discount written into a plan table, and it names both the pharmacy that fills the prescription and the medical practice that writes it.
Strengths
- Names the fulfilling pharmacy with a street address and a phone number rather than describing a category of facility
- Names the medical practice that writes the prescription separately from the company that sells the subscription
- Prints all three plan tiers in one table with the comparison figure beside each, so the discount needs no arithmetic
- Offers the compound as an oral tablet as well as an injection, at the same published plan rates
Trade-offs
- Its own terms describe fulfillment of medication "for the treatment of low testosterone", a program this site sells nowhere
- Says lab costs are excluded from the membership only in the terms, never on the pages that quote the price
- Claims availability in all U.S. states without publishing a list, while its terms say services are limited to certain states
- The money-back guarantee attaches to the longest plan only, so the shortest tier carries no refund promise
29. Trava Health
$157.91/mo — per month at 3 mg; a quarterly package is advertised at a lower total
Summary, strengths and trade-offs8 points
Trava Health attaches a named dose to every peptide price it publishes — 3 mg of sermorelin, 100 mg of NAD+ — which almost nothing else on this roster does, and it names its four fulfilling pharmacies.
Strengths
- Prints the dose beside the price on every peptide product page, so the figure describes a specific quantity
- Names its four fulfilling pharmacies and its laboratory partners in its terms of service
- Tells shoppers on the product page itself that the price moves with the dose, instead of leaving that to checkout
- Publishes a quarterly saving as a dollar figure rather than a percentage
Trade-offs
- A site-wide banner describes its medications as tested in FDA approved labs, wording that is easy to read as FDA approval of the product; a compounded preparation is not an approved drug
- The quarterly package is advertised as a saving without the resulting per-month figure being stated
- No state coverage list is published
- The peptide menu is three compounds, so a shopper comparing a wider protocol will need a second seller
30. Yucca Health
$158/mo — per month on the 3-month plan — $475 billed every 3 months
Summary, strengths and trade-offs5 points
Yucca Health pairs a 24-hour provider review with free expedited shipping, and lists NAD+ and sermorelin alongside its GLP-1 line, with coverage across all 50 states.
Strengths
- States a 24-hour provider-review turnaround up front
- Free expedited shipping is included rather than sold as an add-on
- Coverage is licensed across all 50 states
Trade-offs
- The compounding pharmacies it uses are described only generically, never named
- Program details beyond price and shipping are thin on the public site
31. Ozari Health
$159/mo — per month, "Billed monthly"; a quarterly lane works out at $149 a month, billed $447 every three
Summary, strengths and trade-offs8 points
Ozari Health is the only seller in this batch that publishes a fifty-row table naming which of its two pharmacies fills in each state — and it dates its own prices.
Strengths
- Publishes a fifty-row table naming which pharmacy fills in each state
- Names both dispensing pharmacies, their cities and their accreditations
- Prints its own price-verification date on the treatment pages
- Gives the clearest statement of the compounded category on this roster
Trade-offs
- Its weight-loss figures are quarterly totals presented as monthly rates
- A second GLP-1 price ladder sits behind a JavaScript toggle and is not published as text
- Its "Save $268" and "Save $330" claims name no baseline, so the saving cannot be checked
- Requires a three-month minimum commitment on subscriptions
32. PepHaus
$159/mo — per month on the monthly plan, the only tier that is billed monthly; the same page prints $151/mo on a quarterly plan and $143/mo on a 6-month plan billed $858.60, and advertises the $143 as its "from" price
Summary, strengths and trade-offs8 points
PepHaus prints three plan lengths with a per-month figure and the prepaid total beside each, says on the product page itself that it is not a research-only website, and claims a certificate of analysis in every box — a certificate that is not reachable anywhere on the site.
Strengths
- Prints three plan lengths side by side with the per-month figure and the prepaid total for each, so the commitment behind the lowest rate is visible
- States its own position on research-labeled peptides on the product page, in its own words, rather than leaving the category to the reader
- Claims all fifty states in its own sentence on every peptide page, with the eligibility caveat stated rather than implied
- Lists what a box contains item by item, including the syringes, the swabs and the supply length
Trade-offs
- Claims a certificate of analysis three times per page and publishes no reachable certificate anywhere — no document, no image and no attribute wiring one into the page
- Its own comparison table characterizes the research-chemical market's prices, which is a seller describing its rivals and is not evidence
- The advertised "from" figure is the six-month rate, so the headline price always carries a prepayment
- Only the semaglutide page names its compounding pharmacy; the sermorelin and tirzepatide pages describe it by licensing class alone
33. TeleZen MD
$166/mo — per month on the quarterly plan — the plan block reads "Quarterly Plan - $498 / $166 / month"
Summary, strengths and trade-offs8 points
TeleZen MD, a Florida limited liability company, publishes a first-month rate and the ongoing rate for four compounds, and puts a quarterly, semi-annual and annual lane beside the monthly one on its NAD+ and glutathione pages.
Strengths
- Prints the first-month rate and the ongoing rate together on every treatment page, rather than the introductory one alone
- Publishes four plan lengths on the NAD+ and glutathione pages with the total charge shown next to each per-month figure
- Answers the coverage question directly in its FAQ instead of leaving state availability to the intake
- Prices the nasal-spray route separately from the injection at two strengths
Trade-offs
- Says outright that patients do not choose the dispensing pharmacy and that its pharmacy partners may change at any time
- Names no pharmacy anywhere, describing them only as independent licensed 503A facilities
- Runs three stacked promotional codes on the same page, so the figure a reader sees first is rarely the plan rate
- Describes no lab work as included at any plan length
34. Bionomy
$169/mo — from, per month
Summary, strengths and trade-offs8 points
Bionomy names its two dispensing pharmacies and publishes a full 48-state list with the two it does not serve, which is more than almost any seller here does.
Strengths
- Names both dispensing pharmacies — Strive Pharmacy and Absolute Pharmacy — instead of describing one
- Publishes the full 48-state list and names the two states it will not ship to
- Says its intake will tell an out-of-state reader before any clinical data is shared
- Attaches "/mo" to every peptide figure on its homepage
Trade-offs
- Publishes no operating company on any page read
- Does not serve Alaska or Hawaii
- Publishes no certificate of analysis for any compound
- Its clinical claims cite a 2018 journal paper rather than anything about its own product
35. The Edit
$169/mo — per month, flat at every dose, provider visit and ongoing care included
Summary, strengths and trade-offs8 points
The Edit names its dispensing pharmacy, The Pharmacy Hub in Miami, up front, and prices NAD+, sermorelin, glutathione and GHK-Cu the same at every dose, with nothing charged until a clinician review is complete.
Strengths
- Names its dispensing pharmacy, The Pharmacy Hub in Miami, rather than describing it generically
- Charges one flat rate at every dose on its three injectable peptide lines
- Publishes prices on the treatment page itself, in both English and Spanish
- Runs no first-month teaser on its peptide lines, so the figure shown is the recurring one
- Carries a verifiable LegitScript seal
Trade-offs
- The GHK-Cu cream is quoted as a starting rate that moves with the strength prescribed, unlike the three flat injectable lines
- Longer plans are billed as one upfront charge rather than a lower recurring monthly rate
- Terms note that state availability is confirmed during consultation and may vary, despite advertising all 50 states
36. Prime Vitality Care
$179/mo — the seller states the period — "Sermorelin Therapy Pricing — Transparent, all-inclusive physician management with no hidden fees. Peptide Therapy $179 /mo" — and lists what it covers: initial consultation with the named physician, comprehensive baseline labs, personalised protocol, quarterly lab monitoring and ongoing telehealth check-ins. Do not confuse it with the $799/mo Longevity Protocol printed in the site-wide nav
Summary, strengths and trade-offs8 points
Prime Vitality Care puts baseline labs and quarterly lab monitoring inside its published monthly peptide figure, which two other rows on this roster do — and prints its membership tiers in a nav bar that renders on its privacy policy too.
Strengths
- Includes baseline labs and quarterly lab monitoring inside the published monthly figure and lists them line by line
- Names the operating company, its trading name and the named prescriber
- Publishes exactly which three states it is licensed in rather than an unqualified claim
- Prints the monthly figure with the word "no hidden fees" beside a list of what is actually covered
Trade-offs
- A site-wide nav prints four other monthly figures on every page, including its privacy policy
- Only one of its five declared compounds carries a published price
- Names no dispensing pharmacy
- The $799/mo Longevity Protocol sits in the same nav and is easy to mistake for the peptide rate
37. Raeliva
$179/mo — the monthly plan; prepaid alternatives run $450, $750 and $1,400
Summary, strengths and trade-offs8 points
Raeliva publishes nine per-compound monthly prices, says its providers are licensed in every state, and warns its own readers that the effective rate on a prepaid plan is not a monthly payment.
Strengths
- Publishes a standing monthly price for nine separate products
- Warns readers that a multi-month plan's monthly figure is an effective rate, not a payment
- Prices microdose products separately from full-dose ones
- Says its trial evidence describes a different product from the compounded one it sells
Trade-offs
- Names no dispensing pharmacy anywhere
- Says lab work may be billed separately on top of the plan price
- Its fifty-state claim is a count with no list behind it
- Its corporate name reads like a research supplier, which it is not
38. Somira Health
$179.99/mo — Monthly Plan, per month; the seller also prints "$149.99 / month ($449.99 / quarter)" on a quarterly plan, which is its own division of the quarterly total
Summary, strengths and trade-offs8 points
Somira Health names VialsRX as the compounder for its whole longevity line, publishes monthly and quarterly figures for sermorelin and NAD+, and answers its state question with a licensure claim it then narrows in the next sentence.
Strengths
- Names VialsRX as the compounder for the whole longevity line, on the same page as the prices
- Publishes the quarterly total in brackets beside the quarterly per-month figure, so the arithmetic is visible
- States no membership fee and no hidden fees on the same block as the figures
- Publishes an operating company and a street address in the footer
Trade-offs
- Its state answer opens with a 50-state licensure claim about its providers and then withdraws it for the company
- Publishes no list of the states where fulfillment is actually available
- The quarterly per-month figures are divisions of a quarterly total, and sit in the same table as the billed monthly ones
- Only two of the compounds this site tracks are sold
39. Claya
$199/mo — the product page prints "As low as $199/mo" beneath the benefit list
Summary, strengths and trade-offs8 points
Claya lists its partner pharmacies by name and street address in the footer of every page, prices two compounds compared here on their own pages, and is one of the few sellers here whose terms commit the company itself to all fifty states.
Strengths
- Names two partner pharmacies in the footer, each with a street address, phone number and web address
- Commits the company itself to all fifty states plus the District of Columbia in its own terms
- Names its operating company and state of incorporation rather than trading anonymously
- States on the product page that no bloodwork is needed to get started
Trade-offs
- Both compounds carry the identical figure, so the page gives no sense of what separates them
- The figure is an "as low as" starting rate with no dose or strength attached
- Much of each peptide page is GLP-1 marketing, including a weight-loss calculator that has nothing to do with the compound
- Lab work is excluded rather than included, so any monitoring is a separate cost
40. GobyMeds
$199/mo — for 1 month, printed whole on both the sermorelin page and the pricing page; the '$133+/mo' badge above it is the 3-month total divided and is not this figure
Summary, strengths and trade-offs12 points
GobyMeds names four dispensing pharmacies and its prescribing medical group outright, and prices sermorelin and NAD+ in several delivery formats — though its headline per-month figures are its multi-month totals divided down.
Strengths
- Names four dispensing pharmacies with a phone number, an email address and a domain for each
- Names the medical groups that furnish care rather than describing them generically
- Prints the whole one-month and three-month figures beside every divided badge, so the arithmetic is checkable
- Offers sermorelin in four delivery formats and NAD+ in two, each separately priced
- Says outright on its pricing page that lab work for its testosterone lines costs extra
- Publishes a street address and a phone number rather than a contact form only
Trade-offs
- Leads with per-month badges that are multi-month totals divided down, on both peptide pages and the pricing page
- Its own two pages disagree on the NAD+ injection's one-month figure
- Includes no lab work with either peptide line
- Its telemedicine statement qualifies the advertised fifty-state claim with the state a provider is licensed in
- States no dose or concentration on any peptide line
- Publishes no corporate entity name behind the brand
41. Premier Hormone Health & Wellness
$199/mo — printed as "From $199 / month" on the peptides page's sermorelin card for women, a floor rather than a quoted rate; the card does not say what the monthly figure includes, and the card for men beside it starts at $233
Summary, strengths and trade-offs8 points
Premier draws the line between the platform company and the medical practice more explicitly than anything else on this roster. Its peptides are priced on catalog cards, and its sermorelin page prints no figure.
Strengths
- States that the company is a non-clinical platform and that the practices it supports are independently owned
- Prints a figure and its period on every card of its peptide and general wellness catalogs
- Prices sermorelin and tesamorelin separately for men and for women, each as a monthly starting figure
- Says its compounding pharmacies are US-based and describes the standards claimed
Trade-offs
- Its peptide figures are starting prices on catalog cards, and no card says what its figure includes
- The sermorelin page itself prints no figure and says only that the initial assessment will outline all costs
- Names no dispensing pharmacy
- Its state coverage is a one-line footer claim of serving all states, with no list behind it
42. OrderlyMeds
$200/mo — per month; a $400 lane exists but is gated to existing GLP-1 customers
Summary, strengths and trade-offs8 points
OrderlyMeds carries a June 2026 federal warning letter, names five dispensing pharmacies — one of which carries two federal letters of its own — and gives a different pharmacy roster on two of its pages.
Strengths
- Names five dispensing pharmacies rather than describing a class
- Publishes both the starter rate and the standing rate for each weight-loss molecule
- Says plainly that it does not require blood work before prescribing
- Prices the branded pens alongside the compounded products on one page
Trade-offs
- Carries a June 2026 federal warning letter naming its own website
- One of the pharmacies it names carries two federal letters of its own for adulterated drug products
- Its home page names three pharmacies and its FAQ names five
- Its treatment pages show branded-pen prices under bare molecule labels
43. Habitat Health
$249/mo — per month, month-to-month — "Habitat Health is offered on a month-to-month basis. We do not require you to sign up for any specific length of time."
Summary, strengths and trade-offs8 points
Habitat Health sells sermorelin as a flat monthly membership in three states only, and it is one of the few sellers on this roster that both names the states it serves and says the lab work sits inside the price.
Strengths
- Names the three states it serves on its own locations page rather than leaving coverage to be discovered at checkout
- Says the lab work sits inside the monthly figure, which most sellers here either exclude or never mention
- Requires a two-way video visit rather than an intake form a provider reads later
- States outright that it asks for no minimum term and bills month to month
Trade-offs
- Serves three states, so most of the country cannot buy from it at all
- Prints "$249 per Month Thereafter" without ever publishing a different first-month figure
- Its footer credits a patient-management platform rather than leading with the operating company
- Sells one tracked compound, so there is nothing here for a reader assembling a wider protocol
44. Avono Health
$259/mo — the month-to-month rate, published twice on one page: as "Sermorelin Injection | In stock | Starting at $259.00 per month" in the Wellness tab, and again inside "Strength & Vitality Program (3 Month Bundle) $597.00 … Save $180 (compared to $259/mo with month-to-month pricing)". The oral-dissolving form carries the identical rate, so no separate row is recorded for it
Summary, strengths and trade-offs10 points
Avono answers the two questions this roster asks most often and almost never gets answered: it names four dispensing pharmacies with their phone numbers and web addresses, and it names the medical group and two prescribers behind the platform by registry number.
Strengths
- Names four dispensing pharmacies outright, each with a phone number and a web address, in an answer on its own homepage
- Names the medical group and two individual prescribers by national provider identifier
- Publishes the same two monthly rates in two independent places on one page, so neither has to be taken on its own
- Prices three delivery forms of one compound at one rate instead of quoting a range
- Answers the state question and then says, in the same answer, that specific services may still vary
Trade-offs
- The peptide prices render only after a tab is clicked, so the page as delivered shows a GLP-1 catalog and no peptides at all
- The fifty-state answer qualifies itself in its own second sentence without naming which services vary
- A footer disclosure warns that a reader may be redirected to a third-party platform whose terms govern instead of this one
- No lab work is included in or priced beside either program
- The bundle blocks quote a three-month total beside a monthly rate, which invites a division the seller has already done
45. MultiGen Wellness
$62.70 — Per vial, not per month — read from the formulary row "Sermorelin Acetate Sterile Injection Solution 1mg/ml 6mL Vial ❄ Refrigerate $62.70"; the 1.5 mg/mL 6 mL vial is $80.85 and the oral forms are priced per 30-count pack ($90.75 troches, $107.25 rapid-dissolve tablets). $25 flat-rate overnight shipping is charged separately and stated on the same page
Summary, strengths and trade-offs8 points
MultiGen publishes a per-SKU formulary with the strength, the package size and the storage temperature on every line — and closes it by disclosing its own markup over compounding cost, which nothing else here does.
Strengths
- Publishes a full formulary with strength, package size, storage temperature and price on every row
- Discloses its own markup over compounding cost in plain words, which nothing else on this roster does
- Prices shipping separately and visibly instead of folding it into the medication figure
- Answers the regulatory-status question per compound rather than with one blanket sentence
Trade-offs
- Mixes per-vial and per-month units in the same summary list, so the cards and the table are not comparable to each other
- Publishes no corporate entity at all — a trading name and a Texas address is the whole disclosure
- Names no dispensing pharmacy, describing it only as "our FDA-compliant compounding pharmacy"
- Markets a peptide it does not stock: BPC-157 appears in its prose and its FAQ but not in its formulary
46. RxPepsDirect
$80 — pharmacy price for one vial at wholesale, billed by Optimal Balance Pharmacy, plus a separate $39 medical visit per order and $15 flat shipping; the catalog states no supply length
Summary, strengths and trade-offs9 points
RxPepsDirect charges one $39 fee per order for the medical visit and then steps out of the transaction: Optimal Balance Pharmacy bills the patient directly at its own wholesale price, and that price is printed for every peptide on the site.
Strengths
- Names both the dispensing pharmacy (Optimal Balance Pharmacy, a Texas 503A) and the outside laboratory that tests each batch (Eagle Analytical Services), and publishes the batch reports
- Lists all 29 licensed states by name in its FAQ rather than only printing the count
- Separates its own fee from the medication entirely: $39 per order for the visit, with the pharmacy billing the drug at wholesale and adding $15 flat shipping
- Every peptide price is readable without an account, combination vials included
Trade-offs
- The figure is a per-vial pharmacy price, not a monthly one — the BPC-157 page itself says one vial lasts about five weeks
- KPV is not sold on its own; it is only available inside BPC-157 combination vials
- Semax is sold only as a Semax/Selank nasal spray, so its figure is a combination price
- Caps an order at three different peptides, so a wider protocol needs a second $39 visit
- Its FAQ says the company was founded in 2026, so there is very little independent history behind the pharmacy-at-cost claim
47. Polly
$179 — printed as a bare '$179' badge on the home-page product card, with no billing period stated; the seller publishes no sermorelin product page, so this card is the only place the figure appears
Summary, strengths and trade-offs10 points
Polly names two of its compounding pharmacies and gives NAD+ two priced product pages of its own, but attaches no billing period to any figure — its terms say the interval is disclosed inside checkout, behind an email gate.
Strengths
- Names two of its compounding pharmacies in a public FAQ answer rather than describing them generically
- Gives each NAD+ format its own product page with the figure printed on it
- Answers its own state-coverage question directly on the home page
- Says on each product page what the plan includes, item by item
- Publishes the operating entity behind the brand and a page explaining its rename
Trade-offs
- Attaches no billing period to any published figure, so none of its prices can be compared as a monthly rate
- Its terms disclose the billing interval only inside a checkout behind an email gate
- Publishes no sermorelin product page; that figure appears only on a home-page card
- Names its pharmacies as examples rather than as a complete list, and names none for a given order
- Includes no lab work and states no dose on any line
48. Pepti
$249 — vial price, an average four-week supply; the pen format is $299
Summary, strengths and trade-offs8 points
Pepti prints one all-in monthly figure for every treatment it sells, in two formats side by side, and it is the only roster row that publishes both a fifty-state footprint and a price for epitalon.
Strengths
- Prints an all-in monthly figure on every treatment card and states that no membership fee sits on top of it
- Names the unit each figure covers, so a four-week supply is never left to be guessed at
- Quotes a pen and a vial price side by side, which makes the format premium visible instead of buried in checkout
- States its own coverage as all 50 states and Washington, D.C. in its site footer
Trade-offs
- Bloodwork is a separate charge rather than part of the monthly figure, though recent labs can be uploaded instead
- The 503A/503B compounding pharmacy it uses is described but never named
- The PT-141 card gives no supply length, so its figure is the only one on the catalog that cannot be read as four weeks
- CJC-1295, ipamorelin and TB-500 are sold only inside combination vials
49. Big Easy Weightloss
$267 — starting at, for an eight-week plan; a combined sermorelin-and-NAD+ card carries the same figure for both
Summary, strengths and trade-offs8 points
Big Easy Weightloss names eleven pharmacies and publishes each one's shipping exclusions, then claims to serve all fifty states on the same site where it says its physicians are still applying for the rest.
Strengths
- Names eleven pharmacies and publishes six of their state-by-state shipping exclusions
- Warns in its own words that compounded drugs may vary in strength, quality and purity
- Refunds or credits the consultation fee if the reader is not a good fit
- Offers monthly installments on every eight to twelve-week package
Trade-offs
- Four of the pharmacies it names carry their own federal letters for adulterated or unapproved drug products
- Claims all fifty states on a site that elsewhere says its physicians are still applying for the rest
- Its pricing page and its product pages print different figures for the same package
- Its prices change with the pharmacy the reader picks, so the published figure is only a default
50. PeRx
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
PeRx, the trading name of Wellness MD Group PC, lists twenty-six compounds and blurs the price on every one of them, publishing a floor and a range on a separate pricing page instead.
Strengths
- Tied for the widest compound list on this roster, with each blend spelled out into its constituent peptides on its own page
- Publishes a floor and a range in ordinary body copy, so a reader can bound the cost without an account
- Names its operating company and its trading name in the first paragraph of its own terms
- Says in its terms that it ships to every state, and repeats the claim as a headline figure
Trade-offs
- Blurs the per-compound price on every product page and marks it hidden from screen readers, so no individual compound has a readable figure
- Its own pricing page contradicts itself on the consultation fee, listing "no separate consultation fee" among what every order includes and then answering twice that consultations are $50
- Says all sales are final once an approved prescription is charged
- Names no dispensing pharmacy, only the category
51. Contour Health
$90/mo — printed as 'From $90 / month' with 'At the starting dose.' beneath it, so the figure is a floor rather than a flat rate
Summary, strengths and trade-offs8 points
Contour Health says outright which of its prices is flat and which is a starting dose, and its NAD+ line is the one it calls one price at every dose.
Strengths
- States in its own words which figures are flat and which climb with dose
- Publishes a monthly unit against both peptide figures
- Sells medication by the vial with no subscription on its weight-loss line, and says so
- Publishes a hard error for a path that does not exist, with no body at all
Trade-offs
- Its brand name and its legal company name share no words, so the operator is hard to look up
- The sermorelin figure is a floor, and no page says what a higher dose costs
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
52. Alternate Health Club
$99/mo — per month, printed as '$99.00 / month' on the product page, which titles the line 'Sermorelin (GHRH peptide)'
Summary, strengths and trade-offs10 points
Alternate Health Club prices glutathione, NAD+ and sermorelin on three separate product pages of its own, each printing one figure with the month attached and no second, struck-through number beside it.
Strengths
- Gives each of its three tracked compounds its own product page with the figure and the period in the same line
- Prints one price per page with no struck-through second figure to read the wrong way round
- Says its medication pricing is flat at every dose rather than climbing as a dose is titrated up
- Answers its own question about state coverage instead of leaving the page silent
- Names its operating company and its state of registration in its terms
Trade-offs
- Names no dispensing pharmacy, describing it four different generic ways across four documents
- Publishes no state list and never prints the number of states it serves
- Its coverage answer sits inside a collapsed accordion rather than on the page
- Includes no lab work; its own terms treat laboratory tests as an extra cost
- States no dose or concentration on any of the three product pages
53. MadeMed
$99/mo — 6-month plan, billed $594 every 6 months; the quarterly tab on the same page prints $109/month billed $327 every 3 months
Summary, strengths and trade-offs8 points
MadeMed publishes a plan rate for four peptide products, names the pharmacy behind its nasal line, and states its coverage as a count of states with the excluded ones listed by name.
Strengths
- Prints a per-month plan rate and the full prepayment beside it on the same tile, so the billing cycle is not hidden
- Names the pharmacy behind its nasal line rather than saying only that a US pharmacy is used
- Answers its state question with a count and then lists the states it does not serve
- Publishes both an injectable and a sublingual route for the same compound at separately stated rates
Trade-offs
- The nasal spray page prints one figure in its hero and a different one on the plan tile
- The state list differs by product, so there is no single coverage answer for the company
- Requires a blood test the buyer arranges and pays for at an outside lab
- Publishes no corporate entity, so there is no registered company a reader can look up
54. Belle Health
$119/mo — from, per month; the pricing page publishes this figure only on a 3-month supply and lists no 1-month option
Summary, strengths and trade-offs9 points
Belle Health names the four compounding pharmacies it works with, prices sermorelin, NAD+ and glutathione as flat monthly rates on both a product page and a pricing page, and carries a February 2026 FDA warning letter about telehealth marketing claims.
Strengths
- Names four dispensing pharmacies outright instead of describing an unnamed licensed one
- Publishes every longevity figure twice — on the product page and again in a pricing table — and the two agree
- States that the price does not rise when the dose does, and that there is no consultation or setup fee
- Prices three tracked compounds, which most sellers publishing any peptide figure do not
Trade-offs
- Carries a February 2026 FDA warning letter over telehealth marketing claims
- Its FAQ pharmacy list and its pricing-page pharmacy tags do not name the same set
- Publishes no state list, so eligibility is settled inside the intake
- Its two GHK-Cu products carry prices but a "Coming Soon" control, so neither can be bought
- Lab work is described as ordered only when clinically necessary, never as included in the price
55. Try Ageless
$126/mo — hero reads "Sermorelin Injection / $126 $176 / 1 Month Supply"; $126 is the current figure and $176 the struck-through one, confirmed by the sticky CTA which prints "$126" alone. The page adds "*Exact pricing depends on your prescribed dose. Final amount is shown after clinical review." and an intro code "SERM50 / $50 off"
Summary, strengths and trade-offs8 points
Try Ageless runs a WooCommerce storefront where six preparations of the two compounds compared here each carry a figure, a strength and a supply period on their own product page, and it names a dispensing pharmacy in its terms rather than describing one.
Strengths
- Prices six separate preparations of two compounds, each on its own product page
- States the strength and the supply period beside every figure
- Names a dispensing pharmacy in its terms and again in its site footer
- Names its operating company and its street address in the same document
Trade-offs
- Prints the current figure before the struck-through one, the reverse of the order used elsewhere on the same page
- Attaches a dose caveat to every figure, so the published number is a starting point rather than a charge
- Makes no statement about which states it serves beyond a conditional in its terms
- Prices the nasal spray per bottle while pricing everything else per month, so the six figures are not directly comparable
56. PlexusDx
$129/mo — per month on the seller's "Best value 6-month" tier — the figure its own page headline advertises as "from $129/mo"
Summary, strengths and trade-offs8 points
PlexusDx sells five of the six compounds this site ranks — sermorelin, NAD+, glutathione, GHK-Cu and PT-141 — each as an all-inclusive monthly program, and it is one of only seven sellers here that reaches the PT-141 board at all.
Strengths
- Reaches five of the six compounds this site ranks, one of seven sellers here to reach five or more
- States on every program page that the monthly price does not change as the dose changes
- Names the three commitment tiers and their per-month rates side by side instead of advertising only the cheapest
- Offers GHK-Cu as a topical cream and glutathione as a nasal spray or troche, so two of the five need no injection
Trade-offs
- Publishes its own corporate name two different ways — "PlexusDx, Inc." in one terms document and "PlexusDX LLC" in the other
- The glutathione page states both a 46-state and an all-50-state footprint without resolving which applies
- No compounding pharmacy is named on any of the five product pages
- Five states are said to require a scheduled video visit rather than the async intake, but the page never lists which five
57. AgelessRx
$149/mo — per month after the first; the first month is $99 on a three-month plan billed in full
Summary, strengths and trade-offs9 points
AgelessRx publishes a short, deliberately curated peptide menu and names four compounds it has decided not to sell yet — but every headline figure on it is a first-month rate with a higher number behind it.
Strengths
- Names BPC-157, TB-500, MOTS-c and KPV on its own peptide page as compounds it has chosen not to sell yet, which is rare candor in this category
- Publishes the ongoing rate alongside the introductory one on three of its five peptide pages
- Sells PT-141 and sermorelin in both an injection and a nasal spray rather than a single format
- Says a plan can be paused or canceled at any time
Trade-offs
- Every headline figure on the site is a first-month rate, and the ongoing rate runs $50 to $70 higher
- The GHK-Cu cream page prints the same figure as both a first-month price and an ongoing one, so the two disagree on one page
- The glutathione page gives only the three-month-plan rate, leaving the plain monthly price unpublished
- The compounding pharmacy that fills prescriptions is not named, and no state list is published
- A competition ranking is quoted on the site as a credential; it is marketing, not an independent assessment of the products sold
58. Pomegranate Health
$149/mo — read as the product-page heading "Longevity | Sermorelin Injection | $149/month | Enhances sleep, recovery, vitality" — one figure, one period, no ladder and no plan term anywhere on the page
Summary, strengths and trade-offs9 points
Pomegranate gives each compound its own page with a single monthly figure in the heading, and its terms name the territory it serves rather than leaving availability to be discovered at intake — but the figure for its one non-longevity peptide carries no period at all.
Strengths
- Gives each compound its own product page with one figure in the heading instead of a range or a ladder
- Names the territory it serves in its terms, including two territories beyond the fifty states
- Answers the lab question in its own words rather than leaving it unaddressed
- Publishes the same product list in its navigation and its footer, so the range is visible from any page
Trade-offs
- The one product outside its longevity line carries no billing period at all, while its three siblings all print a monthly one
- No dispensing pharmacy is named — the site badge reads only "FDA-Regulated Pharmacies", which describes a category
- The lab answer says lab testing is often an important part of care, which is the opposite of saying it is included
- The fifty-state claim is immediately qualified by a sentence saying certain services and medications may not be available in certain jurisdictions
- The lab and treatment answers sit inside a collapsed accordion and are absent from the page until it is clicked open
59. Zera Health
$155/mo — Monthly plan, "$155/mo — 3mg/6mg vial — billed monthly"; the same block prints a quarterly column at "$130/mo — billed every 3 months", which is the seller’s own division of a quarterly total, and the hero prints a struck first-month offer, "From $125 $225 /first mo."
Summary, strengths and trade-offs8 points
Zera Health names Strive Pharmacy as its compounder in the footer of every treatment page, publishes a monthly and a quarterly plan side by side for three compounds compared here, and puts a fifty-state marquee above a FAQ that says something narrower.
Strengths
- Names Strive Pharmacy as the 503A compounder in the footer of every treatment page, with its web address
- Prints the monthly and the quarterly plan side by side with the billing cycle written into each, so the arithmetic is visible
- States the strength and the delivery form beside each figure rather than leaving the dose to an intake
- Says plainly on every plan block that there are no hidden fees and that shipping is included
Trade-offs
- A sitewide marquee reads fifty states while its own FAQ says the company operates in most of them
- Publishes no list of the states it actually serves
- One sitemap treatment path answers 200 and renders the homepage instead of the treatment
- Advertises third-party lab testing of the product in the same list as plan inclusions, where it reads like included lab work
60. FormBlends
$158/mo — "1-month plan / Pay monthly \u00b7 Ships monthly / $158 /month / $158 due today". The longer plans quote "$143 /month" against totals of "$429 due today" (3 months), "$859" (6 months) and "$1717" (12 months) \u2014 $143 is the seller\u2019s own division, not a charge
Summary, strengths and trade-offs8 points
FormBlends names its three dispensing pharmacies with their cities and designations, prices seven of the compounds compared here on one-month plans, and publishes a state-by-state map it dates and sources to its own last hundred and sixty-five shipped orders.
Strengths
- Names three dispensing pharmacies with their cities, legal names and designations
- Publishes a dated state map and says the count comes from its own shipped orders rather than a marketing claim
- Prints a one-month plan whose per-month figure is also what is charged that month
- Says plainly that shipping is included and lab work is not
Trade-offs
- Quotes per-month figures on its longer plans that are divisions of the amount actually billed
- Buries seven product pages inside a sitemap of more than a hundred thousand article URLs
- Sells one of the compounds compared here only inside a two-compound blend
- Redirects one product address to a different one, so a cited URL and a read URL can differ
61. Amble
$159/mo — the month-to-month rate, read under the seller's own two-word column header "Plan | Per Month" as "1 Month $159", beside "3 Month $149" and "6 Month $135" — the two lower figures are per-month rates that require a 3- or 6-month plan, not plan totals, because the column they sit in says so; nothing here was divided. The separate Sermorelin ODT page publishes the identical three-rung ladder for the oral-dissolving form, so no second row is recorded for it
Summary, strengths and trade-offs10 points
Amble puts a plan ladder under a column it labels "Per Month", so every rung on it is already a monthly rate and nothing has to be divided — and then contradicts its own cheapest rung with a sitewide banner offer that no product page repeats.
Strengths
- Labels its price column "Per Month", so every rung of the plan ladder is already a monthly rate and a reader never has to divide anything
- Publishes the full ladder for all three priced compounds on the product pages themselves rather than behind an intake
- Names the five states where a live video or audio visit is required instead of leaving that to be discovered at checkout
- Answers the state-availability question about the company separately from the question about its prescribers, which most sellers on this roster conflate
Trade-offs
- A sitewide banner advertises a NAD+ figure that no product page repeats and that carries no billing period, so the seller shows two different NAD+ numbers at once
- No dispensing pharmacy is named — the FAQ answers only that 503A and 503B facilities are regulated, which describes a category and not a supplier
- The fifty-state claim carries the seller's own parenthetical "exclusions apply" and no exclusion is named anywhere on the site
- Twenty-two peptide URLs read as a catalog and are signed editorial articles with no price and no cart, which is easy to mistake for a product range
- Names a fourth compound as an available treatment in its FAQ and publishes no page or price for it
- No lab work is named as part of any plan, and the "what you get" list stops at supplies, shipping and monitoring
62. Gimme Care
$179/mo — per month when three months are bought at once
Summary, strengths and trade-offs8 points
Gimme Care puts a labeled "Billing cycle" control beside every product and shows the one-month and three-month rate together, which is rarer here than it should be.
Strengths
- Labels the billing cycle explicitly instead of leaving a reader to infer it
- Shows the one-month and three-month rate for the same product side by side
- Names Start Gimme LLC as the operating company
- States in its own words that it is "available in all 50 states"
Trade-offs
- Its cheapest figures require buying three months at once
- Publishes no named dispensing pharmacy
- No certificate of analysis is reachable
- Its blog quotes market-wide NAD+ cost ranges that are not its own prices
63. Mondae
$179/mo — the only figure on the page carrying a stated unit; two further figures, 600 and 537, are printed beside it under a plan-length selector whose default state the served page does not reveal. The identical triple appears on its NAD+ and glutathione pages too
Summary, strengths and trade-offs8 points
Mondae names the pharmacy that fills each order and states that shipping states differ by pharmacy — then prints the same three figures on all three of its peptide pages.
Strengths
- Names the dispensing pharmacy on the product page and warns that coverage varies by pharmacy
- States a per-month unit rather than leaving the period to be inferred
- Says in its own words that it charges no membership fee and the same price at every dose
- Names both its own company and the telehealth platform behind it
Trade-offs
- Three different molecules carry an identical set of figures, which no page explains
- Two of the three figures on each page carry no unit at all
- The plan-length selector's default is not visible in the page as served
- Publishes no state list of its own and describes no lab work as included
64. NEUVÉ
$184/mo — "starting at" per month, and the seller's own pricing answer says "Medication, labs, and treatment supplies are billed separately" — so the drug is not in this figure
Summary, strengths and trade-offs8 points
NEUVÉ publishes a starting monthly figure on six peptide protocols, then answers its own pricing question by saying medication, labs and supplies are billed separately — so the figure beside each protocol is not what the therapy costs.
Strengths
- Names the laboratories it draws through, Quest and LabCorp, which most sellers here leave unstated
- Answers its own question about what the monthly price covers instead of leaving the exclusions unwritten
- Publishes a starting figure for six separate peptide protocols rather than one blended program rate
- States the governing law and the county where a dispute would be heard
Trade-offs
- The figure beside each protocol excludes the medication, which is the largest part of what the therapy costs
- Every one of its six figures is a "starting at" floor with no plan term and no ceiling published
- Two of the six protocols price a two-peptide stack, so neither peptide in either pair has a price of its own
- No compounding pharmacy is named, only the category of facility that compounds the medication
65. SuperHealthy Rx
$195/mo — starting at, for a one-month supply
Summary, strengths and trade-offs8 points
SuperHealthy Rx publishes seven per-compound prices and renders two of them without a currency symbol at all — the GLP-1 cards read as bare numbers.
Strengths
- Prices seven separate products, including a microdosing lane for each weight-loss molecule
- Says in its own words that every dose costs the same and explains why
- Prices the injectable and nasal NAD+ forms separately
- Publishes medical-board complaint notices for three states
Trade-offs
- Two of its prices render with no currency symbol at all
- Its two microdosing products are priced but carry a coming-soon button rather than an order button
- Names no pharmacy and directs readers to contact it to find out which one will fill
- Publishes no availability list; the four states it names are about physician assignment
66. Coivas
$199/mo — per month, billed $597 every three months; a new-patient intro runs $119 a month, billed $357 for the first three
Summary, strengths and trade-offs8 points
Coivas prints its own price-verification month on the page, publishes a comparison table whose first column is its own, and gives itself three different legal names across three pages.
Strengths
- Prints its own price-verification month directly on the treatment page
- Publishes both the intro and the standing rate for every product
- Names its clinical group and its address
- Its quarterly arithmetic reconciles exactly against every billed total it prints
Trade-offs
- Gives itself three different legal names across three of its own pages
- Its tirzepatide price renders only inside a comparison table, not as its own figure
- Its fifty-state claim is contradicted by its own terms
- Names no dispensing pharmacy and says the dispenser may vary
67. Concierge MD
$199/mo — starting at, per month on a monthly subscription; the same page also lists a 3-Month Supply at $899.00 in total, which is a total for three months rather than a monthly rate
Summary, strengths and trade-offs8 points
Concierge MD prices NAD+ and sermorelin on the pages that sell them, publishes a table of about two dozen per-state professional corporations in place of one operating company, and runs Drip Hydration under the same structure.
Strengths
- Names the strength of the vial a subscription buys, and offers a second strength as a separate selection, on the page itself
- Publishes a table of the medical entities that provide services in each region, rather than describing them as unnamed third parties
- Names California as the governing law in its own terms
- Prices a subscription lane and a single-month lane separately on both compound pages, so the cost of not committing is visible
Trade-offs
- No single operating company is named for the brand; the footer carries only a trading name and the entity table is a list of about two dozen professional corporations
- Its NAD+ page attaches a sermorelin figure to a monthly subscription that the sermorelin page itself prices differently
- Its coverage claim and its entity table do not reconcile into a list of states a reader can check
- Four more compounds are sold here than are compared on this site, because their pages could not be read on the day this row was written
68. Joi + Blokes
$199/mo — per month, no plan term stated
Summary, strengths and trade-offs8 points
Joi + Blokes names all seven pharmacies that may fill an order, with street addresses, and prices sermorelin and NAD+ as plain monthly figures with no plan term attached.
Strengths
- Names every pharmacy that may fill an order — seven of them — with a street address for each, in its own terms of service
- Quotes sermorelin and NAD+ as flat monthly figures with no prepayment tier to decode
- Warns New York and New Jersey shoppers up front that their pricing differs, rather than surfacing it at checkout
- Sells biomarker panels separately, so lab work is a stated purchase rather than a hidden condition
Trade-offs
- The storefront names no operating company, only the brand, so there is no registered entity a buyer can look up
- Only two of the compounds compared on this site are sold; the peptide menu is narrow
- A GHK-Cu skin cream appears in the navigation without a price on the shop pages
- Lab panels are billed on top of the monthly figure rather than included in it
69. LaSara Medical Group
$199/mo — the subscription tier, printed as "Subscribe & Save 20% — $249 $199 — $6.63 per day" beside a "One-Time Purchase — $249 — $8.30 per day". Both divisions resolve to thirty days ($199 ÷ $6.63 = 30.0; $249 ÷ $8.30 = 30.0), and the shop label reads "$199 - Monthly Subscription", so the month is consistent here. A NASAL SPRAY, not an injection
Summary, strengths and trade-offs8 points
LaSara sells both its peptides as nasal sprays, prints a per-day figure beside each price, and one of those divisions only works if the supply is sixty days rather than the month its shop label claims.
Strengths
- Prints a per-day division beside every figure, which is what made the sixty-day discrepancy visible at all
- Names the route in the product URL and the product title, so a nasal spray is never mistaken for an injection
- Publishes the subscription tier and the one-time price side by side with the discount stated as a percentage
- Publishes a street address and a phone number in the footer of every page
Trade-offs
- The coenzyme's own per-day figure implies a sixty-day supply while its shop label calls it a monthly subscription
- The only corporate name on its terms belongs to its website platform vendor
- Its weight-loss pages carry a figure that does not match the one on its about page, so cross-page consistency is not a habit here
- No pharmacy named, no certificate of analysis, no state coverage list
70. PharmaZee
$199/mo — recurring monthly on the 1-Month Supply tab; the same panel prints a first month of $140.00
Summary, strengths and trade-offs8 points
PharmaZee prices five tracked peptides with a first-month figure and a recurring figure printed side by side, names its two filling pharmacies, and carries a 2026 federal warning letter.
Strengths
- Prints the first-month figure and the recurring figure together, so the introductory rate is not disguised
- Prices five products covering four tracked compounds, including two routes of the same one
- Names both filling pharmacies with street addresses in its FAQ
- States the concentration and bottle size on the products where those differ
Trade-offs
- Carries a federal warning letter that names this exact domain
- Hides the pharmacy names and the coverage answer inside collapsed accordions
- Publishes no state list and answers the coverage question with named prescribers instead
- Serves no sitemap, so the product list can only be found through the navigation
71. HealthiCare
$199.99/mo — per month — the treatment page prints the figure with no period; the seller's own article states "Sermorelin Troches... $199.99/month"
Summary, strengths and trade-offs8 points
HealthiCare, run by Sunshine Health Studios Inc., prices sermorelin and NAD+ in two routes each, and names its dispensing pharmacy and the states it cannot ship sterile preparations to — in an article, not on the treatment page.
Strengths
- Names the dispensing pharmacy and the telehealth group that employs the prescribers
- Names ten states where it says sterile preparations cannot be dispensed, which is more than most sellers disclose about where they cannot ship
- Prices two routes for each compound, so the injection and the non-injection option can be compared directly
- Says the price does not change with dose and charges no membership fee
Trade-offs
- The treatment page attaches no billing period to any figure; the period appears only in a marketing article elsewhere on the site
- Its state claims do not reconcile — all fifty for consultations, forty-four licensed for dispensing, and ten states excluded, which leaves forty
- Its terms of service name two website addresses, neither of which is the site a reader is buying from, and hand off to a third company's platform terms
- No lab work is described as included
72. Zappy Health
$239/mo — monthly subscription: "$239/month", "Monthly Subscription", "All doses", "Billed monthly", with monthly virtual visits included. The product page labels the figure "Limited-time offer!", and the longevity page lists the same product as "AS LOW AS" and "from $239 / month"
Summary, strengths and trade-offs10 points
Zappy is one of the few sellers on this roster that answers the pharmacy question with a name and a web address rather than a category, and it sells its longevity compounds both in multi-compound bundles and one at a time, each with a monthly figure of its own.
Strengths
- Answers the pharmacy question with a named company and its web address on a dedicated page, instead of describing a regulatory category
- Links that page from the footer of every page on the site rather than burying it in the terms
- States plainly that it is not a compounding pharmacy and does not manufacture anything it sells
- Marks stock status beside each product, so an unavailable item is not priced as though it were on the shelf
Trade-offs
- Carries an FDA warning letter that names this company and this exact domain, over claims made about its compounded weight-loss line
- Leads its longevity range with multi-compound bundles, whose figures are not the price of any one compound in them
- The longevity page labels every single-compound figure "AS LOW AS" and "from" without printing a ceiling, and two product pages call their figure a "Limited-time offer!" without saying when it ends
- The terms name no state and make no coverage claim at all
- Two safety pages render under a page title naming an entirely different compound, so the title cannot be used to identify what a page is about
- No lab work is included in or priced beside any plan
73. Eviora MD
$249/mo — the "Sermorelin" card prints "from $249/mo" — a starting floor; the card states no dose or delivery form
Summary, strengths and trade-offs12 points
Eviora MD prints a monthly starting figure on every card of an open twenty-card peptide menu, sells eight tracked peptides on their own, and publishes no price for its GLP-1 programs.
Strengths
- Prints a monthly starting figure on every card of a twenty-card peptide page, with no quiz, account or email gate in front of it
- Sells eight tracked peptides as single products, so those figures can be set against other sellers
- Bills each subscription as one total, which its terms split between the pharmacy, the medical group and the platform
- States fifty-state service in its FAQ and on its About page
- Lists the five cases in which it refunds, one of them a provider declining to prescribe
Trade-offs
- Every figure is a floor written as "from", and only the NAD+ card names a form; no card states a dose
- CJC-1295, ipamorelin, TB-500, KPV and Semax appear only inside stacks, so none has a price of its own
- Several stack cards reuse a single peptide’s description — the four-peptide BPC-157 stack is described only as a copper peptide
- Its semaglutide, tirzepatide and microdose programs publish no price on their own pages
- Its homepage, program pages and terms give three different cancellation terms
- The pharmacy, the medical group and the prescriber all go unnamed
- Its peptide page follows the same template, card list and most of the same figures as other storefronts on this site, so it is not an independent reading of the market
74. New Wave Health
$249/mo — from, per month
Summary, strengths and trade-offs14 points
New Wave Health prints a monthly starting figure beside every product on a twenty-item peptide menu, and sells compounded semaglutide and tirzepatide with no price on either.
Strengths
- Puts a monthly starting figure beside every product on its peptide menu, with nothing advertised without one
- Names its operating company in its terms and prints a street address, a phone number and a support email for it
- Its terms promise an electronic notice 5 to 7 days before every recurring charge, and let a subscriber switch off auto-refill in the portal
- Lists the grounds on which it refunds, including a provider who declines to prescribe
- States under the menu that compounded medications are not FDA-approved
- Checked against FDA's warning-letter record in September 2026: no letter found under its name
Trade-offs
- Every figure is a floor written as "from", and nothing says what moves a program above it
- TB-500, KPV, CJC-1295, ipamorelin and semax are sold only inside combination products, so none has a price of its own
- Seven of its nine combination products carry the description of their first ingredient alone
- Its menu lists the same twenty products at the same figures as another storefront in this comparison that trades under a different company name
- Sells compounded semaglutide and tirzepatide with no price on either drug page
- Names no pharmacy and no prescriber, and its terms call the company a technology platform that does not practice medicine
- Its homepage says all 50 states while its program pages say Virginia and the states where its providers are licensed, without naming them
- Its FAQ says it never sells or shares data; its California privacy notice says it may have sold or shared identifiers and browsing data with advertising networks
75. RX Bella
$249/mo — printed as "Sermorelin · from $249/mo", a floor rather than a quoted rate
Summary, strengths and trade-offs9 points
RX Bella prints a monthly starting figure on every card of a twenty-protocol peptide menu and on its two GLP-1 injections. Nine of those protocols are stacks priced as one, and no card names a dose.
Strengths
- Prints a monthly floor on every one of twenty peptide protocols, grouped by goal, on an open page with no quiz or account in front of it
- Sells eight tracked peptides as single products, not only inside combinations, and prices semaglutide and tirzepatide on its home page
- Its terms say the subscription is one bundled charge covering the drug, the provider and the platform, with no separate membership fee
- Names its operating company, RX Web Meds LLC, with a mailing address, and lists the exact grounds on which it refunds
Trade-offs
- Every figure is a floor written as "from", and no card names a dose, a vial size or, apart from the NAD+ card, a delivery format
- Nine protocols are stacks priced as one, and some reuse a single peptide's description: the four-peptide BPC-157 blend is described as a copper peptide for skin and hair
- Its peptide menu repeats another telehealth brand's page, and every product the two share carries the identical figure, so the two are not independent prices
- Names no compounding pharmacy and no clinician, and its all-50-states claim is hedged by its program pages and terms, which publish no list
- Its program pages and its terms give different cancellation notice periods
76. Rylo
$249/mo — month-to-month plan: "$249 a month", "One price, every month. No contract, cancel any month." The same page's quarterly plan, selected by default, reads "$183 a month" and "Billed $549 every 3 months"
Summary, strengths and trade-offs8 points
Rylo Health LLC names its dispensing pharmacy and its clinical group by name, prices six compounds at a flat rate that does not move with dose, and sells each on a quarterly plan or month to month, with the quarterly rate the lower of the two.
Strengths
- Names the dispensing pharmacy with its street address and phone number, and names the clinical group that writes the prescriptions
- Prints the three-month total beside every quarterly rate, and offers a month-to-month plan with no contract on the same page
- Says the price does not change with dose or refill, and charges no membership fee on top
- States that no lab work is required before starting, rather than leaving a lab fee to appear later
Trade-offs
- The lower rate needs a plan billed every three months; buying month to month costs more on every product
- The home page table shows only the quarterly rate, so the month-to-month price appears only on each product page
- Says formulations and fulfillment vary by state without saying which ones, so the fifty-state claim is qualified in a way a reader cannot check
- No lab work is included, which is the flip side of not requiring any
77. AHBARx
$299/mo — per vial, delivered monthly — the page states "Delivered monthly"
Summary, strengths and trade-offs8 points
AHBARx sells sermorelin by the vial with a monthly delivery, and sells its NAD+ and glutathione only as six-month prepaid supplies.
Strengths
- States the delivery cadence beside every figure, not just the amount
- Says in its own words that services are available "within all 50 states of the United States"
- Publishes the vial strength — 9mg — beside the sermorelin price
- Says its medications are sourced through "U.S.-based, FDA-registered compounding pharmacies"
Trade-offs
- Publishes no operating company on any page read
- Two of its three tracked compounds are sold only as six-month prepaid supplies
- Charges every six months while shipping every three, so the money runs ahead of the medicine
- Names no dispensing pharmacy and publishes no certificate of analysis
78. boostAGErx
$99 — starts at, per month, as a flat rate the seller says covers physician review, clinician visits, the medication and shipping — and does not rise when the dose does
Summary, strengths and trade-offs8 points
boostAGErx names its compounding pharmacy and prices exactly one peptide — and that peptide has no product card, while the two cards its products page does show carry no price at all.
Strengths
- Names the compounding pharmacy — Manifest Pharmacy — in a process step, not buried in a disclaimer
- Names its operating company, its clinical entities and a street address in its own footer
- Commits in writing that the price does not rise when the prescriber raises the dose
- Says plainly what happens if a prescription is declined: the membership fee is refunded in full
Trade-offs
- Its only published price is for a compound its products page does not list, and the two products it does list carry no price
- Its products page answers HTTP 404 while serving the real document, so any status-based check reads the catalog as missing
- Publishes no service-state list and makes no coverage claim at all
- The price lives in an FAQ answer rather than on a product card, so a reader who does not open the FAQ never sees a figure
79. DadVantage Men’s Health
$100 — for a 6 mg vial; the page states no billing period
Summary, strengths and trade-offs8 points
DadVantage prices sermorelin at three vial strengths and NAD+ at two, and every figure it publishes is a quantity price rather than a monthly one.
Strengths
- Names the vial strength beside every figure, so a reader can compare cost per milligram
- Prices three sermorelin strengths instead of one headline number
- States plainly that telehealth visits work anywhere in Florida and in-home visits are local
- Puts its peptide and injection prices on one open page with no intake
Trade-offs
- No figure on the page carries a billing period of any kind
- Publishes no operating company on any page read
- Serves one state, so most readers here cannot use it
- Names no dispensing pharmacy and publishes no certificate of analysis
80. Body Good Studio
$109 — from, the bottom of a range across two vial sizes; the card names no billing period
Summary, strengths and trade-offs8 points
Body Good Studio carries a 2025 federal warning letter, prices five tracked compounds openly, and publishes a line on its own home page conceding that its brand names and final copy are still pending clinical and legal review.
Strengths
- Prices five tracked compounds on one open page with no intake in the way
- Prints the vial sizes behind each range rather than only the floor
- Charges one semaglutide price at every dose
- States in its own words that its compounded products are not FDA-approved
Trade-offs
- Carries a 2025 federal warning letter naming its own website
- Its own page says the brand names and final copy are pending clinical and legal review
- Its fifty-state claim is hedged in the following sentence and no list is published
- Three of its five figures name no billing period at all
81. Good Life Meds
$124 — the page names no supply period; the product carries a coming-soon badge and a $99 first-order promotion
Summary, strengths and trade-offs8 points
Good Life Meds names its pharmacies and prints four green "Passed" test badges on every product page, with no document behind any of them.
Strengths
- Names both dispensing pharmacies and its medical group
- Charges one semaglutide price at every dose level
- Prints the milligram content and the vial volume on its peptide pages
- Says plainly that its published prices exclude promotional offers
Trade-offs
- Prints four green test-passed badges with no certificate behind any of them
- Publishes no statement that its compounded products are not FDA-approved
- Its three peptide products carry coming-soon badges and no supply period
- Its fifty-state operation is a count with no list
82. MD Total Wellness
$125 — per 10mg vial; the page names no billing period
Summary, strengths and trade-offs8 points
MD Total Wellness prices its peptides and NAD+ by the vial with the vial size printed, on a price list of its own that its main service pages do not link to.
Strengths
- Prices its peptides and NAD+ by the vial with the vial size printed
- Includes in-office lab testing inside its published weight-loss price
- States plainly that its compounded weight-loss medicines are not FDA-approved
- Says where it dispenses from and where it can ship, in one sentence
Trade-offs
- Its per-vial price list is on a page its main service pages do not link to
- Serves one state, so most readers cannot buy from it
- Names no dispensing pharmacy and publishes no certificate of analysis
- Its terms name Florida law for a California clinic
83. HealthHub
$129 — "Troche - $129 / Dissolvable tablets designed to be placed under the tongue or inside the cheek. Includes an online consult, four-week supply, supplies and shipping."
Summary, strengths and trade-offs8 points
HealthHub answers the pharmacy question with six named facilities and their street addresses, and prices three of the compounds compared here in five preparations, every one of them on a four-week supply rather than a calendar month.
Strengths
- Names six compounding pharmacies with their street addresses on the product pages themselves
- Says exactly what each figure covers — consult, medication, supplies and shipping
- Prices three preparations of one compound separately rather than quoting one rate for all
- Answers the lab-work question plainly instead of leaving it to the intake
Trade-offs
- Renders a long price table of unrelated medications on every product page, none of it the product being read
- Quotes four-week supplies while most sellers quote months, so its figures need converting before they compare
- Publishes no statement at all about which states it serves
- Prices its on-demand compound from a floor rather than at a rate
84. Ivím Health
$129 — the medication figure only, from "$129 + $75/mo Membership"; this page states no billing period for the $129 at all, unlike the same seller's NAD+ page which labels its own $129 a one-month price. The membership is mandatory either way, so the monthly outlay is at least $204
Summary, strengths and trade-offs8 points
Ivím Health prints the membership charge in the same line as the medication price on both peptide pages, so the advertised figure and the actual monthly outlay are never confused — and it runs a banner announcing peptide therapies as coming soon above a page selling one.
Strengths
- Prints the mandatory membership charge inside the price line on both peptide pages instead of revealing it later
- Labels its two-month option as a single upfront charge and shows the per-month division beside it, so the prepayment is visible
- Names the operating company, a suite address and a support contact in its own terms
- States plainly that the sublingual product is not an injection, which is a form distinction most sellers leave to the reader
Trade-offs
- Its sermorelin page attaches no billing period to the medication figure, while the same seller labels the identical figure a one-month price on its other peptide page
- A site-wide banner announces peptide therapies as coming soon with a waitlist, above a page already selling a peptide
- The membership roughly doubles the monthly outlay on both products, so neither advertised figure is the cost of therapy
- No state coverage list, no named pharmacy and no certificate of analysis in any page read
85. NexLife
$130 — This price sits on a product the seller marks unavailable: the page prints "Nexlife | Sermorelin Injection | Regular price | $130.00 USD | Sold out", with "Sold out" printed twice — once as a status and once in place of the buy control. No billing period, no strength, no quantity and no plan term is stated anywhere on the page, so this is a one-off list price for an item that cannot currently be ordered, not a monthly rate
Summary, strengths and trade-offs11 points
NexLife lists two peptide products and neither one can be bought: one shows a real price above a sold-out button, the other shows a zero. The rest of the catalog is GLP-1, and the company carries an FDA letter that names this exact domain.
Strengths
- Publishes a list price on the peptide product page rather than hiding it behind an intake
- Marks stock status on the product itself, so an unavailable item is visibly unavailable
- States a fifty-state claim in plain words in the first answer of its FAQ
- Names its operating company in the disclosure on every page
Trade-offs
- Carries an FDA warning letter that names this company and this exact domain
- Both peptide products are marked sold out, so neither published figure can currently be acted on
- The second peptide product publishes a zero as its price, which is a storefront default and not an offer
- The sermorelin figure carries no strength, no quantity and no billing period, so it cannot be compared to a monthly program rate
- No dispensing pharmacy is named — the answer is that every pharmacy holds certifications, which describes a standard and not a supplier
- The FAQ answers that would name the pharmacies and the prescribers sit inside collapsed controls that did not open on repeated attempts
- No lab work is included in or priced beside any product
86. REMEVi
$145 — per four weeks, not per month — "$145 / 4 wks · All-inclusive · cancel anytime · no insurance billed", labeled by the seller as "Founder's pricing"; thirteen such periods fall in a year. The figure is stated to cover the clinical evaluation, the prescription from a state-licensed compounding pharmacy, injection supplies and shipping
Summary, strengths and trade-offs9 points
REMEVi charges one flat figure for a four-week subscription, the same figure for every compound and every delivery form it sells, and it says four weeks rather than a month — a distinction worth thirteen charges a year instead of twelve.
Strengths
- Names its billing unit as four weeks rather than calling it a month, which almost no seller on this roster does
- Charges one flat figure across both compounds and, for one of them, across all three delivery routes, so the route costs nothing extra
- States on both product pages that what it sells is a non-approved compounded preparation, not a generic of any approved drug, and has not been studied as a finished product
- Claims coverage as fifty states plus the District of Columbia and prints the count itself
- Runs its intake and its follow-up care in English and Spanish, stated on the page rather than buried in a settings menu
Trade-offs
- The figure is labeled founder's pricing, which is a seller telling you the rate is introductory without saying when it ends
- Four-week billing produces thirteen charges a year, and nothing on the page converts that into an annual figure for the reader
- The compounding pharmacy is described by licensing class and never named
- No certificate of analysis appears on any page read; the quality claim rests on a pharmacy certification badge instead
87. Feel30
$149 — a per-month figure on a YEARLY plan — the same page prints "Total $1,788.00", exactly twelve times it — shown against a struck-through $229.00 compare-at figure
Summary, strengths and trade-offs8 points
Feel30 says bloodwork, consultations, medication and shipping are all inside its protocol price — one of very few sellers here that does — and prices sermorelin against a struck-through figure on a plan billed for a year.
Strengths
- Says bloodwork, consultations, medication, shipping and ongoing care are all included in the protocol price
- Names F3 Health Inc as the operating company in its footer
- Says the price is the same at every dose
- Publishes an in-home bloodwork option at no extra cost
Trade-offs
- Its per-month sermorelin figure belongs to a plan billed for a full year
- Shows an "In Stock" badge and an "out of stock" buy control on the same product page
- Says it serves many states without naming any of them
- Names no dispensing pharmacy and no certificate of analysis is reachable
88. CLYR Health
$159 — one vial, "try it first · no auto-renew"; three vials are $299 and six are $499
Summary, strengths and trade-offs8 points
CLYR Health prices seven tracked compounds by weekly dose with the whole ladder visible before any intake, names its pharmacy, and puts a competitor's cream price in the same table as its own.
Strengths
- Prices seven tracked compounds with the full ladder visible before any intake
- Prints the vial size, concentration and weekly dose beside each figure
- Names its dispensing pharmacy and its medical group
- Its savings arithmetic reconciles against every multi-vial total it prints
Trade-offs
- Puts a competitor's cream price in the same table as its own
- Its tirzepatide hero quotes a cycle rate the ladder below contradicts
- Its LegitScript badge links to its own article rather than to a listing
- Says only that the service is available in certain states, without naming any
89. Lifeforce
$160 — per 25 days, not per month — the purchase option is labeled "25 Days" and the page says "Ships every 25 days"; the medication is sold only to members of a $149/month membership and requires a one-time $599 diagnostic before the first order, and neither of those is included in this figure
Summary, strengths and trade-offs9 points
Lifeforce sells peptides only to members, bills them every 25 days rather than monthly, and puts a paid membership and a one-off diagnostic in front of the first order — three separate figures that are never added together on the page.
Strengths
- Publishes a positive eligible-state list on each product page rather than a coverage sentence, and the two lists are different, which most sellers here never disclose
- Names the operating company, its address and California as the governing law, and separately names each clinical practice entity by state
- States the membership fee, the diagnostic fee and the medication charge as three distinct figures rather than one blended number
- Prints the shipping interval in days on the purchase option itself, so the period is not left to inference
Trade-offs
- Bills every 25 days, which is neither weekly nor monthly, so the figure cannot be set beside a monthly price without converting it
- The medication figure is not the cost of access: a $599 diagnostic and a $149 monthly membership come first, and the page never adds the three together
- Its eligible-state list for PT-141 is four states shorter than its list for sermorelin, so coverage has to be checked per compound
- The pharmaceutical catalog is labeled members only and its category pages show no price at all, so a shopper who stops at the catalog sees nothing
- No compounding pharmacy is named
90. Cosmetic Laser Professionals
$170 — Per vial, with the supply window the seller attaches to it — "Sermorelin- 9mg/6ml vial $170 (30-day supply dosed at 20 units or.20ml daily, 300mcg daily)". A 15 mg / 10 mL vial is $260. This is not a monthly rate: it is a vial the seller says lasts thirty days at one particular dose, and a different dose changes the window
Summary, strengths and trade-offs8 points
This seller names its compounding pharmacy and its accreditation, then prices one product three different ways on one page — per vial, per troche, and in injection packages that expire on a stated date.
Strengths
- Names its compounding pharmacy and that pharmacy's accreditation body
- Publishes beyond-use dates by storage class, which nothing else on this roster does
- Prints the dose the 30-day supply assumes, so the window can be checked against a different dose
- Names the operating company and its trading name in the same footer line
Trade-offs
- Uses three incompatible units for one product — per vial, per troche, and expiring injection packages
- The injection packages carry an expiry, so unused doses can lapse
- Publishes no state coverage
- Its compounding disclaimer sits at the bottom of a long page rather than beside the price
91. Heally
$175 — first month only, as the page labels it — "First month / $175 / 1st mo / Free provider consultation included"; no ongoing rate is published on that page
Summary, strengths and trade-offs9 points
Heally, Inc. runs a marketplace that puts a free consultation in front of three priced peptide programs, and bills only when a patient reorders rather than on a standing subscription.
Strengths
- Charges nothing for the consultation and says so on every program page, so the price of finding out is zero
- Bills on reorder rather than on a standing subscription, and says so beside each peptide figure
- Sells lab panels as a separate, separately priced catalog instead of folding an unnamed lab fee into a program
- Names its operating company in its own privacy policy
Trade-offs
- The sermorelin page publishes a first-month figure and no ongoing rate at all
- Names no dispensing pharmacy, referring to it only as a partner pharmacy
- Lab work is a separate purchase, so a program price is not an all-in figure
- Its per-month figures are floors, and the peptide pages do not say what raises them
- Prints two different starting figures for Zepbound on two of its own pages
92. Effecty
$190 — read as the hero line "Sermorelin ODT — Starting at $190" with no billing period stated and no cost table anywhere on the page; the seller's own /longevity index prices the same product at a lower figure and footnotes it "Price for purchase of 3 month supply", so the two pages disagree
Summary, strengths and trade-offs10 points
Effecty prints a three- or four-rung cost table under the heading "How much does treatment cost?" on its injectable pages, with the billing cycle spelled out beside every rung — and then prices the same compound differently on its own index page than on the product page it links to.
Strengths
- Names the billing cycle beside every rung of its injectable cost tables, so no rung has to be interpreted
- Footnotes its own headline figures with the prepayment they require, on the same page, rather than leaving the asterisk unexplained
- Prices five distinct longevity products including two delivery forms of one compound
- Splits the shipping answer between its weight-loss line and its longevity line instead of giving one blanket claim
Trade-offs
- Prices one product differently on its index page than on the product page that index links to, and only the index says which figure requires prepayment
- The oral-dissolving page has no cost table at all, so its single hero figure carries no billing period
- No dispensing pharmacy is named — the answer is "state-licensed compounding pharmacies" and, elsewhere, "our trusted pharmacy partner"
- The availability claim is "all states nationwide" and never counts them, so it cannot be checked against a list
- A nonsense path on this host lands on the homepage rather than returning a document, so a URL cannot be verified by status alone
- No lab work appears in any plan description
93. Solas Health & Wellness
$195 — Per cycle, not per month: the clinic's sermorelin comparison prices it in a table row reading "Per cycle (5ml vial)" at $195 and says "Sermorelin is $195 per cycle". The same page puts a typical cycle at "4-12 weeks depending on goals" and says "Sermorelin protocols often run 12+ weeks". The $100 consultation is "credited to first cycle"
Summary, strengths and trade-offs8 points
Solas publishes no corporate entity and instead puts one named, licensed clinician on every page — and prices peptides per cycle rather than per month, which is a unit almost nothing else here uses.
Strengths
- Publishes a per-cycle range as well as a starting figure, so the spread a buyer faces is visible
- Puts one named, licensed clinician on the pages and states the two states she is licensed in
- Says the consultation fee is credited toward the first cycle rather than charged on top
- States plainly that no membership, enrollment or hidden fees apply
Trade-offs
- Publishes no corporate entity anywhere on the pages read
- The peptide price is per cycle, and the only cycle length it publishes is a four-to-twelve-week range on its blog, so it cannot be compared with a monthly rate
- Names no dispensing pharmacy, describing them only as licensed compounding pharmacies
- Its NAD+ figures use two different units — four injections for one price, and a single infusion for another
94. Better Med Spa
$200 — printed as 'Starting at $200' with no billing period, vial count or supply length stated anywhere on the page
Summary, strengths and trade-offs8 points
Better Med Spa sells epithalon and GHK-Cu only as one combined protocol at one price, and attaches no billing period to any figure it publishes.
Strengths
- Names thirteen tracked compounds, one of the deepest menus on this roster
- Publishes a figure on each individual treatment page rather than gating them
- Gives epithalon and GHK-Cu a dedicated page rather than burying them in a list
- Separates its NAD+ IV from its at-home and in-office shot plans
Trade-offs
- Attaches no billing period to any peptide figure, so none can be compared
- Sells epithalon only bundled with GHK-Cu, so neither has a price of its own
- Its legal company name shares no words with its brand
- Publishes no state list and names no dispensing pharmacy
95. PeptidesRx
$208 — "Sermorelin / Injection or oral. Anti-aging, lean muscle, recovery and sleep. / from $208 per vial / 3 and 6 month pricing available / One vial typically lasts four to six weeks". The seller\u2019s other live catalog prices the same compound at "$ 176.00".com/product/sermorelin/
Summary, strengths and trade-offs8 points
PeptidesRx prices ten of the compounds compared here, names the pharmacy that fills the orders and gives its address, and runs two live catalogs on one domain whose figures do not agree with each other on a single compound.
Strengths
- Prices ten of the compounds compared here, more than any other seller on this roster
- Names its dispensing pharmacy, its street address and its telephone number
- States the vial strength and the expected duration of a vial beside most figures
- Publishes the states its pharmacy is not licensed in rather than only the count
Trade-offs
- Runs two live catalogs whose figures disagree on every compound they share
- Prints a third, templated figure on every product page that belongs to no product
- Gives two coverage numbers in one paragraph that cannot both be right
- Prices a third figure for one compound on a marketing page separate from both catalogs
96. Rejuvia Wellness
$240 — per vial, printed as $240 in the table's "VIAL" column beside a course of "1 vial / 1 month"; the page says vials start at $240, and this course is a single vial
Summary, strengths and trade-offs8 points
Rejuvia prices its peptides by the vial and prints beside each figure how many vials a course takes and how long it runs. The cost of a full course is mapped out at the consultation, not printed.
Strengths
- States the vial count, the milligram strength and the course length beside every vial price
- Publishes a figure for eight separate tracked compounds
- Charges nothing for the initial consultation and says so
- Marks each course as a standard or premium tier rather than blending them
Trade-offs
- Each figure is the price of one vial, and most courses take more than one, so no figure on the table is the cost of a multi-vial course
- Publishes no corporate entity on any page read
- Charges separately for the initiation visit on top of every course
- Publishes no state list and names no dispensing pharmacy
97. Vitalex Health
$249 — from, per month — a floor rather than a quoted bill
Summary, strengths and trade-offs8 points
Vitalex Health publishes the broadest open peptide price list read in this pass — twenty priced protocols across six goal areas, singles and stacks alike — on a page that ships the same template, the same headline and two identical figures as another seller entering this roster the same day.
Strengths
- Prices seventeen distinct protocols in visible text on one open page, with no quiz, account or gate in front of any of them
- Groups the catalog by goal rather than by compound, and names the exact combination in every stack
- Prices the stacks as well as the singles, so a reader can see what adding a peptide actually costs
- Claims fifty-state service for itself with a number on its own About page
Trade-offs
- Its peptide page is the same template, headline and disclaimer as another seller on this roster, with two figures identical to the dollar — the two are not independent readings of the market
- Every figure is a "from" floor, so none is a quoted monthly charge
- CJC-1295, ipamorelin, TB-500, KPV and Semax are sold only inside stacks and are never priced alone
- No compounding pharmacy is named anywhere, and the disclaimer places prescribing entirely with independent third parties
98. Invigorate Advanced Aesthetics
$250 — No unit is published — "Sermorelin | Boosts natural growth hormone for improved sleep, recovery, and vitality | $250"
Summary, strengths and trade-offs8 points
Invigorate publishes a per-compound price for eleven peptides and attaches no unit to any of them — not a vial, not a month, not a dose — on a page that prints the same list twice in two different orders.
Strengths
- Publishes a per-compound figure for eleven peptides rather than one starting rate
- Prints the catalog as a proper table as well as a card grid
- Prices blends as their own lines instead of implying them from the singles
- The price list sits on the service page itself, not behind an intake
Trade-offs
- Not one figure carries a unit — no vial size, no dose, no billing period
- The card grid prints prices before the names they belong to on about half the rows
- Publishes no corporate entity; the only company named on the legal page is its web agency
- Names no dispensing pharmacy and publishes no state coverage
99. Rehydra+ Wellness
$250 — starting at
Summary, strengths and trade-offs7 points
Rehydra+ Wellness grew out of a mobile IV-therapy business and now sells a broad peptide catalog — BPC-157, KPV, MOTS-C, tesamorelin, sermorelin and GHK-Cu — with prices posted openly on its storefront, though it names neither a legal entity nor the pharmacy that fills its orders.
Strengths
- Publishes a phone and text line plus a named staff email, unusual for this category
- Its catalog spans six named peptides beyond a GLP-1 and testosterone line
- Consultations are free and financed payment plans are offered
Trade-offs
- No legal entity is named anywhere on the site; the terms identify only the brand
- Says it serves 20 states but never lists which ones, so coverage cannot be confirmed before intake
- Its LegitScript badge is a self-hosted image linking to a generic checker page rather than a confirmable certification record
- The compounding pharmacy is not named, and no page says which of its named clinicians prescribes
100. Fridays
$259 — the product page prints the figure with no billing period, supply length or cycle stated
Summary, strengths and trade-offs8 points
Fridays lists four partner pharmacies with street addresses in its own terms, prices three longevity products at one flat figure each, and trades under two different corporate names.
Strengths
- Publishes four partner pharmacies by name with street addresses and phone numbers
- Prints one figure per product with no ladder that climbs as the dose rises
- Says in its own terms that labs and pharmacies are not operated by the company
- Offers the same compound in both an injectable and an oral route at a stated strength range
Trade-offs
- Publishes two different corporate names for itself, one in the footer and one in the terms
- Prints its figures with no billing period, supply length or cycle attached
- Publishes no state list, so eligibility is settled inside the intake
- Places lab work outside the program the figures cover
101. SynergyRx
$275 — starting at, the bottom of a range; the catalog names no billing period
Summary, strengths and trade-offs8 points
SynergyRx prices four tracked peptides at exactly the same figure and its two GLP-1s separately, prints that figure before the product name rather than after it, and runs terms of service naming a different company as the operator.
Strengths
- Puts a figure beside four separate tracked peptides rather than behind one category floor
- Says plainly that it neither manufactures nor dispenses what it sells
- Prices PT-141, which few sellers on this roster price at all
- Publishes its catalog without an intake in the way
Trade-offs
- Prices four different peptides at exactly the same number, with no dose or vial size to separate them
- Its terms of service name a different company as the operator throughout
- Publishes no price for either weight-loss molecule
- Will not publish its state list, directing readers to customer service instead
102. CoraDoc
$295 — for ten weeks, struck through from $495
Summary, strengths and trade-offs8 points
CoraDoc prices its peptides in four and ten-week blocks rather than months, and runs a countdown sale whose banner figures contradict the program cards on the same page.
Strengths
- Prices three peptides individually rather than behind its own category floor
- Prints the block length — four weeks, ten weeks — beside each peptide figure
- States in its own words that its compounded weight-loss drugs are not FDA-approved
- Disclaims the similarly named company its brand could be confused with
Trade-offs
- Its sale banner and its program cards give different prices for both weight-loss molecules
- The sale carries a hard end date, so every figure here is perishable
- Names no dispensing pharmacy and publishes no certificate of analysis
- Its nationwide claim is prose with no state list behind it
103. HealthSource
$295 — Four weeks, not A month: printed as "Sermorelin Anti-Aging — Wellness — $295.00 every 4 weeks", and repeated in the same words on the product page. Thirteen charges a year, so the annual outlay is $3,835 rather than the $3,540 a monthly reading would give
Summary, strengths and trade-offs8 points
HealthSource prices every peptide "every 4 weeks" — thirteen charges a year, not twelve — on a page that also carries "every 30 days" and "/ month" against other products.
Strengths
- States the billing period on every single line rather than leaving it to be assumed
- Prices four peptide SKUs across three routes on one browsable catalog
- Distinguishes fixed-price SKUs from variant SKUs and says which is which on the card
- Tags every prescription item on the catalog rather than only at checkout
Trade-offs
- Its peptides bill every four weeks, which is thirteen charges a year and will read as twelve in any monthly column
- Three different billing periods appear on the same catalog page against different products
- No operating company was found on the pages read
- No pharmacy named, no certificate of analysis, no state coverage list
104. Bridgeside Telehealth
$300 — the same flat "Peptide medication: $300 (if prescribed)" that applies to every peptide here, with a separate $99 consultation; the growth-hormone page states no strength, format or supply length
Summary, strengths and trade-offs9 points
Bridgeside Telehealth prices every peptide identically, at $99 for the consultation and $300 for the medication if it is prescribed, and charges nothing for the visit when therapy is judged inappropriate.
Strengths
- One published figure covers any peptide it prescribes, so the price does not move with the compound chosen
- States that there is no charge for the visit at all if peptide therapy is not clinically appropriate
- Names its operating entity, Bridgeside Telehealth LLC, in its own Terms of Use rather than trading under a bare brand
- Says plainly that additional peptides are only considered after the first month, instead of selling a stack up front
Trade-offs
- Publishes two incompatible price structures on one site: the home page says "The total cost is $300" including the consultation, while every peptide page says the consultation is $99 and the medication $300 on top of it
- Its own FAQ asks "Is the $300 a subscription?" and the answer field still reads "Tab Item Content"
- Says it is licensed in 44 states and publishes no list of which ones
- Names no compounding pharmacy, only "a licensed U.S. compounding pharmacy"
- The category pages name only GHK-Cu and NAD+ outright; the rest of the menu appears as categories and disclaimer text rather than a catalog with strengths
105. Healthy Resolutions
$375 — the 9 mg strength; the same line prints $450 for 15 mg and names no billing period
Summary, strengths and trade-offs8 points
Healthy Resolutions names three partner pharmacies with full addresses and prices sermorelin at two strengths, but its "States We Cover" page publishes no states at all.
Strengths
- Names three partner pharmacies with street addresses, phone numbers and one facility class
- Prices two sermorelin strengths separately instead of publishing a single range
- Publishes its registered company name rather than trading under a bare brand
- States its coverage explicitly, however small, rather than leaving it to the intake
Trade-offs
- Its "States We Cover" page publishes no states, so the only list is a footer sentence
- Serves four states, so most readers are ineligible before anything else matters
- Attaches no billing period to either priced compound
- Makes no statement about lab work on either priced page
106. Balanced Healthcare
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Balanced Healthcare publishes two prices for everything — one for members, one for everyone else — and prices its peptide programs by tier rather than by compound.
Strengths
- Publishes both the member and the non-member figure instead of only the discounted one
- States the dose count and the number of days its NAD+ loading course covers
- Says the loading course is recommended rather than required
- Runs a full published pricing page rather than quoting only at consult
Trade-offs
- Its peptide tiers do not name the compounds they cover, so no figure is compound-scoped
- Every figure has two values, and which one applies depends on a membership sold separately
- Its NAD+ course covers eight days, which no monthly comparison can absorb
- Publishes no corporate entity, no state list and names no dispensing pharmacy
107. Enough! Wellness
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Enough! publishes a commitment ladder that prints the total charge and the derived monthly rate on the same line — so the cheapest number on the page is attached to a two-thousand-dollar up-front payment, in writing.
Strengths
- Prints the total charge and the derived monthly rate on every rung of its commitment ladder
- States the billing period as four weeks rather than calling it a month
- Says plainly what is in the stack and that a clinician adjusts it
- Publishes an unqualified fifty-state claim in its own trust bar
Trade-offs
- The best-value figure requires a $2,327 payment up front, which only the same line discloses
- No compound in the stack has a price of its own
- Publishes no corporate entity and no copyright line on the page read
- Prints "No $5,000 clinic" as marketing copy, which is a competitor figure and not its own
108. Form by GBY
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Form by GBY prices GHK-Cu by the unit and NAD+ and glutathione by the month on single-compound pages, and sells its weight-loss medicines only inside a three-component formula.
Strengths
- Gives GHK-Cu, glutathione, NAD+ and sermorelin their own pages instead of one combined menu
- Answers "Is compounded GHK-Cu FDA-approved?" with "No" in its own FAQ, on each product page
- Prints the unit its GHK-Cu price is charged against rather than implying a month
- Says plainly that the FDA does not review compounded products for safety, effectiveness or quality
Trade-offs
- Sells its weight-loss medicines only inside a three-component formula, so neither drug has a scoped price
- Its bundle page prints a figure for glutathione that its own product page contradicts
- Publishes no state list and names no dispensing pharmacy
- No certificate of analysis is reachable
109. Next Vial
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Next Vial names its pharmacy with a street address and lists the forty-nine states it serves, and then hides every price but one behind a plan selector.
Strengths
- Names its dispensing pharmacy with a street address and a telephone number
- Lists the forty-nine states it serves rather than printing a count
- Names the clinician network that reviews the intake
- States plainly that compounded medicines are not FDA-reviewed
Trade-offs
- Four of its five peptide products show a plan selector where a price should be
- Its weight-loss floor covers two different drugs behind one figure
- The one published figure names no billing period
- Alaska is absent from its own state list, so the coverage is not nationwide
110. PeptideMD
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
PeptideMD prices peptides by tier rather than by molecule, and its homepage and its pricing page quote two different figures for the same single-peptide tier.
Strengths
- Says which pharmacy class compounds its medication and that shipping is cold-chain
- Includes a baseline lab panel in its higher peptide tiers and says so on the page
- Publishes a full pricing page rather than gating rates behind intake
- Quotes two- and three-month terms alongside the one-month rate
Trade-offs
- Its homepage and its pricing page disagree on the price of its own entry peptide tier
- Peptide pricing is per tier, so no figure attaches to any named molecule
- Publishes no corporate entity on any of the four pages read
- Publishes no state list and names no dispensing pharmacy
111. REX MD
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
REX MD sells sermorelin inside a testosterone program whose subscription is published as a range covering whichever medication is prescribed, so no sermorelin figure is recorded. Its recorded prices are brand-name semaglutide: the Wegovy pill with provider care at one monthly figure across every dose, and the Wegovy pen, bought through NovoCare, the manufacturer's pharmacy platform.
Strengths
- Says in a footnote exactly what the initial fee covers and what the subscription covers
- States that sermorelin is a compounded drug that is not FDA approved
- Cites named journal articles with digital object identifiers beside its testosterone claims
- Marks its aggregated ratings as covering all its services rather than the program being read
Trade-offs
- Publishes no figure scoped to sermorelin; its subscription range spans whichever medication is prescribed
- Charges a separate initial fee for lab tests and the consultation on the testosterone program that sermorelin sits in
- Its host answers a success code for a page that does not exist, so no absence here can be proven by status
- Publishes no state list and names no dispensing pharmacy of its own; brand-name Wegovy comes through the manufacturer's NovoCare platform
112. Rixa Health
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Rixa Health prices its weight-loss ladders in four- and five-week blocks rather than months, prints the weekly milligram at every rung, and says the figure is a pass-through of what the compounding pharmacy charges.
Strengths
- Prints the weekly milligram beside every rung of both ladders
- States the block each figure buys — four weeks, five weeks or thirty days — instead of implying a month
- Says its price is a pass-through of what the preparing compounding pharmacy charges, shipped separately
- Says it offers no contracts or long-term commitments
Trade-offs
- Nothing it prices is priced by the month, so nothing compares cleanly to a monthly rate
- Its oral semaglutide is a two-ingredient tablet, so that route carries no scoped price
- Names no dispensing pharmacy and publishes no state list
- Several rungs of its own ladder still carry the placeholder text "Your description goes here"
113. Team Wellcore
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Team Wellcore names its dispensing pharmacy with an address, a phone number and the ten states that pharmacy cannot ship sterile compounds into — and then charges for a consult before it will quote the price of any medication.
Strengths
- Names the dispensing pharmacy with a street address and a phone number rather than describing a class of facility
- Names the ten states that pharmacy cannot ship sterile compounds into, which is a checkable exclusion list rather than a coverage claim
- States the consult charge up front and says the medication is billed only after a provider approves
- Describes its compounded products as patient-specific and not FDA-approved in its own FAQ rather than burying the point
Trade-offs
- Four of its six tracked products publish a price only inside structured data, where no reader ever sees it
- Where a visible figure and a structured-data figure both exist they disagree, and the visible one is the higher
- Its own state arithmetic is wrong — it claims licensure in forty-four states while naming ten it is excluded from
- No visible figure carries a billing period, so nothing it publishes can be read as a monthly rate
114. Thrivelab
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Thrivelab names 503A compounding as its source and condemns the research-peptide gray market by name — then publishes no price for any peptide it lists, only for its two weight-loss molecules.
Strengths
- Warns readers away from research-labeled peptides sold without medical oversight
- Names 503A compounding as the source for everything it sells
- Prints an intro month and a following-month figure rather than one number
- Publishes a consultation price alongside the medication price
Trade-offs
- Its peptide page names ten tracked compounds and prices none of them
- Its following-month figures are ranges, so the standing price is not a number
- Its most eye-catching figure belongs to a competitor column, not to itself
- Names no dispensing pharmacy and makes no state-coverage claim
115. Vita Bella
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Vita Bella prices NAD+ against IV clinics in a two-column table, and both of its own figures are conditioned by a footnote most readers will skip.
Strengths
- Names Vita Bella Health LLC as the operating company
- States the vial size and the number of injections it contains
- Publishes its footnote conditions on the same screen as the figures
- Sells four tracked compounds rather than one
Trade-offs
- Its headline per-shot figure requires a membership whose price is not on the page
- Prices only NAD+ — its sermorelin, tesamorelin and PT-141 carry no published figure
- Describes a "US FDA-Inspected Pharmacy" without naming one
- Its comparison column is a competitor category, which is easy to misread as its own price
116. Green Cap Health
$99/mo — per month as an add-on, which the pricing page lists as "Available on top of any tier" of its weight-loss plans; prepay tiers of $279 for three months and $499 for six sit beside it
Summary, strengths and trade-offs9 points
Green Cap Health sells compounded semaglutide and tirzepatide at one monthly price at any dose, and prices NAD+ and sermorelin injections as add-ons to those plans. It publishes two different monthly figures for the same GHK-Cu foam on two of its own pages.
Strengths
- Puts the per-month figure and the prepay total side by side for each injection
- Prices each weight-loss drug the same at any dose, with no separate membership charge
- States in its own words that its compounded products are not FDA-approved
- Says it requires third-party batch testing from its pharmacy partners and reviews the reports
- Prices NAD+ and sermorelin separately rather than behind one longevity floor
Trade-offs
- Publishes two different monthly prices for the same copper-peptide foam on two of its own pages
- Names no dispensing pharmacy and publishes no certificate of analysis
- Names Texas as where its people hold licenses without saying where it can ship
- Sells NAD+ mainly as a cream and a foam, so the injection is the only tracked form with a clean figure
117. Harbor
$99/mo — a flat monthly program rate, read in the seller's own pricing block as "Sermorelin program | Most chosen | $99 /mo | Flat monthly price — no increases as your dose changes | Medication, clinician care, and check-ins in one price"; the same figure appears in the page banner as "Start today for $99/mo" and in the footer product list
Summary, strengths and trade-offs10 points
Harbor publishes one flat figure per compound with "no increases as your dose changes" written beside it, names its partner medical group in a footer disclosure, and then tells you in its own terms that it makes no promise the service reaches your state.
Strengths
- Prints one flat figure per compound with an explicit promise that it does not rise as the dose is titrated
- States what the figure covers — medication, clinician care and check-ins — on the same line as the figure
- Names its operating company, its state of incorporation and its registered address in the first paragraph of its terms
- Names the partner medical group that provides consultations, separately from the platform company
- Says plainly that it is not a pharmacy and does not dispense, rather than implying it fills its own prescriptions
Trade-offs
- The terms decline to say where the service is available, so no state coverage can be recorded at all
- Advertises a large saving on multi-month prepaid plans without publishing a single prepaid rung to check it against
- No dispensing pharmacy is named — prescriptions go to an unnamed pharmacy "within a pharmacy network"
- The claim that a prescriber is licensed in your state is a fact about the prescriber and reads, in context, like a coverage promise the terms explicitly refuse to make
- No lab work is included in or priced beside the program rate
118. PepScribe
$99/mo — from; the product page and its FAQ both print the same figure
Summary, strengths and trade-offs8 points
PepScribe prices six tracked compounds individually from one catalog and says in its own FAQ which pharmacy class fills them — 503A — while declining to name the pharmacy itself, because the one that fills your order depends on your state.
Strengths
- Prices six tracked compounds individually rather than behind one category floor
- Says which pharmacy class fills its orders and which sterile-compounding standards apply
- Publishes the same sermorelin figure on the catalog and on the product page
- Says the online visit costs nothing and that there is no membership fee
Trade-offs
- Names the clinician network but not the dispensing pharmacy, because it varies by state
- Makes no state-coverage claim of any kind on the pages read
- Publishes no certificate of analysis
- Its catalog prints each price between one product and the next, which is easy to misread
119. Stealth Health
$114.93/mo — from, per month
Summary, strengths and trade-offs8 points
Stealth Health prices to the cent and attaches a month to every figure, and it is the only seller in this batch whose glutathione comes in two separately priced formulations.
Strengths
- Attaches "/mo" to every figure across every product page
- Prices two glutathione formulations separately instead of quoting one number
- Names Stealth Health Inc as the operating company
- Says no payment is taken upfront — only when a prescription is approved
Trade-offs
- Publishes no state list, and its shipping claim spans two countries
- Names no dispensing pharmacy
- Its GHK-Cu price buys a combination topical, not the copper peptide alone
- No certificate of analysis is reachable
120. Jently
$119/mo — as low as, per month; the nasal spray is listed at the same figure
Summary, strengths and trade-offs8 points
Jently names the compounding pharmacy that fills its prescriptions, with its street address and its 503A status, and prices five tracked compounds at the same monthly floor.
Strengths
- Names Precision Compounding Pharmacy, with its street address and its 503A status
- Says compounded drugs are not FDA-approved for safety, efficacy or quality, in its own words
- States that it is a telehealth platform and not a pharmacy or a manufacturer
- Prices five tracked compounds openly rather than behind an intake
Trade-offs
- Its host answers a success code for a page that does not exist, so no absence can be proven by status
- Publishes no state list, saying only that notices are on a partner’s page
- Every headline figure is an "as low as" floor rather than the rate at a stated dose
- No certificate of analysis is reachable
121. PreventiveMD
$119/mo — "As low as $119/mo per month, all-in" — the seller's own wording, a floor rather than a quoted rate, on a page that separates its all-in lane from its branded lane where the membership fee and the medication are billed as two named lines
Summary, strengths and trade-offs8 points
PreventiveMD prints an all-in monthly figure for each compounded protocol and, on the same page, breaks its branded lane into a membership fee plus a medication rate as two named lines — and it publishes a list of the peptides it will not sell yet, with the review dates it is waiting on.
Strengths
- Prints an all-in monthly figure per compounded protocol and, on the same page, breaks the branded lane into a membership fee and a medication rate as two separate named lines
- Publishes a list of eleven peptides it does NOT offer because they are under regulatory review, with the anticipated review dates, instead of quietly not selling them
- Says in its own FAQ that its compounded medications are not FDA-approved and describes the pharmacy category and the standard they work under
- Distinguishes the topical form of its copper peptide from the injectable form and states plainly that it does not sell the injectable
Trade-offs
- Every peptide figure is an "as low as" floor rather than a quoted rate, so no page states what a given patient would pay
- No state coverage list appears anywhere, on any page read
- The compounding pharmacies are described as a class it works with and are never named
- Its participating medical group is named as the current one, which is a disclosure that the arrangement can change
122. Villas Health
$119/mo — subscription rate, struck through from $149.00; the same page prices a one-time purchase at $149.00
Summary, strengths and trade-offs8 points
Villas Health carries a 2025 federal warning letter naming its own website, and prints a one-time price and a subscription price side by side on every product, several of them marked down from a struck-through figure.
Strengths
- Prices the injection and the nasal form of each peptide separately rather than as one product
- Prints the one-time price and the subscription price on the same line
- Publishes its site in Spanish as well as English from the same navigation
- Says its GLP-1 products are compounded rather than implying they are the branded drug
Trade-offs
- Carries a 2025 federal warning letter naming its own website address
- Every listing shows a struck-through figure beside the live one, and a related-products strip whose prices run into the same text
- Names no dispensing pharmacy and publishes no certificate of analysis
- Makes no state-coverage claim on the pages read
123. Meto
$120/mo — per month a la carte, on top of a $29/month membership billed at $320 annually and a one-time $149 Peptide Readiness Panel; the member rate the site refers to is not published
Summary, strengths and trade-offs8 points
Meto puts a $149 blood panel in front of the prescription and bills in two published lines: a $29 monthly membership charged $320 a year, and the medication itself at a monthly rate that starts at $85 for BPC-157.
Strengths
- Splits the bill into two published lines, membership and medication, and says so plainly instead of quoting one blended figure
- Publishes a monthly figure for each single peptide as well as for the stacks, so a one-peptide protocol can be costed before signing up
- Marks its MOTS-c and tesamorelin stack "Not currently available while awaiting FDA regulatory action" rather than quietly delisting it
- Requires a blood panel before prescribing and prices it openly at $149 instead of burying it in an intake
Trade-offs
- The $149 panel and the $29 monthly membership both sit on top of every medication price, so no single figure on the site is the cost of therapy
- Says medication is billed "at your member rate - typically 15-25% below a la carte" without publishing what that member rate actually is
- Publishes a headline of 50 states covered by its clinician network but no state-by-state list
- Describes its pharmacies only as FDA-registered and 503A; none is named anywhere on the site
124. PrescribedRX
$123/mo — the seller’s own per-month equivalent of a $369 three-month plan, listed against $419
Summary, strengths and trade-offs8 points
PrescribedRX publishes a monthly rate and a three-month equivalent for every peptide it sells, and shows the arithmetic on the same tile.
Strengths
- Publishes the prepaid total and the per-month equivalent for every plan
- Gives each compound and each route its own priced page
- Names PrescribedRX LLC as the operating company
- Prices the nasal glutathione separately from the injection instead of quoting one figure
Trade-offs
- Publishes no state list
- Names no dispensing pharmacy
- No certificate of analysis is reachable
- Its struck-through comparison prices are never explained
125. TrueMe
$129/mo — per month on the month-to-month cadence; $79 a month on the three-month cadence
Summary, strengths and trade-offs8 points
TrueMe publishes an actual list of the states it serves, prices NAD+ and sermorelin on a one-month and a three-month cadence, and prints two different versions of that state list on its own site.
Strengths
- Publishes an itemised list of the states it serves rather than a count
- Prints the month-to-month and the three-month rate side by side on every product
- Says compounded medications are not FDA-approved and have not been evaluated for safety, effectiveness or quality
- States that it is not a state-licensed pharmacy nor a drug manufacturer
Trade-offs
- Publishes two different versions of its own state list, one with five states and one with six
- Sells its weight-loss products under drug-class names without naming the drug
- Lists glutathione with no price attached
- Names no dispensing pharmacy and no certificate of analysis is reachable
126. Magnolia Regenerative Medicine
$135/mo — starting at, per month; monthly and quarterly options offered
Summary, strengths and trade-offs8 points
Magnolia Regenerative Medicine publishes a flat per-compound rate for twelve of the peptides this site tracks, on one catalog page, with the billing cadence printed beside each figure.
Strengths
- Prices twelve tracked compounds individually on one catalog page instead of behind an intake
- Prints the billing cadence beside each figure, so a quarterly item is visible as one
- Names Magnolia Regenerative Medicine Health LLC as the operating company in its own footer
- Separates single-compound products from its blends by name, which makes a scoped price readable
Trade-offs
- Publishes no list of states it serves
- Names no dispensing pharmacy; its comparison table says only "US FDA-Inspected Pharmacy"
- Sells five of the compounds it stocks only inside blends, so those carry no scoped price
- No certificate of analysis is reachable
127. Tonik Wellness
$140/mo — printed as "Sermorelin — As low as $140.00 / month". The same page states, in visible text, "This product is out of stock. Product is not available in this quantity."
Summary, strengths and trade-offs8 points
Tonik Wellness gives each peptide its own page with one clean figure and one clean unit, and then prints, under each of them, that the product cannot be bought.
Strengths
- One product, one page, one figure, one stated unit — the plainest price disclosure in this batch
- States its own limits in writing: the operating company "does not provide medical or pharmacy services"
- Names the operating company in its footer and again in its trademark notice
- Marks stock status on the product page itself rather than at checkout
Trade-offs
- Both peptide products were out of stock on the date read
- The figure is an "as low as", and the page does not say what raises it
- No dispensing pharmacy named, no certificate of analysis, no state coverage list
- A narrow catalog beside sellers on this roster carrying a dozen compounds
128. Tuyo Health
$145/mo — "Sermorelin Injection / $145/mo / Save 15% with subscription / In Stock"; the foot of the same page repeats "Plans start at just $145/month". The homepage and FAQ separately publish "$155/month" for specialized programs and "$9.99/month" for a primary-care membership — neither is this compound\u2019s figure
Summary, strengths and trade-offs8 points
Tuyo Health prices one of the compounds compared here at a flat monthly rate and repeats that figure twice on the same page, but the page it sits on also carries two unrelated membership figures that a skimming reader will take for the same thing.
Strengths
- Prints one flat monthly figure for the compound and repeats it at the foot of the same page
- Names the subscription discount as a percentage rather than burying it at checkout
- Publishes a separate membership rate so a reader can see which charge is which
- Serves the priced page as fully rendered text rather than hiding it behind a script
Trade-offs
- Carries a federal warning letter that names its own domain
- Puts three unrelated monthly figures within one navigation of the compound’s own rate
- Answers a question headed "what lab tests are included" with a conditional about programs in general
- Puts its terms behind a login redirect, so the governing document cannot be read before signing up
129. Biopreventative
$149/mo — printed on the same page as both a discounted first month, struck through from $199, and the standing monthly rate
Summary, strengths and trade-offs8 points
Biopreventative carries a 2025 federal warning letter and publishes three incompatible answers to the question of which states it serves — including a state list that names Alaska after its product pages exclude it.
Strengths
- States its dose ceiling and exactly what the price rises to above it
- Restates every package price as a daily and a monthly figure, and the arithmetic holds
- Publishes a per-drug state list rather than one list for the whole site
- States in its own words that its compounded semaglutide is not FDA-approved
Trade-offs
- Carries a 2025 federal warning letter naming its own website
- Publishes three incompatible answers to which states it serves, one of which contradicts the other two on Alaska
- Prints the same sermorelin figure as both an introductory rate and the standing rate
- Its terms of service were last revised in 2022 and its footer names a different entity type from its terms
130. EdgeRx
$149/mo — per month; the sublingual route is priced identically on the same site
Summary, strengths and trade-offs8 points
EdgeRx sells the same compound in two needle-free formats at the same monthly price, and says in its own words that it is "not the peptide gray-market".
Strengths
- Charges the same monthly figure for the nasal and sublingual route of a compound
- Groups its catalog by goal and prints a protocol count beside each group
- Says its GHK-Cu topical is "pharmacy-compounded, not the OTC version"
- Attaches the month to every protocol figure it publishes
Trade-offs
- Publishes no operating company on any page read
- Its PT-141 and glutathione lines are sold inside multi-protocol categories with no single figure
- Publishes no state list and names no dispensing pharmacy
- Says its compounds are "tested for purity" but publishes no certificate of analysis
131. Measured
$149/mo — catalog card prints "FROM" above "$149/mo", with "No insurance required" and "Medication included"
Summary, strengths and trade-offs8 points
Measured prices three of the compounds compared here in one catalog table, marks each as medication-included, and is the rare seller that publishes its service area as a named list of states rather than a claim.
Strengths
- Publishes its service area as a named list of twenty-six states rather than a nationwide claim
- Prices three of the compounds compared here in one catalog table, so they can be compared without three intakes
- Marks every peptide card medication-included and no-insurance-required beside the figure
- Answers its own lab-work question plainly instead of leaving it to an intake
Trade-offs
- Carries a federal warning letter over false and misleading telehealth claims
- Names no dispensing pharmacy — only "independent, state-licensed pharmacies"
- The sitemap advertises per-compound URLs that all serve the same catalog page
- The catalog states no form for any peptide, so injection, oral and nasal are not distinguished
132. Rebody Health
$159/mo — per month after the first month, which is $79.50 — the page reads "$79.50 today. Then $159 monthly. Pause or cancel any time."
Summary, strengths and trade-offs8 points
Rebody Health, operated by Compound Technologies, Inc., prices five compounds across injection, nasal spray, troche and cream, and prints the ongoing rate beside the first-month rate on every product page instead of only the discounted one.
Strengths
- Prints the recurring rate beside the discounted first month on every product page, so the ongoing cost is readable before checkout
- Enumerates its jurisdictions state by state in its terms, District of Columbia included, rather than asserting a count
- Sells one compound in more than one route — sermorelin, NAD+ and PT-141 each have an alternative to the needle, priced separately
- States in its terms that the consultation fee sits inside the plan price and names the amount
Trade-offs
- Names no compounding pharmacy — its terms say only that orders are dispensed by independent licensed pharmacies
- The injectable NAD+ line bills in two-month blocks, so its advertised per-month figure is a division rather than a charge
- Every headline figure on the site is an introductory one, and the ongoing rate is roughly double it on most products
- No lab work is described as included at any tier
133. Factor Health MD
$176/mo — as low as, per month
Summary, strengths and trade-offs8 points
Factor Health MD publishes the deepest plan ladder in this batch — four terms plus a pay-as-you-go rung priced by milligrams — and names two different states as its governing law in one contract.
Strengths
- Publishes four subscription terms and a pay-as-you-go rung for both weight-loss molecules
- Prices the pay-as-you-go rung by vial strength, so a reader can see what milligrams cost
- Every stated monthly-times-term total reconciles exactly
- Prices NAD+, sermorelin and glutathione individually as well as inside bundles
Trade-offs
- Its own terms name Florida law in one section and Delaware in another
- Calls its suppliers FDA-approved compounding pharmacies, a category that does not exist
- Points readers to a state list that is not on the site
- Both weight-loss products are vitamin blends by default rather than the bare active
134. Midi Health
$179/mo — starting per month, printed exactly as "$179 / Starting per month"
Summary, strengths and trade-offs8 points
Midi Health, a midlife and menopause telehealth practice, sells sermorelin and an NAD+ nasal spray from its own formulary and publishes a figure for each, one as a monthly rate and one as a 30-day supply.
Strengths
- Prints the unit beside each figure, and the two units genuinely differ rather than being flattened into one
- Attributes the NAD+ explainer on that page to a named person at the company rather than to an anonymous team
- Frames both compounds around midlife symptoms rather than generic longevity copy
- Puts the FDA-status disclaimer directly under the product claim rather than in a footer
Trade-offs
- Describes "our trusted compounding pharmacy" without naming it
- Publishes no state list, and its insurance-and-pricing path returns a 404
- Only two of the compounds this site tracks are sold, so anything else means a second seller
- The NAD+ figure is a supply price, which is easy to misread as a monthly rate beside the sermorelin row
135. Neo Soma Healthcare
$179/mo — the sale figure on a running countdown, printed beside a struck-through regular figure of 229; the page labels it 'Monthly Refills'
Summary, strengths and trade-offs8 points
Neo Soma states a dose schedule next to each monthly refill price, which is rarer here than the price itself — but both figures are sale figures running against a countdown clock.
Strengths
- States the dose and weekly frequency beside the price, not just a product name
- Labels both peptide figures as monthly refills rather than leaving the period unstated
- Names its operating company on two separate legal pages
- Keeps its two peptide products on separate pages with separate figures
Trade-offs
- Both published figures are promotional and sit beside a struck-through regular figure
- A running countdown means the figure a reader sees may not be the figure they are charged
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
136. Transparent Meds
$179/mo — per month as a program fee, struck through from $229 — the same pair of figures the tesamorelin card carries
Summary, strengths and trade-offs8 points
Transparent Meds names its compounding pharmacy, its clinician network and the forty-five states it serves in its own FAQ, and prices tesamorelin and sermorelin at the same figure on its home page.
Strengths
- Answers "Who are your pharmacies?" with a name — Rush Pharmacy — rather than with a regulatory category
- Publishes the states it serves as a list and names the five it does not, instead of printing a nationwide badge
- Names the clinician network separately from the platform, and says the platform is not a medical practice or a pharmacy
- Says in a footnote beneath the grid that the figures are monthly program fees, so the unit is not left to inference
Trade-offs
- The price grid does not exist until the page renders — the served document is the same shell for every path
- Its two peptide cards carry the same live figure and the same struck-through figure, so neither is priced against the other
- Labs are ordered only at a clinician's discretion and are not covered by the program fee
- Its own AI-use policy warns that images and videos on the site "may contain or consist entirely of AI-generated or AI-enhanced depictions"
137. Luma Meds
$180/mo — per month
Summary, strengths and trade-offs8 points
Luma Meds says it is available in all fifty states on its product page and only in certain states in its terms, and its compounded tirzepatide plan card renders no price at all.
Strengths
- States in its own words that compounded medicines are not FDA-reviewed
- Prices the oral and injectable forms of the weight-loss molecules separately
- Publishes a standing monthly figure for NAD+, sermorelin and glutathione
- Names its medical group in its terms
Trade-offs
- Its terms contradict its own fifty-state claim
- Its injectable tirzepatide card renders no price, leaving one navigation entry as the only figure
- Semaglutide carries three different prices across one page
- Its three-month anchor price does not match three times its own monthly rate
138. Elevated Health
$196/mo — per month; a three-month plan is $182 a month
Summary, strengths and trade-offs8 points
Elevated Health carries a 2025 federal warning letter, publishes a four-rung ladder for both weight-loss molecules, and runs terms of service that govern a different website entirely.
Strengths
- Publishes a four-rung ladder for both weight-loss molecules with every rate printed
- Prices NAD+ and sermorelin on monthly and quarterly lanes
- States its potency tolerance as a number rather than as an adjective
- Says what the treatment price includes, down to the supplies and the shipping
Trade-offs
- Its terms of service govern a different website and never name this one
- Its cross-sell chip prices tirzepatide at a figure its own tirzepatide page contradicts
- Its NAD+ page calls the same number both the monthly and the three-month rate
- Carries a 2025 federal warning letter naming its own website, and publishes no statement that its compounded products are not FDA-approved
139. Ambiante Health and Wellness
$199/mo — from, per month, on the peptide menu
Summary, strengths and trade-offs8 points
Ambiante Health and Wellness is the fourth seller found serving a byte-identical peptide menu under a different company and a different price list, and it prices seven tracked compounds on its own.
Strengths
- Prices seven tracked compounds individually rather than only as blends
- States that its medications are compounded in a United States pharmacy on every product card
- Says a licensed provider reviews each case before a prescription is written
- Publishes its menu without an intake wall, so the figures can be compared before signing up
Trade-offs
- Serves the same peptide menu as three other sellers on this roster under a different company
- Its own template misfiles some descriptions, so a blend can carry a single compound’s sentence
- Publishes no state list and names no dispensing pharmacy
- No certificate of analysis is reachable
140. Layla
$199/mo — per month after a $99 first month on the quarterly plan
Summary, strengths and trade-offs8 points
Layla publishes three different tirzepatide prices on one page, two mutually exclusive discount labels on another, and a savings total that does not match its own arithmetic.
Strengths
- Publishes a monthly and a quarterly lane for each of its three peptides
- Names its provider entity in its terms
- Prices NAD+ and glutathione separately rather than as one longevity product
- Prints the standing rate beside the first-month rate rather than only the discount
Trade-offs
- Carries three different tirzepatide prices on a single page
- Its sermorelin card prints two first-month discounts that cannot both be true
- Two of its savings totals do not match its own arithmetic
- Publishes no statement that its compounded products are not FDA-approved
141. Lovely Meds
$199/mo — from, per month; this page carries no tier table, and its body copy is a GLP-1 product's
Summary, strengths and trade-offs8 points
Lovely Meds carries a 2025 federal warning letter, names seven dispensing pharmacies outright, and prints weight-loss body copy on a sermorelin product page.
Strengths
- Names seven dispensing pharmacies with their cities, which almost no seller here does
- Charges one price at every dose on both weight-loss molecules
- Publishes the full plan ladder from one month to twelve
- Says in its own words that its compounded medicines are not FDA-evaluated
Trade-offs
- Carries a 2025 federal warning letter naming its own website
- Its sermorelin page carries a weight-loss product's body copy word for word
- Its home page prints an FDA-approval claim beside compounded product cards
- Admits it is available in many but not all states without saying which
142. LunaRx
$199/mo — from, per month
Summary, strengths and trade-offs8 points
LunaRx is the only seller on the shared peptide template that prices semax, and it is the cheapest of the three on sermorelin, MOTS-C and epitalon.
Strengths
- Prices eight compounds per month, including semax, which few sellers here price at all
- Says on its own homepage that its protocols are "503A compounded — no reconstitution required"
- Names LunaRx LLC on the site itself, not only in a buried terms page
- Undercuts both of its template siblings on sermorelin, MOTS-C and epitalon
Trade-offs
- Its peptide menu is identical to two other sellers here, under a different company
- Prices semax only as a two-compound "Semax / Selank" line
- Publishes no state list and names no dispensing pharmacy
- No certificate of analysis is reachable anywhere on the site
143. LVNG RX
$199/mo — printed as "Sermorelin · from $199/mo" — a floor rather than a quoted rate
Summary, strengths and trade-offs7 points
LVNG RX puts a monthly starting figure on each single-peptide program and on both weight-loss injections. The weight-loss figures sit on its home page; the program pages that advertise flat, transparent pricing print none.
Strengths
- Puts a monthly figure on each of its single-peptide programs, with the period printed beside it
- Names its corporate entity plainly in its own terms
- States that its programs carry no consultation charge and no dose-change surcharge
Trade-offs
- Its semaglutide and tirzepatide pages advertise flat, transparent pricing and print no figure; the only weight-loss figures are starting prices on the home page, under a banner quoting a lower figure that names no medication
- Every figure, peptide or weight-loss, is a floor written as "from", so none is a rate the seller has committed to
- Two products price a pair of peptides at one figure, which is not a price for either compound
- No pharmacy is named and no service area is published anywhere, including in its terms
144. WeightCare
$199/mo — per month, monthly plan, stated as "NO COMMITMENTS"; the page also prints its own "$6.42 / DAY" division of this figure
Summary, strengths and trade-offs9 points
WeightCare publishes the ten states it will not serve, prices sermorelin as a flat monthly program and NAD+ by the dose, and carries a February 2026 FDA warning letter over telehealth marketing claims.
Strengths
- Names the ten states it cannot serve instead of leaving coverage to the intake
- States the sermorelin figure as a monthly rate with no commitment and no separate membership
- Lists the telehealth visit, the medication and unlimited prescriber messaging as included in the published figure
- Puts the compounding disclaimer above the price rather than below the fold
Trade-offs
- Carries a February 2026 FDA warning letter over telehealth marketing claims
- Prints per-day and per-dose divisions of its own figures beside them, which is how a comparison ends up quoting an invented rate
- Its NAD+ figure is priced by dose count, not by month, so it is not comparable to the sermorelin row as printed
- Sends prescriptions to "an accredited pharmacy" and never names one
- Publishes no operating company anywhere on the site
145. Whoosh Wellness
$199/mo — starting at, per month; a second block on the same page prints $499/mo for the same compound with no stated difference
Summary, strengths and trade-offs8 points
Whoosh Wellness says every batch it ships is third-party tested and publishes two sermorelin ladders on one page whose lower rungs differ by three hundred dollars.
Strengths
- Says in visible text that every batch is third-party tested for potency and purity
- Prices GHK-Cu at two named strengths rather than one blended figure
- States it compounds only at licensed 503A/503B pharmacies
- Attaches a month to almost every figure on its pricing page
Trade-offs
- Prints two sermorelin ladders on one page, $300 apart, with no stated difference
- Publishes no certificate of analysis despite claiming batch testing
- Publishes no operating company on any page read
- Its product page for GHK-Cu drops the period its pricing page states
146. FWD
$199.99/mo — the member monthly cell of the seller's own two-row grid, read as "Vial (3mg/ml) | Monthly | Quarterly | Member Price $199.99 $449.99 | Non-Members $299.99 $559.99" — the non-member monthly rate is the higher figure in that same row and a reader who is not a member pays it; the quarterly cells are prepaid totals, not per-month rates, and were not divided. The page title rounds the member figure down by a cent
Summary, strengths and trade-offs11 points
FWD publishes a two-column price grid on every product page — one column for members, one for everyone else — so the difference a membership makes is visible before anyone signs up, which almost nothing else on this roster shows.
Strengths
- Publishes a member rate and a non-member rate side by side, so the cost of not joining is visible before signup
- Prints the strength of every product beside its price, which most of this roster leaves out entirely
- Prices three separate delivery forms of one compound rather than a single headline product
- Labels its quarterly columns as quarterly, so a prepaid total is not mistaken for a monthly rate
Trade-offs
- Carries an FDA warning letter that names this company and this exact domain
- Reuses one grid layout for two different meanings — billing terms on some pages, container sizes on others — with only the column header to tell them apart
- The terms state that services are available only in certain states and no state is ever listed
- No dispensing pharmacy is named — the answer is "our state-licensed compound pharmacies around the country"
- One page advertises a percentage saving against an unnamed comparison price that is not this seller's own
- The FAQ page footer carries a copyright year two years behind the about page on the same site
- No lab work appears anywhere in the program description
147. Harmony Wellness Clinic
$200/mo — for a 1 month supply, as the clinic states it
Summary, strengths and trade-offs8 points
Harmony Wellness Clinic prices its peptides by supply length rather than by month, and three of its four supply lengths are not a month.
Strengths
- Attaches a supply length to almost every figure instead of printing a bare number
- Prices eleven tracked compounds on one open services page
- Says its prescriptions "may include FDA-approved medications or compounded formulas, which are not reviewed by the FDA"
- Names the regulatory class of its suppliers — 503A pharmacies licensed by state boards
Trade-offs
- Charges the same $200 for a five-week supply and a one-month supply of different compounds
- Its PT-141 price names no supply length at all
- Publishes no operating company, no state list and no named pharmacy
- No certificate of analysis is reachable
148. WePeptideRx
$220/mo — per month supply, injectable or nasal spray, consultation included
Summary, strengths and trade-offs8 points
WePeptideRx prices three peptides per month supply on one page and prices PT-141 only as a fixed-milligram bundle, so its cheapest and dearest figures are not comparable.
Strengths
- Prints "per month supply" beside its three main figures rather than a bare number
- States the milligram total behind every bundle price
- Says the provider consultation, medication and shipping are included with no separate fees
- Describes itself as LegitScript-certified telehealth in its own words
Trade-offs
- Publishes no operating company on any page read
- Its PT-141 and NAD+ bundles carry no period, so they cannot be compared to its monthly rows
- Answers 200 at a nonsense path, so absence cannot be proven from status alone
- Publishes no state list, no named pharmacy and no certificate of analysis
149. Mirabel Meds
$224/mo — printed as "Sermorelin · from $224/mo" — a floor, not a quoted rate; the seller states no upper bound for the program
Summary, strengths and trade-offs7 points
Mirabel Meds publishes a wide peptide menu with a monthly figure on every product, and prices five of them as multi-peptide stacks rather than as single compounds.
Strengths
- Puts a monthly figure on every product in a wide menu, with the period printed beside each one
- Sells eight tracked compounds as single products rather than only inside combinations
- Names its corporate entity plainly in its own terms
Trade-offs
- Every figure is a floor written as "from", so no product has a quoted rate a buyer can hold it to
- Five products price a multi-peptide stack at one figure, which cannot be compared against a single-compound price
- No pharmacy is named — the site refers to partner pharmacies as a category
- No service area is published anywhere on the site, including in its terms
150. Loop Health
$229/mo — starting at, per month, on both the men’s and the women’s shop pages
Summary, strengths and trade-offs8 points
Loop Health sells peptides inside a membership, prices four tracked compounds at a flat monthly rate that does not climb with dose, and states a state count rather than publishing a list.
Strengths
- Charges the same monthly figure at every GLP-1 dose, so titrating up does not raise the bill
- Prices four tracked peptides on the same page as its weight-loss medicines
- Cites named trials by name and journal beside its GLP-1 claims
- Describes itself as an independent health research collective rather than a pharmacy
Trade-offs
- States a count of forty-four states but publishes no list of them
- Its host answers a success code for a page that does not exist, so nothing can be shown absent by status alone
- Names no dispensing pharmacy
- Sells peptides only inside a membership, so the peptide figure is not the whole cost
151. HeliMeds
$239/mo — per month for one vial; a three-vial first order works out at $129 a month
Summary, strengths and trade-offs8 points
HeliMeds names its pharmacy and prints specific batch-testing tolerances, and sells its flagship weight-loss product on a page that never says which drug it is.
Strengths
- Names its dispensing pharmacy and says plainly that it is not one itself
- States its potency tolerance as a number and names the sterility chapter
- Prints the vial size and volume beside its sermorelin figure
- Says its compounded medicine is not FDA-approved, in those words
Trade-offs
- Its weight-loss product page never names the drug it sells, so no price could be filed for it
- Its own terms give two incompatible answers about which states it serves
- Its NAD+ headline price is footnoted as the twelve-month first-order rate
- Its terms carry another brand's pharmacy network in an unedited clause
152. Arc-1
$239.99/mo — as low as, per month with subscription
Summary, strengths and trade-offs8 points
Arc-1 publishes a list price and a lower subscription price for each injection, and the subscription figure is the only one on the page that carries a month.
Strengths
- Shows the list price and the subscription price side by side rather than only the lower one
- Prices three separate injections on an open storefront with no intake first
- Attaches the month explicitly to the subscription figure
- Publishes a glutathione injection price, which most sellers here do not
Trade-offs
- Publishes no operating company on any page read
- Its regular prices carry no billing period at all
- Publishes no state list and names no dispensing pharmacy
- A product page URL says "one-time-purchase" while the page sells a monthly subscription
153. Alinwell
$249/mo — from, per month on the peptide menu — the homepage prints $349/mo for the same compound on the same day
Summary, strengths and trade-offs8 points
Alinwell prices eight peptides per month on one page and prices sermorelin twice — its homepage and its peptide menu carry different sermorelin figures on the same day.
Strengths
- Prices eight separate peptides on a single readable menu page
- States a monthly period on every peptide figure it publishes
- Names its operating company in its own terms rather than only a brand
- Says in its own words that its peptides are compounded in a U.S. pharmacy
Trade-offs
- Publishes two different sermorelin figures on two of its own pages
- Its peptide descriptions are misfiled — a copper-peptide sentence sits under a four-compound blend
- Publishes no list of states it serves
- Names no dispensing pharmacy and publishes no certificate of analysis
154. Believe Health
$249/mo — from, per month
Summary, strengths and trade-offs8 points
Believe Health runs the same peptide menu as two other sellers on this roster under a different company, and it is the dearer of the three on every compound they share.
Strengths
- Publishes a monthly figure for seven separate compounds
- Names Believe Health LLC as the operating company in its own terms
- Prices its NAD+ line on the homepage rather than behind an intake
- Says its peptides are "reviewed individually by a licensed provider and compounded in a U.S. pharmacy"
Trade-offs
- Runs a peptide menu identical to two other sellers here under a different company
- Carries the misfiled compound descriptions that template ships with
- Publishes no state list, no named pharmacy and no certificate of analysis
- Its homepage and menu price different subsets, so no single page shows the whole catalog
155. BluefitMD
$249/mo — the monthly membership; packages run $597 for three months, $1,074 for six and $1,908 for twelve
Summary, strengths and trade-offs8 points
BluefitMD prices sermorelin and NAD+ with a full package ladder, publishes two different per-month figures for the same six-month sermorelin package, and links a weight-loss page from every page that returns not-found.
Strengths
- Prints the vial size, the milligrams and the weekly injection count beside each NAD+ tier
- Publishes a package ladder from one month to twelve with the total on each rung
- States its potency tolerance as a number and cites the sterility chapters by name
- Sells two NAD+ strengths as separate products rather than as one range
Trade-offs
- Its own six-month sermorelin package carries two different per-month figures, one of which the total contradicts
- Its NAD+ starting price differs between two of its own pages
- Three pages linked from every navigation return not-found, so no weight-loss price is reachable
- Names no dispensing pharmacy and makes no state-coverage claim
156. Coby Health
$249/mo — per month, billed monthly — the pricing table reads "Monthly / $299 $249 / Billed monthly / Subscription for one vial every four weeks". The hero selector on the same page prints $199 against the word Monthly, which the table gives as the quarterly rate
Summary, strengths and trade-offs8 points
Coby Health LLC sells sermorelin and NAD+ on stacked subscription lanes, and its sermorelin page carries two different price tables that disagree about what the monthly lane costs.
Strengths
- Puts the billing period beside every peptide figure — billed monthly, billed quarterly, billed biannually — rather than printing a bare per-month rate
- States the vial count on its peptide lanes, so the quantity behind the figure is readable
- Says plainly in its own footer that it is a marketplace and does not itself provide medical or pharmacy services
- Names the cancellation fee it keeps if an order is stopped before it reaches a pharmacy
Trade-offs
- The sermorelin page prints two price tables that disagree about which figure is the monthly rate
- Its six-month sermorelin lane repeats the quarterly lane's description word for word, so what that lane actually ships is unclear
- Publishes no service-state list for its peptide lines; the only coverage sentence on the site is scoped to its GLP-1 programs
- Names no dispensing pharmacy, and says the patient does not choose one
157. Longevixx
$249/mo — starting rate, per month
Summary, strengths and trade-offs7 points
Longevixx runs one of the wider peptide menus on this roster — twenty programs, each quoted as a monthly figure — including PT-141, epitalon and semax, which few sellers price.
Strengths
- Publishes a monthly figure beside every one of its twenty peptide programs, not a starting price for the catalog as a whole
- Prices PT-141, epitalon and semax, three compounds most sellers on this roster do not list at all
- Charges nothing when a request is turned down
Trade-offs
- Semax, KPV, TB-500 and CJC-1295 are sold only inside combination vials, so the figure beside each is the price of a pairing rather than of that peptide alone
- Its terms limit service to the states where the company operates without naming them, so coverage cannot be checked before signup
- The compounding pharmacy that fills prescriptions is not named on the site
- Every figure is a starting rate, and the catalog does not say what moves a program above it
158. Pause Rx
$249/mo — starting at, per month — the needle-free route is the cheaper one here
Summary, strengths and trade-offs8 points
Pause Rx prices eight peptide products at a monthly rate, names Rush Pharmacy as its filler, and says on every page that it is not a pharmacy itself.
Strengths
- Names Rush Pharmacy as the pharmacy that fills its prescriptions
- Repeats on every product page that it is "not a state-licensed pharmacy nor a drug manufacturer"
- Prices five tracked compounds across eight products, injection and needle-free alike
- Charges less for the sermorelin troche than for the injection
Trade-offs
- Its GHK-Cu cream is the one product with no stated billing period
- Publishes no operating company on any page read
- Publishes no state list
- No certificate of analysis is reachable
159. Vytora Health
$249/mo — per month on a month-to-month plan, from the page's own FAQ answer, which also gives $186/month on a 3-month plan billed $559 every 3 months. The price block at the top of the same page prints "$199 / month · Billed monthly" — an unreconciled third figure; the more expensive month-to-month reading is the one recorded
Summary, strengths and trade-offs8 points
Vytora Health answers the cost question in a sentence on each product page, giving the month-to-month rate and the prepaid rate together with the actual charge beside each — and on the sermorelin page that sentence contradicts the price block at the top of the same page.
Strengths
- Answers the cost question in one sentence per product page, giving the month-to-month rate, the prepaid rate and the actual prepaid charge together
- States what the figure covers — medication, consultation, supplies, shipping and support — instead of leaving a reader to discover the extras
- Says the price is the same at every dose, so titrating up does not change the bill
- Separates the marketing company from the clinical practice in its own terms, and says the brand is not a medical provider or a pharmacy
Trade-offs
- Its sermorelin page prints one figure at the top and a different month-to-month figure in its own FAQ, with nothing reconciling them
- The clinical practice is named with two different corporate suffixes — one form in the body of the terms, another in the footer of every page
- No state list is published; the terms say only that some services are available in certain states
- The compounding pharmacies are described as a network and never named, and no certificate of analysis appears on any page read
160. ElitePhysiqMD
$267.30/mo — the catalog rate of $267.30/mo., which the product page shows is the member price — that page prints $297.00/month struck through beside it and states the membership is $99.00/month, renewing automatically; a single one-time order of this item is $376.00 all-in ($297.00 plus a $49.00 visit fee and $30.00 overnight shipping)
Summary, strengths and trade-offs8 points
ElitePhysiqMD publishes the widest prescription peptide catalog on this roster — fifteen of the sixteen compounds this site tracks, each with a figure in visible text — and every one of those figures is a member rate that sits on top of a separate monthly membership charge.
Strengths
- The widest prescription peptide catalog on this roster, with a figure in visible text on every item
- Its product pages state that compounded preparations are not FDA-approved and that human evidence for peptides is limited, on the page taking the order
- Calls one of its weight-loss compounds investigational, which is accurate and rare
- Publishes the one-time-purchase total, the visit fee and the shipping charge as separate named lines rather than one blended figure
Trade-offs
- Every catalog figure is a member rate, and the catalog page itself never mentions the monthly membership those rates depend on
- Two of the compounds it lists are sold only inside a two-peptide stack, so neither has a price of its own
- The compounding pharmacy is described by licensing class on every page and is never named
- No state coverage list and no certificate of analysis appear anywhere in the pages read
161. Hartwater Wellness
$285/mo — the seller states the period and the flat basis in one sentence — "$285 per month for a single peptide … The same per-peptide pricing applies regardless of which peptide you are prescribed." A two-peptide bundle is $239 per month each and a three-peptide bundle $215 per month each
Summary, strengths and trade-offs8 points
Hartwater charges the same figure for every peptide it prescribes and says so in one sentence — so its price column has one number in it, and any table that gives this seller eleven different figures has invented the variance.
Strengths
- States one price for every peptide and says so explicitly, which removes the whole per-compound guessing game
- Publishes the bundle rates as well as the single rate
- Describes its pharmacies by license class and locates them in its own metro
- Draws the line against research-chemical vendors in its own words rather than by implication
Trade-offs
- Publishes no corporate entity
- Lists NAD+ and glutathione inside a peptide menu, which blurs a category the flat pricing then covers
- Names no dispensing pharmacy
- Publishes no state coverage; it is a single Texas clinic
162. Onyx Weight Loss
$299/mo — printed on the product's own page as "Sermorelin $299/Month", directly beside the product name. The seller's peptide index prints eight unattributed figures including "$129/MONTH" and "Starting at $199"; none of those is recorded, because the index does not say which product any of them belongs to
Summary, strengths and trade-offs8 points
Onyx prices its growth-hormone peptide plainly on that product's own page, and on its peptide index prints eight figures in a row with no product attached to any of them.
Strengths
- The product page attaches its figure to a product name and a period, in that order, with nothing between them
- Names several peptides openly in its navigation rather than gating the catalog
- Runs a booking flow with a free consultation stated up front rather than a payment-first intake
- Its nonsense-path control returned a clean, small not-found page rather than a full site
Trade-offs
- Its peptide index prints eight figures with no product attached to any of them — the page cannot be priced from
- The index carries a spelling error inside a price label, which is what a price nobody proofreads looks like
- No operating company published anywhere on the pages read
- No pharmacy named, no certificate of analysis, no state coverage list
163. Garcia Weight Loss
$300/mo — printed as "Sermorelin Therapy pricing — $300 monthly, minimum 3 months of therapy". The minimum term is stated separately from the figure, so the monthly rate is real but the commitment is three months. The coenzyme page also prices a combined "Sermorelin + NAD+ (6-month package): $3120.00"
Summary, strengths and trade-offs8 points
Garcia Weight Loss publishes six different units for one compound on a single page — per infusion, per milligram tier, per injection, per vial, per package of three and per package of twelve.
Strengths
- The most itemised price list in this batch — six units for one compound, each labeled
- Separates the in-clinic infusion from the at-home vial and prices both
- States the minimum term for the growth-hormone program separately from the monthly figure
- Publishes package pricing beside single-unit pricing so the discount is calculable
Trade-offs
- Six units for one compound means no single figure represents what the compound costs here
- Its legal name contains neither brand it trades under, so a company search on the brand finds nothing
- A regional clinic model, so the infusion figures assume travel a shipped program does not
- No dispensing pharmacy named, no certificate of analysis, no state coverage list
164. iThriveMD
$79 — the member price; the page states no billing period and shows $249 without membership
Summary, strengths and trade-offs8 points
iThriveMD prints a non-member and a member price for every peptide it sells, and the member price is between a half and a fifth of the other.
Strengths
- Prints the member and non-member figure together instead of only the discounted one
- Says its compounding happens "under Section 503A in a USP <797>-compliant sterile cleanroom"
- Operates in-person clinics as well as telehealth and says so
- States that compounded drugs "have not been reviewed or approved by the FDA"
Trade-offs
- None of its figures carries a billing period
- Its cheapest prices require buying a separate hormone or weight-loss plan first
- Answers 200 at every path, so nothing about the site can be proven absent
- Publishes no operating company, no state list and no named pharmacy
165. Mavés Health
$120 — a first-month rate: the product page prints "$120 first month — then $160/mo after" twice, once beside the buy button and once inside a "Monthly Plan" panel, and adds "5mL (10mg) vial and homekit included". The homepage card for the same product reads "Sermorelin — Starting at $120/month" with the first-month condition removed
Summary, strengths and trade-offs8 points
Mavés Health labels its growth-hormone figure a first-month rate on the product page and strips that condition off the same number on its homepage, and its terms of service name a company operating a different website entirely.
Strengths
- The product page states both the first-month rate and the standing rate in one line
- Prints the vial volume and the milligram strength beside the figure and says a home kit is included
- Discloses an unusually complete vendor stack — platform, two clinical entities and a named pharmacy — in its own terms
- Marks stock status on the product page
Trade-offs
- The homepage advertises the promotional figure without the condition that makes it promotional
- Its terms of service name a company operating a different domain than the one serving them
- The testing language on this site sits on the weight-loss pages, never on either peptide page
- No state coverage list and no certificate of analysis
166. VIV RX
$124 — from — the shop grid and the product page both print this as a floor per month
Summary, strengths and trade-offs8 points
VIV RX prices three tracked peptides as floors on one shop page, itemises what each plan includes, and carries a 2026 federal warning letter naming its own domain.
Strengths
- Lists what each plan includes as an itemised set rather than as a promise of value
- States the administration route and frequency for each compound on its own page
- Says plainly that FDA registration is not FDA approval, on the same line as the claim
- Prices three tracked compounds on one page a reader can compare at a glance
Trade-offs
- Carries a federal warning letter that names this exact domain
- Every figure is a floor, so the price a buyer actually pays is not published
- Names no dispensing pharmacy, only a license held by an unnamed one
- Publishes no state list and settles eligibility inside the intake
167. Get Thin MD
$129 — read from the site-wide navigation rail as "Sermorelin Injections — As low as $129/mo*", which carries an asterisk. The seller's own sermorelin product page publishes no figure of any kind — 18,725 characters of text and no dollar sign
Summary, strengths and trade-offs8 points
Get Thin MD trades under a legal name most readers would never guess, publishes a month-to-month figure well above its advertised one, and runs a growth-hormone product page carrying no price at all.
Strengths
- States the month-to-month price in a plain sentence, which most sellers on this roster never do
- Names its operating company in the first person in its own privacy policy
- Its growth-hormone page states plainly that the compound "is not currently available as an FDA-approved drug product"
- Tags every prescription item in the navigation with a prescription marker
Trade-offs
- The advertised figure and the month-to-month figure differ by seventy dollars on the same page
- The growth-hormone product page carries no price at all — the only figure for it sits in a navigation rail on a different product's page
- The privacy policy and the terms name different corporate forms for the one brand
- No certificate of analysis, no named pharmacy, no state coverage list
168. Sky Health Wellness Clinic
$140 — A FLOOR with no period — the chart reads "Sermorelin From $140" and states no unit at all, neither vial nor month. The medication is priced separately from the appointment: "Peptide Therapy Visit $99" is its own line on the same chart
Summary, strengths and trade-offs8 points
Sky Health publishes a single alphabetical price chart covering seventy-one services, prices the peptide visit separately from the medication, and puts a "From" in front of the figures that are floors.
Strengths
- Publishes one chart covering its entire service list, alphabetically, on a single page
- Prices the peptide appointment as its own line rather than folding it into the medication
- Marks which figures are floors with an explicit "From" and which are not
- Names its operating company in the terms
Trade-offs
- No peptide figure on the chart states a unit — not a vial, not a dose, not a month
- The peptide menu page publishes only the $99 visit fee, so a reader landing there sees no medication price
- Its terms decline to say where the service is available
- Names no dispensing pharmacy
169. Highland Longevity
$150 — The bottom of A published range, not a rate — "Peptide therapy at Highland Longevity typically ranges from $150-$350 per month depending on the specific peptide protocol. This includes physician oversight, dosing adjustments, and follow-up monitoring." Its own cards give two narrower overlapping ranges, "$200–350 /mo" and "$175–300 /mo", so the site publishes three ranges and no point value
Summary, strengths and trade-offs8 points
Highland publishes its peptide pricing as two overlapping monthly ranges under a heading that calls them transparent — which they are, so long as nobody collapses a range into a number.
Strengths
- Publishes a range with the period attached rather than a bare starting figure
- Says what the range covers — oversight, dosing adjustments and follow-up monitoring
- Describes screening and alternatives as part of the consultation, in writing
- Names the metro and the surrounding towns it serves
Trade-offs
- Publishes three overlapping ranges and no single figure for anything
- Publishes no corporate entity
- Only one compound this site tracks is named on the page
- Reviews labs rather than including them, which the "transparent pricing" heading does not make obvious
170. OurView Health
$150 — the product-page figure; no billing period is stated
Summary, strengths and trade-offs8 points
OurView Health says its parent company is the pharmacy, and publishes a membership table that halves its NAD+ figure without naming a billing period on either side.
Strengths
- Publishes a with- and without-membership comparison instead of only the member rate
- Says it compounds and ships "across all 50 states"
- States that completing an assessment does not guarantee a prescription
- Prices products on open pages rather than behind an intake
Trade-offs
- No figure anywhere on the site carries a billing period
- Describes its parent pharmacy without naming it
- Publishes no operating company on any page read
- Its own savings table prints a malformed annual figure
171. YourHealthRx
$150 — printed as 'Sermorelin · As low as $150/mo' in the same goal panel, under the same code-or-six-month-supply condition
Summary, strengths and trade-offs8 points
YourHealthRx prints a rate against five separate peptides and conditions every one of them on a promotional code or a six-month commitment that expires on a stated date.
Strengths
- Publishes a rate for five distinct peptides rather than one blended protocol
- States the condition attached to its rates instead of hiding it after intake
- Prints an expiry date on the promotion rather than running it indefinitely
- Groups its catalog by goal so a reader can find the compound for their purpose
Trade-offs
- Not one advertised rate is a plain month-to-month price
- Every figure requires a promotional code or a six-month supply, or both
- Its own page says it does not prescribe and routes to partner workflows, leaving unclear whether it is the seller
- Publishes no state list and names no dispensing pharmacy
172. Regenics
$159 — member price; the same line prints $399 as the non-member figure, membership is $39/month, and no billing period is stated for the vial
Summary, strengths and trade-offs9 points
Regenics prints two figures for every peptide it sells — a list price and a lower member price — and the member price is the only one a buyer can reach, because the catalog itself says ten further peptides are visible only after a $39-a-month membership.
Strengths
- Prints the non-member figure beside the member figure on every peptide page, so the discount is visible rather than implied
- Says on the NAD+ page that the compound is "Not FDA-approved for weight loss or athletic performance", which is a scoping most sellers leave out
- Its sermorelin page states plainly that adult wellness use is off-label and that the evidence for it is limited
- Sells GHK-Cu as a prescribed compounded cream and says so, rather than as a cosmetic jar
Trade-offs
- The full peptide catalog is behind a paid membership — the site says ten further peptides are member-only and names none of them
- Every published figure is a member rate that sits on top of a $39-a-month membership charge
- Its NAD+ page shows no price at all until a potency is selected, so the page reads as priceless on arrival
- Two of its own pages describe the same sermorelin item at two different strengths
- The 503A compounding pharmacy is never named, and no service-state list is published anywhere
173. Nuform Health
$160 — the per-month figure printed beside a prepaid four-month kit — "$160/mo large kit · $650 (4 month plan) · Billed in 4 month increments · INCLUDES SUPPLIES"; the small kit is $175/mo charged as $350 every two months, so the cheaper per-month rate is the larger prepayment
Summary, strengths and trade-offs8 points
Nuform Health, Inc. sells prescription peptide kits that are prepaid in multi-month blocks, and it says in its own copy that it does not offer monthly prescriptions or subscription plans — so the per-month figure printed beside each kit is arithmetic, not a bill.
Strengths
- States its own position on research-labeled peptides in plain words on its product pages, rather than leaving the category question to the reader
- Prints the prepaid total and the plan length beside every per-month figure, so the arithmetic is visible
- Says outright that it does not sell monthly prescriptions or subscriptions, which is the fact most sellers with prepaid kits leave out
- Names its operating company in its own footer and again in its terms
Trade-offs
- Every peptide price is a division of a prepaid block, so the advertised per-month figure is never what is charged
- Two entities appear across the site and the terms, and neither document explains which one a buyer contracts with
- The compounding pharmacy is described only as a 503A/503B facility and is never named
- No state coverage list, and no certificate of analysis or third-party testing anywhere in the pages read
174. Dr. Gillis' Wellness Center
$165 — Per MILLILITER, not per month: printed as "Sermorelin Therapy – $165/.2mL | $200/.3mL". Two syringe volumes at two figures, and the page does not print the concentration, so neither figure can be converted into a monthly cost or compared against any subscription on this roster
Summary, strengths and trade-offs8 points
Dr. Gillis' Wellness Center prices its growth-hormone peptide by the fifth and the third of a milliliter — the only per-volume peptide price on this roster — and never prints the concentration those volumes contain.
Strengths
- One of the widest clinical peptide lists on this roster, named openly in its own navigation
- Publishes a single pricing page covering every service rather than scattering figures across product pages
- Defines its own marketing name for a peptide in the seller's own words instead of leaving it opaque
- States its service area by naming the towns it serves
Trade-offs
- Prices the growth-hormone peptide by syringe volume without printing the concentration, so the figure converts to nothing
- Prices two peptides as one combination, so neither has an individual figure
- No operating company established on the page read
- No dispensing pharmacy named, no certificate of analysis, and a regional clinic model rather than a shipped program
175. Rewinding RX
$169 — printed on the treatments index as "Rewind Sermorelin — $169.00" with no billing period attached, unlike the same seller's coenzyme product which states "$139/month" explicitly. The requested /shop path redirects to /treatments; the effective URL is the one cited
Summary, strengths and trade-offs8 points
Rewinding RX publishes a flat monthly subscription with the dose printed beside it, and names itself as an LLC and a Ltd. in two places on the same page.
Strengths
- Prints the milligram strength and the volume beside the coenzyme figure, which almost nothing else on this roster does
- Offers a one-time thirty-day option beside the subscription and labels which is which
- States a flat price with no dose ladder and says so in its own words
- Names the clinical practice separately from the brand
Trade-offs
- Names itself as an LLC in one paragraph and a Ltd. in the footer of the same page
- The growth-hormone figure carries no period at all while the coenzyme figure does
- Claims third-party testing in its own copy with no certificate reachable anywhere
- The shop path redirects, so a cited shop URL is not a URL this seller serves
176. Peaks Curative
$169.99 — the category listing names no billing period, and the product page carries no figure at all
Summary, strengths and trade-offs8 points
Peaks Curative carries a February 2026 federal warning letter, names its pharmacy, and tells readers in one place that its treatments are FDA-approved and in another that compounded products are not.
Strengths
- Names its dispensing pharmacy as a legal entity
- Lists the nine states its doctors and pharmacy are licensed in
- Prints the vial size, the concentration and the sprays per bottle beside each figure
- Offers PT-141 as a nasal spray with a one-time price beside the subscription
Trade-offs
- Carries a February 2026 federal warning letter naming its own website
- Says its treatments are FDA-approved on one page and that compounded products are not on another
- Three of its four prices appear only on a category listing, not on the product page
- Its checkout offers a fifty-state dropdown while it names nine licensed states
177. Take10Rx
$172.96 — printed "per month" directly beneath a heading reading "QUARTERLY PLAN — Billed $518.87 today"; the charge is quarterly and the figure is that total divided by three
Summary, strengths and trade-offs8 points
Take10Rx prices sermorelin, glutathione and two forms of NAD+ per month on a quarterly plan, and its own product page asks whether a buyer can pay monthly instead — which is the clearest sign that the per-month figure is not a monthly charge.
Strengths
- Prints the amount actually charged today beside the per-month figure
- Puts the plan heading directly above the price rather than in a footnote
- Answers on its own page whether monthly billing is possible instead of quarterly
- Gives sermorelin, glutathione and both NAD+ routes their own product pages
Trade-offs
- Prints "per month" for a charge its own heading says is quarterly
- Carries a second billed figure on two pages with nothing saying what it buys
- Publishes no state list and names no dispensing pharmacy
- No certificate of analysis is reachable
178. Healthon
$175 — the catalog figure, printed as "Sermorelin ODT. Original price:. Final price: $175 Out of Stock". An orally-disintegrating tablet, not an injection, and no billing period is stated
Summary, strengths and trade-offs8 points
Healthon publishes four peptide SKUs, three different figures for the injectable coenzyme across its own pages, and an out-of-stock notice on every single one of them.
Strengths
- Publishes a browsable catalog with a figure against every SKU rather than gating prices behind an intake
- Sells the growth-hormone peptide in two routes and the coenzyme in two routes, each priced separately
- Marks stock status honestly on the catalog rather than letting a reader discover it at checkout
- Names the operating company and the clinical group in its own pages
Trade-offs
- All four peptide SKUs were out of stock on the date read
- Three different figures for the injectable coenzyme across the catalog, the product page and the site-wide rail
- Carries an FDA warning letter over online sale of unapproved and misbranded drugs
- The product page prints a period fragment — "first month /mo after Billed every 3 months" — with the numbers missing
179. StackMD
$175 — starts at; the homepage states no billing period for this figure
Summary, strengths and trade-offs8 points
StackMD prices NAD+, sermorelin and glutathione from one homepage list and settles every product page at a single "plans starting at" figure.
Strengths
- Says explicitly there are "no membership fees or hidden charges"
- Explains in its own words what compounding is and why a pharmacy may do it
- Prices three tracked compounds on one homepage list
- Gives each compound and each route its own product page
Trade-offs
- Its per-compound figures carry no billing period
- Publishes no complete operating company name
- Its product pages quote a plan floor that is lower than any compound figure it names
- Publishes no state list, no named pharmacy and no certificate of analysis
180. Invyncible
$179.10 — the current price against a struck-through $199.00 anchor for the 9 mg presentation, with no billing period or supply length stated anywhere on the page
Summary, strengths and trade-offs9 points
Invyncible names six compounding pharmacies with street addresses and phone numbers, says the patient chooses which one fills the prescription, and prints a two-state exclusion at the top of every product page — three disclosures almost nobody else on this roster makes.
Strengths
- Names six compounding pharmacies in a table with street addresses, phone numbers and websites, rather than describing a category
- States that the patient chooses which of those pharmacies fills the prescription, and may nominate one outside the network
- Prints its two-state exclusion in visible text at the top of every product page rather than revealing it at checkout
- Names the operating company, its brand relationship and a street address in the footer of every page
- Warns on the glutathione page that the product needs refrigeration and overnight shipping, before the order is placed
Trade-offs
- No product page states a billing period or a supply length, so none of its figures can be read as a monthly cost
- Every figure is a discount against a struck-through anchor, which is a promotional shape rather than a settled price
- The glutathione page offers two vial sizes under a single displayed figure without saying which it applies to
- No certificate of analysis or third-party testing claim appears on any page read
181. Nex Gen Health Rx
$195 — from; the product page states no billing period
Summary, strengths and trade-offs8 points
Nex Gen Health Rx names its dispensing pharmacy, prices four tracked compounds, and states a period for none of them.
Strengths
- Names Manifest Pharmacy rather than describing an unnamed accredited one
- Publishes a PT-141 figure, which most of this roster does not
- Prices glutathione to the cent instead of rounding to a marketing number
- Cross-links each product to the others from within the product page
Trade-offs
- None of its four figures carries a billing period
- Publishes no operating company on any page read
- Its sermorelin price is published on a testosterone product page rather than a sermorelin one
- Publishes no state list and no certificate of analysis
182. Fidelity Medical Clinic
$198 — an eight-week supply
Summary, strengths and trade-offs8 points
Fidelity Medical Clinic advertises "$99 a Month" for a figure its own pricing box says buys two months, and charges one tirzepatide price for eight doses, seven doses and four doses.
Strengths
- Prints the dose count, the vial size and the concentration inside every price box
- Publishes an initial, a step-up and a maintenance rung for each product
- Prices the oral forms of both weight-loss molecules identically and separately
- Says what the package includes, down to the supplies and the shipping
Trade-offs
- Its headline calls a two-month price a monthly one
- Charges the same tirzepatide price for eight, seven and four doses
- Its NAD+ price buys three months as an initial order and two as maintenance
- Its comparison figures for branded drugs are unsourced and its step-up unit is left indeterminate
183. Apex MD
$199 — first month only; the page states $249 after the first month
Summary, strengths and trade-offs8 points
Apex MD charges one figure — $249 a month — for NAD+ injectable, NAD+ nasal spray and sermorelin alike, and discounts only the first month on a separate funnel page.
Strengths
- Prints the monthly period beside every figure on its peptide page
- Charges the same figure for the nasal and injectable routes rather than upselling one
- Says in its own terms that fulfillment runs through "compounded pharmacies" licensed in the states it serves
- Publishes its prices without an account or an intake
Trade-offs
- Publishes no operating company anywhere on the pages read
- A separate funnel page prices sermorelin differently from the peptide page
- Publishes no state list and names no dispensing pharmacy
- No certificate of analysis is reachable
184. Bowery Clinic
$199 — flat product-page price; the page prints a strength and a supply length beside it that this figure does not reflect
Summary, strengths and trade-offs9 points
Bowery Clinic puts one flat sticker price on each peptide with the strength and the supply length printed beside it, and tells shoppers on the product page that nothing further is added at checkout.
Strengths
- Prints the strength, the format and the words "Lasts approximately 4 weeks" beside each sticker price, so the figure describes a stated quantity instead of a billing cycle
- Offers a dissolvable troche as well as a vial on several peptides, so most of the catalog is usable without injecting
- One of the widest published peptide menus on this roster: KPV, Semax, Epithalon and MOTS-c each carry their own visible price
- Answers the price question head-on in its FAQ, explaining why its peptides cost more than research-grade material
Trade-offs
- Its own Terms say charges "may include" consultation fees, laboratory or diagnostic services and membership or administrative fees, which contradicts the product pages saying there are no additional fees
- Section 32 of the same Terms states the products "are not intended for human or animal consumption of any kind" and are "Not medical treatments", wording that sits oddly on a site selling prescribed therapy
- Describes its pharmacies only as "503A FDA-Registered Pharmacies" and never names one
- Publishes no state list at all, so a shopper cannot tell before signing up whether care is available where they live
- Prices Semax, MOTS-c and Epithalon against a five-week supply, so those three figures are not monthly costs
185. Mochi Health
$199 — starting at, plus a separate Mochi Health membership; the page states no billing period for the medication figure
Summary, strengths and trade-offs8 points
Mochi Health prices NAD+ in three formats and sermorelin in one, and states under every figure that the medication cost sits on top of a separate membership fee rather than inside it.
Strengths
- Prices NAD+ in three delivery formats, so the injection is not the only option with a figure attached
- States on every product page that the medication figure excludes the membership, rather than burying that in terms
- Names the dosage each figure corresponds to, and says additional dosages exist
- Runs a pharmacy marketplace and says so openly, rather than implying a single in-house facility
Trade-offs
- No medication figure carries a billing period, so none is comparable to a monthly rate without arithmetic
- Every figure requires a separate membership the product page does not add in
- Names no dispensing pharmacy; its pharmacy page is a recruitment page for pharmacies, not a disclosure
- Publishes no state list — its FAQ describes the program as virtual and available "anywhere in the United States", which is a format claim rather than a licensure list
186. Alpha MD
$229.99 — for a supply the page calls ten to fifteen weeks, outside California; printed as a size option beside the California one
Summary, strengths and trade-offs8 points
Alpha MD prices one product under three peptide names and publishes a second, higher figure for buyers in California — and neither figure is a monthly rate, because both buy a supply the page measures in weeks.
Strengths
- Publishes a separate figure for California buyers rather than surfacing the difference at checkout
- Publishes a figure on its own site with the unit recorded beside it
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Both published figures buy a supply window whose width the page says depends on the dose prescribed
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
187. LeadWest Medical
$250 — per vial at the entry strength; 10 mg is $350 and 15 mg is $450, and the page closes with "Pricing shown is for presentation and consultation flow purposes"
Summary, strengths and trade-offs9 points
LeadWest Medical is a Newport Beach telemedicine practice serving California and Nevada that prints a price and a milligram strength for every peptide it carries, then states underneath the list that those figures exist for presentation purposes.
Strengths
- Prints the milligram strength beside every price and sells several strengths of the same peptide, so each figure is tied to a stated quantity
- Publishes a street address and two working phone numbers rather than an email form alone
- States a service footprint of California and Nevada instead of implying nationwide coverage
- Itemizes a $30 care-logistics and shipping-coordination charge on its pricing page rather than folding it into the product price
Trade-offs
- Closes its own price list with "Pricing shown is for presentation and consultation flow purposes", which withdraws most of what the list appears to promise
- The peptide page claims "No Extra Charges" while the pricing page adds $30 per order for care logistics and shipping coordination
- Sells retatrutide, which has no FDA approval for any indication and therefore no approved labeling to dose against
- Coverage is two states, so most readers of this comparison cannot buy from it at all
- No compounding pharmacy is named anywhere on the peptide pages
188. Lyfe Rx
$250 — from; the collection page names no billing period
Summary, strengths and trade-offs8 points
Lyfe Rx carries a 2025 federal warning letter naming its own website, and today publishes a flat storefront price for bremelanotide and for two glutathione products with no billing period stated anywhere on the listing.
Strengths
- Puts a figure beside every product in an open storefront rather than behind an intake
- States in its own words that compounded drugs are not reviewed by the FDA and are not generic equivalents
- Says plainly that it is a telehealth platform and not a pharmacy
- Sells bremelanotide under its molecule name rather than a brand alias
Trade-offs
- Carries a 2025 federal warning letter that names its own website address
- Prints no billing period beside any storefront figure, so no price here is a monthly one
- Lists a nasal spray and a "protocol" at different prices for the same compound without saying what separates them
- Names no dispensing pharmacy and publishes no certificate of analysis
189. South Florida Face & Body
$250 — the bottom of the range it publishes for its entire peptide menu — 'roughly $250 to $600 per month, depending on which peptide(s) you're prescribed' — so the figure is not scoped to sermorelin or to any single compound. Consultation and baseline labs are quoted separately and the page says so
Summary, strengths and trade-offs8 points
South Florida Face & Body publishes a whole-menu price range instead of a price per compound, and says plainly that a quote far below the market usually means gray-market product.
Strengths
- Publishes a price range rather than refusing to discuss cost before intake
- States that consultation and baseline labs are quoted separately
- States that an outside licensed pharmacy fills prescriptions, rather than implying it dispenses in house
- Warns in its own words what an unusually low quote usually means
Trade-offs
- Its range covers the whole menu, so no compound has a price of its own
- Publishes no corporate entity, only a named clinician and a license number
- Charges for consultation and labs on top of the quoted range
- Publishes no state list beyond the one state it operates in
190. The NP 2 Go
$250 — per vial for home delivery, with no billing period stated; the page sets it under "Peptide Therapy" and says only "Available in select states"
Summary, strengths and trade-offs8 points
The NP 2 Go publishes a full dose ladder for its two weight-loss drugs under two different programs, prices sermorelin and NAD+ by the vial, and prints three different state counts on its own site.
Strengths
- Publishes a complete dose ladder for both weight-loss drugs rather than a single starting figure
- Prices the same dose under two different programs side by side, so the trade-off is visible
- Says in its own words that compounded semaglutide and tirzepatide are not FDA approved
- Prints the unit its peptide figures are charged against — a vial, or a single in-office treatment
Trade-offs
- Prints three different counts of the states it serves on its own site, unreconciled
- Publishes no list of states, only counts
- Names no dispensing pharmacy, saying only "reputable pharmacy partners"
- No certificate of analysis is reachable
191. BioGlow Health
$259 — the price beside "~1 month supply"; the shop names no billing cycle, and the tilde is the seller's own
Summary, strengths and trade-offs8 points
BioGlow Health puts every peptide figure in visible text on an open shop page with no account gate, and then describes two of its three nasal sprays with the word "Injectable" — the injection copy pasted onto the nasal listing.
Strengths
- Every product figure sits in visible text on an open shop page — no account, no quiz and no blur between a reader and the price
- Publishes a dose ladder for its GLP-1 line rather than one headline figure, which is the same transparency applied to a different lane
- Runs the whole site in English and Spanish from a header toggle
- Claims fifty-state service for itself in its own footer
Trade-offs
- Two of its three nasal-spray listings — NAD+ and glutathione — describe themselves as injectable, so the delivery copy contradicts the product name
- Every price is labeled "~1 month supply" with a tilde and no billing cycle, so no figure is a quoted monthly charge
- The compounding pharmacies are described only as licensed and are never named
- Lab panels are required by its own process description but are not stated to be included in any price
192. Onus IV
$260 — the bottom of a published range and not a rate — the peptide menu reads "Price: $260-$400 (depending on dosage / protocol)" and states no period, no strength and no supply length, so this figure is a floor rather than a cost of treatment
Summary, strengths and trade-offs9 points
Onus IV is a Colorado clinic chain that publishes a dose-by-dose NAD+ ladder with a member price beside every rung — and the member discount widens from 18 percent at the smallest dose to 38 percent at the largest.
Strengths
- Publishes a dose-by-dose NAD+ ladder with a stated milligram amount and a figure on every rung, which almost nothing else compared here does
- Prints the member price beside the standard price on every rung rather than advertising a discount in the abstract
- Names its operating company and a privacy officer by name in its own policy
- Names the clinics and the mobile service it operates, so a reader can tell where the treatment happens
Trade-offs
- Colorado only, so most readers of a national comparison cannot buy here at all
- No governing-law clause exists: the site publishes a privacy policy and a disclaimer and has no terms-of-service page at all
- Its sermorelin listing is a range with no strength and no protocol, and its GHK-Cu listing is a bare figure with no quantity
- The published address omits the city, giving only a street, a state and a ZIP code
- No compounding pharmacy is named and no lab work is described as included
193. LifespanningRx
$270 — one-time purchase of a 1 month supply, in the seller's own words — "Single delivery of your selected duration. No subscription required." The 3 months supply lane on the same page is $590.00 in total, not $590.00 a month.
Summary, strengths and trade-offs6 points
LifespanningRx names its operating company and its state of incorporation in its own terms, and puts a supply-duration control on each product page so a reader can see what one month and what three months cost before starting an intake.
Strengths
- Names its operating company, its state of incorporation and a street address in its own terms, and names Florida as the governing law
- A supply-duration control sits on each product page, so the one-month and three-month figures can both be read before an intake starts
- States beside the price that a prescription follows a telehealth consultation and that the preparation is dispensed by a licensed compounding pharmacy
Trade-offs
- No state coverage list appears anywhere on the site, so eligibility can only be settled by starting an intake
- The compounding pharmacy that fills an order is described by category and never named
- The home page carries a patient-count claim and a clinician-credential claim that a reader has no way to check from outside
194. Avara Rx
$299 — starting at; the page states no billing period
Summary, strengths and trade-offs8 points
Avara Rx prints "Starting at" and a number on each of its three peptide pages and states no period on any of them, while its GLP-1 copy on the same site says "per month".
Strengths
- Publishes a figure for all three of its tracked compounds without an intake
- Describes itself in its own words as "a LegitScript-certified telehealth pharmacy"
- Gives each compound its own page rather than burying them in one menu
- States a review cadence — "1:1 doctor-led care, every quarter" — beside each price
Trade-offs
- None of its three peptide figures carries a stated billing period
- Publishes no operating company on any page read
- Publishes no state list and names no dispensing pharmacy
- Its GLP-1 copy states a period its peptide pages do not
195. TeleWellnessMD
$299.95 — per vial as listed — "Sermorelin / 3mg/mL / 5mL Vial"; the seller publishes no billing period for it
Summary, strengths and trade-offs8 points
TeleWellnessMD prices by the vial rather than by the month, printing the strength and the vial volume beside every figure, and it folds the consultation fee into the price of the therapy instead of billing it separately.
Strengths
- Prints the strength and the vial volume beside every figure, so a reader can see what the money buys
- Folds the consultation fee into the therapy price rather than charging for the visit separately
- Offers glutathione in two vial sizes at two published figures instead of one blended rate
- States that further consultations are scheduled at no additional cost
Trade-offs
- Publishes no billing period at all, so none of its figures can be compared against a monthly rate
- Ships its whole formulary inside a hidden block of the catalog page, where the prices render for nobody
- Names its own corporate entity two ways — "TeleWellnessMD®, LLC" in the Terms of Use, "TeleWellnessMD™ Inc." in the footer
- Describes its pharmacies as LegitScript certified without naming any of them
196. Endocrinology Associates
$300 — Per vial, and a floor — "Sermorelin Starting at $300 per vial". The same page prices pinealon at $200 per vial, a compound this site does not compare
Summary, strengths and trade-offs8 points
A named Ohio endocrinology practice that publishes a dedicated peptide pricing page — per vial for the peptides, per treatment for the coenzyme — and also runs a retail storefront it links from the same site.
Strengths
- Publishes a dedicated peptide pricing page on a named medical practice's own domain
- States the unit on every line — per vial for the peptides, per treatment for the coenzyme
- Names the operating company in the sentence that describes who runs the site
- Publishes a street address and a contact route in the same document
Trade-offs
- Every figure is a "starting at", and no vial size sits beside any of them
- Publishes no state coverage and names no dispensing pharmacy
- Runs a consumer retail arm it links from its own clinical site, which is a commercial surface a reader should know about
- The only PDFs it links are intake and records-release forms, not testing documents
197. Miami Bariatric & Plastic Surgery
$349 — printed as 'From $349' against a term the page writes as '6-Week (1.5 Months)' — the seller's own conversion, not adopted here; a ten-week course is priced separately and a consult fee is charged on top
Summary, strengths and trade-offs8 points
Miami Bariatric prices six peptides on one table and gives almost every one a different term — four to eight weeks, six weeks, nine to twelve weeks — while calling four weeks a month.
Strengths
- Publishes a figure for six separate compounds on a single readable table
- States the program length beside every figure rather than leaving the term unstated
- States the injection count for its NAD+ courses rather than only a duration
- Publishes its consultation fees separately and says when they are credited back
Trade-offs
- Six compounds carry six different terms, so no two figures on its own table are comparable
- Calls a four-week program one month, which is thirteen payments a year rather than twelve
- Every figure is a floor, and no page says what the ceiling is
- Publishes no corporate entity, no state list and names no dispensing pharmacy
198. Nip & Tuck Wellness Institute
$360 — Two FIGURES, one PAGE, both published TODAY: one table prints 'Sermorelin: $360 Monthly' and a branded table lower on the same page prints 'The Growth Signal Sermorelin $249+'. The higher figure is recorded and the conflict is stated rather than resolved
Summary, strengths and trade-offs8 points
Nip & Tuck publishes a figure against each of eight compounds and its own overall range in words — and prints two different sermorelin prices on the same page.
Strengths
- Publishes a figure for eight separate tracked compounds on one page
- States its own overall price range in plain words rather than leaving it to be inferred
- Prices oral and injectable forms of the same compound separately
- Prices multi-peptide stacks separately from the single compounds inside them
Trade-offs
- Publishes two different sermorelin figures on one page with no explanation
- Almost every figure is a floor marked with a plus sign rather than a settled rate
- Publishes no corporate entity, only a named physician
- Publishes no state list and names no dispensing pharmacy
199. AgeRejuvenation
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
AgeRejuvenation names fourteen tracked compounds on one peptide page, the deepest single menu in this batch, and does not price a single one of them.
Strengths
- Names fourteen tracked compounds on one page, the deepest single menu here
- Names its operating company on two separate legal pages
- Runs separate NAD+ and glutathione pages beneath the main peptide menu
- Covers KPV, semax, epitalon and MOTS-c, which most rosters miss entirely
Trade-offs
- Carries no figure on its peptide menu or on any compound page
- Its legal name is tied to one location while the brand is presented as regional
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
200. the biostation
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
the biostation links per-compound fact sheets from its peptide page, and one of the two, fetched directly, answers successfully with an empty file.
Strengths
- Publishes per-compound reading material of its own, which most sellers here do not
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- One of the two linked documents answers with an empty file, and neither is a certificate
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
201. Companion Health
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Companion Health publishes its operator as a professional limited liability company on four separate pages, which is more than most sellers here manage, and no price on any of them.
Strengths
- Publishes its operator in a professional-corporation form on four separate pages
- Names five distinct compounds including PT-141
- Describes itself as concierge medicine rather than a subscription storefront
- Returns a clean hard error for a path that does not exist
Trade-offs
- Carries no figure on any page read
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
- Exposes a small site, so little can be cross-checked
202. Delphi Wellness
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Delphi sells peptides in "credits" rather than dollars, so no peptide on its menu has a price — and it claims third-party batch testing while publishing no certificate a reader could open.
Strengths
- Names the corporate entity, its state of formation and the DBA relationship in one sentence
- Names its Medical Director on the service page
- Explains why its credit costs vary rather than leaving the mechanism unstated
- Says which pharmacies fill orders by license class and says peptides ship from them directly
Trade-offs
- No peptide on the menu has a dollar price — the unit is a credit, and credit costs are not published
- Claims third-party batch testing twice and publishes no certificate, no PDF and no link
- The only two figures on the service page are a credit top-up and a valuation gloss
- Publishes no state coverage and names no dispensing pharmacy
203. Eden Health Club
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Eden Health Club runs a separate page for each of thirteen compounds tied to one Colorado location, and the only number on any of them is the same one repeated sitewide.
Strengths
- Publishes a page per compound rather than one combined peptide menu
- Names thirteen tracked compounds, among the deepest menus here
- Names its operating company on the pages it serves
- Ties each compound page to a named location rather than a vague service area
Trade-offs
- Carries no compound-specific figure on any of its per-compound pages
- The only figure sitewide repeats identically on every page, so it prices nothing
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
204. GoalBMI Wellness
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
GoalBMI Wellness sells peptides as fixed four-to-six-week programs from a Brooklyn telehealth practice, quoting each one as a starting figure with a $99 consultation stated separately alongside it.
Strengths
- Quotes each peptide as a program with a stated length of about four to six weeks rather than as an open-ended monthly charge
- Lists on every product page exactly what the program price covers: medication, syringes, alcohol pads, supplies and shipping
- Prices the required consultation separately at $99, so the entry cost is not hidden inside the program figure
- Publishes a figure for the four-peptide KLOW combination and a separate one for oral KPV, which most sellers leave to a phone call
Trade-offs
- Its Terms name only "New York, Florida, Pennsylvania, Michigan, New Jersey, and additional participating states", so the real footprint is not published
- The MOTS-c program at $599 for four to six weeks is the most expensive figure for that compound anywhere on this roster
- Every figure is a starting price its own disclaimer says may change with dose, formulation or program length
- Does not name the compounding pharmacy that fills its prescriptions
205. Immortals
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Immortals quotes its headline offer per day over a catalog priced per item, and only one of the four tracked compounds it names carries a figure at all.
Strengths
- Names four tracked compounds as products in its own navigation
- Publishes a figure on its own site with the unit recorded beside it
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Its headline figure is quoted per day, a unit nothing else here can be compared against
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
206. InjectCo
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
InjectCo publishes two different monthly prices for the same compounded semaglutide program on two of its own pages, and prints "We Only Use FDA-Approved, Trusted Products" above copy describing compounded drugs.
Strengths
- Itemises what the monthly subscription buys, down to the injection supplies and the training
- Prices a sublingual form separately from the injection
- Names the pharmacy class — 503B — rather than leaving it unstated
- Publishes street addresses for two physical clinics
Trade-offs
- Publishes two different monthly figures for the same compounded semaglutide program
- Prints an FDA-approval headline above compounded product copy
- Its five dedicated peptide pages carry no price for any peptide
- Serves one state, so most readers cannot buy from it
207. Ivologist
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Ivologist publishes no price on any product page. The only figure it attaches to itself is a range inside its own blog comparison table, which is where this record’s single price comes from and why it is recorded as a range.
Strengths
- Says plainly that compounded medications, if prescribed, are not FDA-approved
- Names the pharmacy categories it works with — 503A and 503B — rather than saying only "licensed"
- Puts its own price range beside branded, commercial-program and surgical costs in one table
- Says eligibility is determined by licensed providers through a medical evaluation
Trade-offs
- Publishes no price on any product or program page
- Its only self-scoped figure is a range in a blog post, and the top of that range is three-quarters higher than the bottom
- Publishes no state list and names no dispensing pharmacy
- Sells sermorelin and NAD+ with no figure attached to either
208. Just Wellness
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Just Wellness prices nine things on its home page and not one of them is a peptide; its peptide page, the one document that should carry a figure, carries none.
Strengths
- Publishes detailed prices for its other services in clearly stated units
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Its peptide page is the only page on the site with no figure on it at all
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
209. Modern Wellness Clinic
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Modern Wellness Clinic names eight tracked compounds on one service page and tells readers, in its own words, that many of its patients arrive after buying peptides from research chemical companies with no medical oversight.
Strengths
- States plainly, on the page selling the treatment, what it thinks of the unsupervised market
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Its own linked storefront serves a page with no products, so nothing is priced anywhere
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
210. Nava Health
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Nava Health publishes a full price list with a member and a non-member column for every line, prices NAD+ and glutathione by the infusion at three strengths each, and adds a third column for two membership tiers on its packages.
Strengths
- Publishes a full itemised service price list rather than a headline figure
- Prints the member and non-member price on the same row, so the discount is visible
- Prices NAD+ and glutathione at three strengths each rather than one
- Warns readers in its own words against buying research chemicals online
Trade-offs
- Its host answers a success code for a page that does not exist, so no absence here can be proven by status
- Prices infusions per session, so nothing here is a monthly cost
- Publishes no state list and names no dispensing pharmacy
- Sells seven other tracked peptides that carry no published figure at all
211. Nolu
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Nolu prices three weight-loss options at the same figure regardless of dose, and every one of those figures is quoted on a twelve-month plan. It says it serves all fifty states and, two lines later, that some services may not be available in all of them.
Strengths
- Charges the same figure at every dose and says so on the page
- Names Nolu LLC as the operating company in its footer
- Says compounded medications are not FDA-approved and have not been reviewed for safety, effectiveness or quality
- Notes that its product image is stylised and does not reflect the actual label or vial size
Trade-offs
- Every published figure is quoted on a twelve-month plan, and no shorter-plan rate is published
- Says it serves all fifty states and, in the next breath, that some services may not be available in them
- Lists sermorelin and NAD+ with no price attached
- Names no dispensing pharmacy and no certificate of analysis is reachable
212. Nucore Health
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Nucore Health charges one monthly figure at any dose for each of its three NAD+ and glutathione products and says it serves all fifty states.
Strengths
- Prints "Any Dose" beside every figure, so titration does not change the price
- Says in its own words that services are "available nationwide in all 50 states"
- States that prescription treatment is not guaranteed and clinical review is required
- Marks its products FSA/HSA eligible on the product page
Trade-offs
- Charges more for the nasal spray than for the injection with no stated reason
- Publishes no operating company on any page read
- Names no dispensing pharmacy
- No certificate of analysis is reachable
213. Nurture Wellness & Aesthetics
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Nurture Wellness prices two peptide programs at the same starting figure and names the compounds in neither, so the number buys a program rather than a drug.
Strengths
- Publishes a full pricing page rather than quoting only at consultation
- States a monthly starting figure for its programs rather than an unqualified number
- Prints its consultation fee separately instead of folding it into the program
- Keeps its peptide programs on the same page as the rest of its fee schedule
Trade-offs
- Neither peptide program names the compounds it contains
- Two different programs carry an identical starting figure with no stated difference in cost
- Publishes no corporate entity on any page read
- Publishes no state list and names no dispensing pharmacy
214. Pure Hydration
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
The only two dollar figures on Pure Hydration's copper-peptide page are the seller describing what the market charges, in an answer that never says what it charges.
Strengths
- Names its operating company in the footer of every page read
- Publishes per-compound pages rather than one undifferentiated peptide menu
- Publishes patient injection guides as documents a reader can actually open
- Answers a cost question at all, which several sellers in this batch do not
Trade-offs
- Prices only its in-person NAD+ infusions; the figures on its GHK-Cu page describe the market, not its own peptide programs
- Serves its own patient PDFs over plain HTTP from an HTTPS page
- Names no dispensing pharmacy and publishes no state coverage
- Its cost answer reads like a quote and is not one, which is the easiest error on this host to make
215. RegenCen
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
RegenCen argues against the research-use market by invoking FDA prohibition, and publishes its operator under a management-company name a reader would never guess.
Strengths
- States its position on research-use compounds explicitly rather than staying silent
- Publishes its operating company, even though the name shares nothing with the brand
- Runs a dedicated peptide-therapy treatment page separate from its IV line
- Names five distinct compounds across its treatment pages
Trade-offs
- Its legal name shares no words with its brand, so the operator is effectively hidden in plain sight
- Carries no figure on any of the six pages read
- Its regulatory claim about prohibited compounds is its own assertion with no source attached
- Publishes no state list and names no dispensing pharmacy
216. Relive Health
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Relive Health's terms name a franchising company rather than a clinical one, so the party on the other side of the contract is the brand owner.
Strengths
- Names the contracting company and publishes a postal address for it
- Names the company on the other side of the transaction rather than only a trading name
- Declares nine of the sixteen compounds this site tracks on pages a reader can reach
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Its terms carry a last-modified date from nearly three years before this reading
- Publishes no figure for any compound on the pages read
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
217. Spa Sydell
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Spa Sydell organizes its peptide menu three ways — by compound, by blend and by concern — and prices none of them; the numbers on its site belong to its skincare shop.
Strengths
- Lets a reader browse peptides by individual compound, by blend or by concern
- Names eleven tracked compounds across its browse pages
- Keeps its retail shop on separate pages from its therapy menu
- Returns a clean hard error for a path that does not exist
Trade-offs
- Carries no figure on any of its four peptide browse pages
- Publishes no corporate entity on any page read
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
218. Talon Wellness
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Talon claims all fifty states in its own header and publishes nothing at all about what peptide therapy costs — its peptide page carries no figure of any kind.
Strengths
- States a fifty-state footprint in its own header rather than burying it in terms
- Separates peptide therapy from its weight-loss and hormone lines as its own service
- Publishes a described process rather than only a booking form
- Names the two compounds this site tracks plainly on the service page
Trade-offs
- Publishes no figure of any kind on its peptide page or its terms
- Publishes no corporate entity
- Names no dispensing pharmacy
- The pricing language the seller carried in an earlier capture is no longer on the page, so nothing about cost is currently disclosed
219. Tyde Wellness
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Tyde Wellness publishes two company names and tells a reader which is the brand and which is the clinic — then sells access by membership and prices neither peptide.
Strengths
- Discloses both its brand company and its clinic company, and distinguishes them
- Publishes a separate notice of privacy practices as well as a privacy policy
- Publishes its membership terms rather than describing membership only in marketing copy
- Names sermorelin and NAD+ specifically rather than selling an unnamed protocol
Trade-offs
- Publishes no figure for either peptide it sells
- Sells through a membership, so a drug price and an access fee are two separate unknowns
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
220. Voxy Health
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Voxy Health prints four plan lengths for each weight-loss drug with the billing cadence written beside every rate, so a prepaid figure can never be mistaken for a monthly one. It sells three tracked peptides with no price attached to any of them.
Strengths
- Prints the billing cadence beside every rate, so a prepaid figure is never shown as a monthly one
- Publishes a street address and a telephone number in its footer
- Says compounded medications are not reviewed by the FDA for safety or efficacy, twice on the same page
- Says what each plan includes — medication, supplies, shipping and check-ins — rather than leaving it to checkout
Trade-offs
- Lists NAD+, glutathione and sermorelin as treatments and prices none of them
- Says availability may vary by state without publishing a list of states
- Names no dispensing pharmacy, saying only that it is 503A licensed
- Its batch-testing sentence is a claim; no certificate of analysis is reachable
221. Vyora Wellness
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Vyora Wellness describes independent third-party potency and purity testing in its own FAQ, and publishes one peptide price behind a shop that hides most of the rest.
Strengths
- Describes what its third-party testing checks — strength, match to prescription, contaminants
- Names Vyora Wellness LLC and publishes an informed-consent addendum
- Says it partners with "U.S.-based 503A certified pharmacies"
- Attaches a month to the one peptide figure it shows publicly
Trade-offs
- Publishes no certificate of analysis despite describing third-party testing
- Gates most product pages behind a password, so most prices cannot be read
- Publishes no state list and names no dispensing pharmacy
- Its one readable NAD+ figure appears only in a related-products strip
222. Taurus Meds
$79/mo — printed as "Sermorelin — Natural Growth Hormone — $179 $79 /mo", the identical promotional figure and identical anchor as this seller's other two peptides. A flat cross-compound price, not a per-compound one
Summary, strengths and trade-offs8 points
Taurus Meds charges the same promotional figure for three different peptides against the same anchor, and the research-use language an automated scan finds on its site turns out to govern patient records, not products.
Strengths
- A dedicated peptide route with all three products, their anchors and their figures on one page
- Names the operating company, its state of registration and its street address in its own terms
- Names the clinical partner organization separately from the brand
- A flat price across three compounds, which removes the guesswork about which one is cheaper here
Trade-offs
- Every figure is promotional against the same anchor, with no expiry stated, so all three will decay together
- A flat cross-compound price tells a reader nothing about what any individual compound costs to supply
- No pharmacy named, no certificate of analysis, no state coverage list
- Its clinical partner stands behind other brands, so naming it distinguishes little
223. Ok Pharmacy
$99/mo — the reduced price; the same listing prints a struck-through higher figure, and the body text says monthly fixed pricing and describes the supply as approximately one month with one injection weekly
Summary, strengths and trade-offs8 points
Ok Pharmacy resells another company's branded peptide and publishes more about that company than the company publishes about itself, including a testing claim with no certificate behind it.
Strengths
- States the supply length and the injection frequency in the body text beside the figure
- Publishes a figure on its own site with the unit recorded beside it
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Its testing claim reports what the brand says its partner pharmacies do, with no certificate anywhere
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
224. Brello Health
$116/mo — per month, advertised as a special; the homepage shows $199 as the undiscounted rate
Summary, strengths and trade-offs8 points
Brello Health advertises a three-month plan and then bills it every eleven weeks, which makes its cheapest peptide figures shorter-lived than they look.
Strengths
- Prints the discounted and undiscounted figure together rather than only the promotional one
- States the billing interval in plain words on the product page
- Prices sermorelin and NAD+ separately instead of bundling them into one plan
- Publishes a cancellation term — a $50 professional services fee after a prescription is written
Trade-offs
- Calls a plan "3 month" and bills it every eleven weeks on the same page
- Answers 200 at every path, so nothing about the site can be proven absent
- Publishes no operating company, no state list and no named pharmacy
- Its lowest figures are described as specials with no stated end date
225. Alyve
$129/mo — from, per month
Summary, strengths and trade-offs8 points
Alyve prices seven tracked-compound products across injectable and sublingual forms, and runs a site-wide banner quoting a tirzepatide figure that matches neither of its own tirzepatide products.
Strengths
- Prices the injectable and the sublingual form of each molecule separately
- Says what the price includes — the vial size and a home kit
- States in bold on its own safety page that its compounded products are not FDA-approved
- Marks products that are not yet purchasable as coming soon rather than pricing them silently
Trade-offs
- Its site-wide banner quotes a tirzepatide price that matches neither of its tirzepatide products
- Names no dispensing pharmacy, only a "Pharmacy Network"
- Makes no state-coverage claim at all
- Its terms of service still carry an unreplaced template placeholder in the date line
226. TMates
$129/mo — from, per month, in the open catalog
Summary, strengths and trade-offs8 points
TMates prices semaglutide, tirzepatide, NAD+ and sermorelin by the month in an open catalog, states plainly that it is not a compounding facility, and lists two branded drugs at a figure a fraction of their list price.
Strengths
- Publishes an open catalog with a price on every row and no intake in the way
- States in its own words that it is not a 503A or 503B compounding facility
- Says compounded medications are not evaluated by the FDA for safety, quality or efficacy
- Names TMates Inc as the operating company and prints trademark attributions for the branded drugs it lists
Trade-offs
- Lists two branded drugs at a figure a fraction of their published list price, with no explanation of what it buys
- Says it has doctors in all fifty states and, elsewhere, that it ships to most states
- Publishes no state list and names no dispensing pharmacy
- No certificate of analysis is reachable
227. VEVArx
$133/mo — the seller’s own stated equivalent of its $399 three-month plan
Summary, strengths and trade-offs8 points
VEVArx sells peptides only as three-month plans and prints the total and the per-month equivalent together, except for PT-141, which it also sells monthly.
Strengths
- Prints the prepaid total and the per-month equivalent on the same card
- Offers PT-141 month to month as well as on a three-month plan
- States plainly that compounded medications are not approved by the FDA
- Lists what each plan includes rather than only what it costs
Trade-offs
- Sells sermorelin, glutathione and NAD+ only in three-month blocks
- Publishes no operating company on any page read
- Publishes no state list and names no dispensing pharmacy
- No certificate of analysis is reachable
228. Fitish
$149/mo — "SERMORELIN / $149 / Pricing is for a monthly supply"; the FAQ reads "Starting at $149 for a monthly supply, including your provider consult, the medication if approved, and shipping." Same page: "No-Ship States: AK, AR, CA, IN, MI, MN, SC"
Summary, strengths and trade-offs8 points
Fitish prices three of the compounds compared here across five preparations, says in one sentence what each figure covers, and is one of very few sellers on this roster that publishes the states it will not ship a product to.
Strengths
- Publishes the states one of its products will not ship to, which most sellers here do not do at all
- Says in one sentence that the figure covers the consult, the medication and shipping
- Prices two preparations of the same compound separately at two different figures
- States the dose options beside the compound rather than leaving them to the intake
Trade-offs
- Carries a federal warning letter that names its own domain
- Publishes a no-ship list on one product page and none on the other four
- Prints a zero inside its own price block, where a compare-at figure would sit
- Names no compounding pharmacy on any page read
229. Revel Health
$149/mo — the ongoing rate, printed as "from", with a lower first-month figure printed on the same line
Summary, strengths and trade-offs8 points
Revel Health prints two figures on every product line — a first month and the ongoing rate — which is honest and is also the easiest way for a comparison to go wrong.
Strengths
- Labels the first-month figure as such rather than presenting it as the ongoing rate
- Publishes a figure on its own site with the unit recorded beside it
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Publishes no company name; the only corporate-looking string on the page is a pair of state abbreviations
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
230. OBU Health
$149/mo — the monthly plan figure on the product page, which the seller describes as the same price per vial
Summary, strengths and trade-offs7 points
OBU Health publishes two different figures for the same product on the same page, in two different units, and neither one corrects the other.
Strengths
- Publishes a monthly plan and a prepaid three-month plan side by side, with the terms stated
- Names the company on the other side of the transaction rather than only a trading name
- Publishes a figure on its own site with the unit recorded beside it
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Its product block and its own comparison table give two different figures for the same product
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
231. GoodGirlRx
$158/mo — the one-month plan; this page mislabels its own $158 as a tirzepatide price
Summary, strengths and trade-offs8 points
GoodGirlRx carries a February 2026 federal warning letter and prints a compounded-tirzepatide price on three product pages that do not sell tirzepatide — each one quoting that page's own figure.
Strengths
- Publishes a four-rung plan ladder for every product rather than a single floor
- Prices sermorelin in both an injectable and an oral form, separately
- Says plainly that it is not a pharmacy, a prescriber or a manufacturer
- Its discount arithmetic reconciles on all four ladders against the savings it prints
Trade-offs
- Carries a February 2026 federal warning letter naming its own website
- Three of its product pages label their own price as a compounded tirzepatide price
- Its headline figures are twelve-month prepay averages, not a month's price
- Names no dispensing pharmacy and makes no state-coverage claim
232. TelePeptide
$159/mo — the month-to-month column, printed as "Sermorelin Therapy — Self-administered subcutaneous shot · or sublingual troche — Monthly — No commitment — $159/mo", with "6-month — $654 upfront — $109/mo" and "Annual — Best — $1,188 upfront — $99/mo" beside it. The page adds "Every price includes clinician evaluation, prescription" and shipping
Summary, strengths and trade-offs8 points
TelePeptide publishes a four-column ladder for each peptide — month-to-month, six-month and annual, each with the upfront charge printed beside the per-month division — which is the clearest price table found anywhere in this batch.
Strengths
- Publishes the upfront charge beside every discounted per-month figure, so no prepayment is disguised as a billing cycle
- Labels its month-to-month column "No commitment" rather than leaving the reader to infer a term
- States that the price includes clinician evaluation, prescription and shipping, and that nothing is billed until prescribed
- Names the trade name and the operating company and says the company does not itself practice medicine
Trade-offs
- The advertised range starts at a figure that requires a twelve-month prepayment, and only the table shows that
- Publishes a state count rather than a state list, so a reader cannot check their own state
- No dispensing pharmacy named and no certificate of analysis anywhere
- The three-month column is empty for both peptides, so the ladder jumps from a month to six
233. Nu Image Medical
$169/mo — "As low as", per month, and the identical figure on all three formats the seller lists — injection, rapid-dissolve tablet and nasal spray; the same page adds "*Subject to medical consultation / If prescribed. Compounded medications are not approved by the FDA" and marks each card "Compounded Medication / Rx Only"
Summary, strengths and trade-offs9 points
Nu Image Medical prices sermorelin at the same figure in all three formats it sells, and its NAD+ and PT-141 pages say "Coming soon" while showing dollar figures that belong to other products entirely.
Strengths
- Prints the same figure across the injection, the tablet and the nasal spray, so choosing a format does not change the published price
- Marks every card as a compounded medication and states on the page that compounded medications are not FDA-approved
- Names its operating company and a street address in its terms and footer
- Says outright that products not yet available are coming soon rather than quietly listing them as purchasable
Trade-offs
- Its NAD+ and PT-141 pages render dollar figures that belong to a cross-sell strip for unrelated products, beside a "Coming soon" where those products' own prices would be
- No governing-law clause exists in its terms — only a venue in one Florida county, which is not the county its own address is in
- The terms page is paginated across twenty-one screens and only the first renders, so the venue and arbitration wording is invisible to a normal read
- Publishes no state list, only the phrase available in most states
- No compounding pharmacy is named and no lab work is described as included
234. Ivy Rx
$175/mo — per month on the six-month plan, paid upfront
Summary, strengths and trade-offs7 points
Ivy Rx is one of the few sellers here that prints a full plan table — one, three and six months, with the per-month figure for each — so the discount for prepaying is visible rather than implied.
Strengths
- Prints a three-row plan table on its sermorelin page giving the total and the per-month figure for one, three and six months
- Operates as a professional entity rather than a plain trading company, a structure its own terms of service name
- Includes free temperature-controlled shipping in the published price
Trade-offs
- The headline sermorelin figure is the six-month prepaid rate; a buyer paying month to month pays about a quarter more
- Its glutathione page gives a starting figure for an order containing one vial without saying what period it covers
- The compounding pharmacy is described as FDA-registered but is not named
- No state coverage list is published
235. Royal Medical Centers
$175/mo — per month; the same page prices two months at $325
Summary, strengths and trade-offs8 points
Royal Medical Centers publishes its whole peptide catalog as eleven product pages, prices each one for a month and for two months, and prints an FDA compounding disclaimer on every page.
Strengths
- Publishes a complete peptide catalog as individual product pages rather than a menu behind a form
- Prints a one-month and a two-month price on each product page
- Says in its own words that the FDA does not verify the safety, effectiveness or quality of compounded drugs
- Prints the vial strength and volume on its tesamorelin page, so the month it prices is checkable
Trade-offs
- Three of its eleven peptide products are blends, so those carry no scoped price
- Publishes no state list
- Names no dispensing pharmacy, saying only that medications are dispensed by licensed pharmacies
- No certificate of analysis is reachable
236. Näky
$195/mo — the month-to-month rate, stated by the seller in one sentence: "Sermorelin Weekly Injection — starting at $185/mo ($195/mo for month-to-month plan)". The page then prints the arithmetic behind the headline: "Plan options: 1-Month Supply — $195 · 3-Month Supply — $555" — and $555 ÷ 3 = $185, so the advertised figure is a division of a prepayment. The page adds "No hidden fees and no surprise charges"
Summary, strengths and trade-offs8 points
Näky prints its headline growth-hormone figure and its month-to-month figure in the same sentence, and then shows the arithmetic that separates them.
Strengths
- Prints the headline figure and the month-to-month figure inside one sentence, in brackets, so neither can be read without the other
- Publishes the prepaid total beside the per-month division, which makes the advertised figure checkable
- Names the operating company, the clinical practice and the platform vendor in its own terms
- States the dosing frequency in the product title rather than leaving it to the description
Trade-offs
- One peptide only, priced; its coenzyme carries no figure on the pages read
- Its clinical practice and platform vendor stand behind other brands on this roster, so naming them distinguishes little
- No pharmacy named, no certificate of analysis, no state coverage list
- The host rate-limits repeated requests, so a reader checking several pages quickly may be blocked
237. YOURx Health
$196/mo — per month
Summary, strengths and trade-offs8 points
YOURx Health prices six tracked peptides by the month on one protocol page, and sells every one of its weight-loss medicines combined with vitamin B12, so none of those four carries a price scoped to the drug.
Strengths
- Prices six tracked peptides individually, each on its own card with its own figure
- Names YOURx Health LLC as the operating company in its footer
- Marks products that are not yet available as coming soon rather than selling them
- Says on the BPC-157 card that lab work is required before a prescription
Trade-offs
- Every weight-loss product is combined with vitamin B12, so none carries a price scoped to the drug
- Sells PT-141 only inside a three-ingredient troche
- Publishes no state list and names no dispensing pharmacy
- No certificate of analysis is reachable
238. Alan Health
$199/mo — per month, and true only on a three-month plan paid upfront — the page's own footnote reads "*Paid upfront with a 3-month plan. Actual price to the consumer will depend on the product and plan purchased"; the figure is displayed as a reduction from a stated former price of $295, and nothing here establishes that $295 was ever charged
Summary, strengths and trade-offs9 points
Alan Health prints a per-month figure on each of three product pages and a footnote under each one that names a different prepayment term — six months, two months and three months — so the three numbers are not the same kind of number.
Strengths
- States the prepayment term under every published figure rather than printing a bare per-month number
- Names its operating company, its trading names and a notice address in its own terms, and names both the governing law and the venue
- Names the clinical groups it works with separately from the company that runs the website
- Sells each of its three compared compounds in more than one format — injection, nasal spray and patch on two of them
Trade-offs
- The prepayment term is different on each of its three product pages, so the three per-month figures are not comparable with each other
- Received an FDA warning letter in February 2026 over website labeling that presented the company as the compounder of drugs it does not compound
- Publishes no state list at all, and its terms say only that certain services are available in certain states
- One figure is shown as a reduction from a former price, and nothing on the page establishes that the former price was charged
- No compounding pharmacy is named and no lab work is described as included
239. Maximus
$199.99/mo — a starting rate — "Prescription starting at $199.99 /mo" — and it is one of three units the same page uses for the same product: it also prints "Daily injections starting at less than $6/day" and "Feel younger and live better for under $9/day". A reader taking the first figure on the page gets $6/day; none of the three is reconciled to the others
Summary, strengths and trade-offs8 points
Maximus prints three different units for one product on one page — a monthly rate and two different daily rates — and publishes a state footprint by naming the single state it excludes.
Strengths
- Publishes its coverage as a named exclusion, which is more checkable than an unqualified fifty-state claim
- Prints the FDA compounding disclaimer as visible text on the product page rather than burying it
- Names its operating company in the terms
- States that pharmacies are US licensed compounders
Trade-offs
- Carries a June 2026 federal warning letter addressed to its operating company at its own email address
- Uses three different units for one product on one page, at two different daily rates
- Names no dispensing pharmacy
- A reader who takes the first figure on the page reads $6/day and not the $199.99 monthly rate
240. TRT Nation
$199.99/mo — per month; alone among the peptide cards on this page it carries no minimum-purchase footnote
Summary, strengths and trade-offs8 points
TRT Nation prices sermorelin, NAD+, glutathione and tirzepatide by the month and footnotes a minimum purchase of two and a half or three months beneath most of them, so the monthly figure is not the smallest commitment.
Strengths
- Footnotes the minimum purchase directly beneath the monthly figure rather than at checkout
- Says there are no membership fees that are not applied to the prescription
- Lists the specific blood tests it requires and how old they may be
- Notes on its own cards that California pricing may differ
Trade-offs
- Most of its monthly figures cannot be bought for one month
- Publishes no state list; its own FAQ poses the question as a heading
- Names no dispensing pharmacy
- No certificate of analysis is reachable
241. Vital Edge
$200/mo — per month, flat regardless of dose, with consultation and shipping included — the card prints "then $200/month"
Summary, strengths and trade-offs8 points
Vital Edge hides a five-compound peptide price list behind a tab on its homepage — nothing about peptides renders until that tab is clicked — and serves a different toll-free number on every page load.
Strengths
- States that the monthly fee is flat regardless of dose, so titrating up does not raise the bill
- Says the figure covers consultation, medication and shipping rather than medication alone
- Publishes what happens if treatment is declined: "If medication isn't prescribed, the tele-health consult fee is $80"
- Prices its GLP-1 line in the open too, brand and compounded side by side
Trade-offs
- Nothing about peptides renders until a tab is clicked, so the peptide prices are invisible on arrival
- A different toll-free number is served on each page load, so the contact number a reader notes down is not stable
- Names no compounding pharmacy and publishes no service-state list
- Its GHK-Cu card names no delivery format, so a reader cannot tell whether the figure buys an injection or a cream
242. Ark Health
$220/mo — printed as "Injectable Sermorelin — $349/mo — $220/mo" with the higher figure struck through, in the same grid as its weight-loss SKUs. An earlier sweep of this seller could not read this figure because its extraction window truncated the grid; it was read in full here after joining the page's text nodes
Summary, strengths and trade-offs8 points
Ark Health prices its one peptide in a grid of struck-through pairs beside brand-name weight-loss drugs, and its terms name the exact domains it operates rather than a vendor's.
Strengths
- Names the exact domains its operating company runs, in its own terms, rather than a platform vendor's address
- Publishes every figure as a struck-through pair so the anchor and the charge are both visible
- Puts its whole catalog on one products page with no intake in the way
- Attaches a month to every figure in the grid
Trade-offs
- One peptide only, against sellers on this roster carrying a dozen
- The peptide sits in the same grid as brand-name weight-loss drugs, so the discount framing is shared with products priced ten times higher
- Runs the same platform and clinical stack as other brands on this roster, so its clinical disclosure distinguishes little
- No pharmacy named, no certificate of analysis, no state coverage list
243. Remi Meds
$249/mo — printed as "SERMORELIN 3 ml per week | $249/mo ~ starting dose". The same page prints "SERMORELIN 9 ml per week | $349/mo" as a separate line, so the volume, not the compound, is what moves the figure
Summary, strengths and trade-offs8 points
Remi Meds is the only brand in its template family that prints a volume and a dosing frequency beside the figure — and it puts a volume, a frequency and a month into a single price label.
Strengths
- The only brand in its template family that prints a volume and a dosing frequency beside the figure
- Publishes two volumes of the growth-hormone peptide at two figures rather than one "starting at"
- Attaches a month to both peptide figures where three siblings attach nothing
- Says the dose is determined by the licensed provider based on medical judgment
Trade-offs
- The "~ starting dose" hedge means the printed figure is a floor and the page never says what the ceiling is
- Its terms name only the arbitration provider, never an operating company
- Both requested product paths redirect, so a cited product URL must be the effective one
- No pharmacy named, no certificate of analysis, no state coverage list
244. The HCG Institute
$269/mo — "Sermorelin Injections $269.00... Monthly Program: One 9mg or 15mg vial of Sermorelin." The program selector prints uplifts on that base: "Three Month Program - 9mg +$526.00 / One Month Program - 15mg +$100.00 / Three Month Program - 15mg +$726.00". Same page: "Unavailable in: MS" and "Must start with 9mg vial unless previously prescribed a higher dose"
Summary, strengths and trade-offs8 points
The HCG Institute runs a forty-three item storefront where four of the compounds compared here carry list prices, states in a dropdown what each program length adds to the base figure, and names the one state it cannot ship to.
Strengths
- Publishes a list price against every one of forty-three catalog items
- Prints the longer-program cost as an uplift on the base figure rather than as a divided rate
- Names the one state it cannot ship to on each product page
- Lists exactly what a purchase includes, item by item, so what is missing is visible
Trade-offs
- Carries a federal warning letter that names its own domain
- Publishes no price on any of its compound-named editorial pages, only inside its store
- States no supply period or strength on four of its five priced items compared here
- Names no compounding pharmacy while stating it does not compound or dispense itself
245. Elara MD
$349/mo — printed as "Sermorelin Injection — Starts at $349/month". The same number appears on Kin Meds as a bare "Starts At $349" with no period at all, and on Wellspring Longevity Clinic as "Starts at $349". Of the family, only this brand states the unit
Summary, strengths and trade-offs8 points
Elara MD publishes the same two figures as Kin Meds to the dollar, and is the only brand in that family that attaches the word "month" to either of them.
Strengths
- The only brand in its five-brand template family that attaches a period to its figures
- Names the route in the product title rather than leaving injection and troche to be inferred
- Publishes a phone number in the header of every product page
- Sells a sublingual troche alongside the injection and prices it separately
Trade-offs
- No operating company published anywhere reachable — its about page returns a not-found status
- Its arbitration clause is the same clause four sibling brands publish, which is where an entity search on this family goes wrong
- Identical figures to a sibling brand, so the two together are one price observation and not two
- No pharmacy named, no certificate of analysis, no state coverage list
246. FitFlow Rx
$95 — the orally disintegrating tablet; the treatment page states no billing period
Summary, strengths and trade-offs8 points
FitFlow Rx charges one flat figure per compound at every dose, and prices a GHK-Cu foam lower than anything else it sells.
Strengths
- Repeats "same price at every dose" on every treatment page, so titration does not raise the bill
- Prices six separate formats rather than one figure per compound
- Says on every product page that compounded drugs are not FDA-approved
- Includes the provider consultation and shipping in the published figure
Trade-offs
- Its treatment pages omit the billing period its homepage states
- Publishes no operating company on any page read
- Publishes no state list and names no dispensing pharmacy
- No certificate of analysis is reachable for any product
247. HelloWellness
$116 — the card prints "$199 $116 Per Month" with the higher figure struck through. The same page's footnote states a three-month plan minimum renewing every eleven weeks, and the seller's weight-loss pages carry two different renewal intervals — "every 11 weeks" in one place and "billed every 10 weeks" in another — so no card figure on this site can be read as a month
Summary, strengths and trade-offs8 points
HelloWellness prints "Per Month" on every peptide card and, in a footnote further down the same page, says the plan renews every eleven weeks — which is neither a month nor a quarter.
Strengths
- Prints the plan minimum and the renewal interval on the same page as the price rather than burying them in terms
- Names the anchor figure and the charged figure together on every card
- Discloses the pharmacy category it works with rather than saying nothing about dispensing at all
- Sells the two peptides individually and as named bundles, each priced
Trade-offs
- Every card says "Per Month" and the renewal interval is eleven weeks, which is neither
- The two legal pages name different corporate forms for one brand
- The pharmacy is described only by its licensing category, never by name
- No certificate of analysis and no state coverage list anywhere
248. Woodwork
$116 — from, printed as "/mo" but footnoted "Based on a 4-week cycle" — thirteen cycles a year, not twelve
Summary, strengths and trade-offs8 points
Woodwork is Grindr’s telehealth arm, and its sermorelin figure carries a footnote that quietly redefines a month as four weeks.
Strengths
- Names Woodwork By Grindr LLC as the operating company
- Prints the four-week basis of its price rather than hiding it entirely
- States that compounded products have not been approved by the FDA
- Gives a shipping window in days rather than a vague promise
Trade-offs
- Prints "/mo" on a figure its own footnote bases on a four-week cycle
- Sells only one tracked compound
- Bundles an unrelated app subscription into the peptide offer
- Publishes no state list, no named pharmacy and no certificate of analysis
249. eDrugstore
$129 — total price for a three-week supply per vial; the page names no billing period
Summary, strengths and trade-offs8 points
eDrugstore prices three tracked peptides as flat catalog items with a total and a per-dose figure side by side, and carries a 2025 federal warning letter naming its own domain.
Strengths
- Puts a total and a per-dose figure side by side on every product page, so the unit is explicit
- States the supply length on the vial product rather than leaving the quantity implied
- Publishes a street address and staffed ordering hours a reader can check
- Lists three tracked compounds as ordinary catalog items rather than behind an intake
Trade-offs
- Carries a federal warning letter that names this exact domain
- Describes the pharmacy that fills an order only by accreditation, never by name
- Publishes no state list, so eligibility is settled after the order starts
- Sells the required blood test as a separate line item rather than including it
250. Healthy Male
$129 — "Sermorelin Acetate 0.2 mg / Mfg : Strive / In-Stock / Maximum Doses: 1 / Your saving $ 0.00 / Per Dose $ 129.00 / Total Price $ 129.00" — one dose, so the per-dose and total figures are the same number; no billing period is stated anywhere on the page
Summary, strengths and trade-offs8 points
Healthy Male sells one of the compounds compared here in two preparations at published figures, names the maker on each product card, and divides one of those two figures into a per-dose rate that is not a charge.
Strengths
- Names the maker of each product on the product card itself
- States the strength and the number of doses beside every figure
- Prints a total price rather than only a per-dose rate
- Renders a genuine not-found document for a path that does not exist
Trade-offs
- Carries a federal warning letter that names its own domain
- Serves zeros in place of every price until its scripts run
- Returns a full priced catalog on a not-found page, larger than any real product page
- Divides one of its two figures into a per-dose rate nobody is charged
251. LevelUp Rx
$195 — the single figure printed beneath a "1 Month Supply / 3 Month Supply" selector, attributed in the visible text to neither term — so it cannot be read as a monthly rate
Summary, strengths and trade-offs7 points
LevelUp Rx ships the same clinical product copy as another seller already on this roster — twenty-three byte-identical paragraphs on the sermorelin page alone, measured in one run — at roughly double the price, and publishes no operating company of its own on any of its three legal pages.
Strengths
- Every product page carries a figure in visible body text, with no account gate and no blur
- The catalog is grouped by condition, so the peptide lane is reachable in one click from any page
- The three peptide pages each print their figure in the same place and the same shape
Trade-offs
- No operating company appears anywhere on its about, terms or privacy pages — the only corporate names on them are the arbitration provider and an analytics vendor
- Its sermorelin page shows a one-month and a three-month option with a single price attached to neither
- Twenty-three of its thirty substantial sermorelin paragraphs are byte-identical to another seller on this roster, so the two rows are not independent readings of the market
- No compounding pharmacy is named, no state list is published, and no certificate of analysis appears on any page read
252. Try Invigor
$220 — starting at; the plan page names no period at all, unlike this seller's NAD+ and PT-141 pages, so this figure carries no term
Summary, strengths and trade-offs8 points
Try Invigor names its operating company, its clinical groups and a street address, and prices four tracked compounds on plan pages — three of which name a billing period and two of which name none at all.
Strengths
- Names the operating company, its trading name and a service address in its own arbitration clauses, and names California as the governing law
- Names the two clinical groups it works with, separately from the company that runs the website
- Says in its own footer that it does not prescribe for bodybuilding, athletic performance or cosmetic purposes, which is a narrower scope than most sellers here claim
- Prices each compound in an injectable and an oral or nasal form on separate plan pages
Trade-offs
- Two of its five plan pages print a figure with no billing period at all, while the other three say per month
- The privacy policy still names a website address the company no longer serves
- No state coverage list, and the compounding pharmacy that fills an order is not named
- No lab work is described as included in any plan figure
253. TRT Kingdom
$233 — TERM-GATED: printed as "$233/mo — 3-month plan" on the product page, immediately after a sentence about whether the compound "may be appropriate as part of a personalized treatment plan". The page publishes no month-to-month alternative, so the figure is only available on a three-month commitment
Summary, strengths and trade-offs8 points
TRT Kingdom names sixteen peptides on its homepage and routes its own peptide category URL to a single product page, so a crawler following that link indexes one item as the whole category.
Strengths
- Prints the plan term in the same breath as the figure rather than in an asterisk
- Names both the operating company and the clinical practice, separately, on its own pages
- Names a wide peptide list openly on the homepage instead of hiding the catalog behind an intake
- Frames the product as something a clinician may or may not find appropriate rather than as a purchase
Trade-offs
- Its peptide category URL resolves to one product, so the catalog it advertises is not browsable at that address
- Only one of the sixteen peptides it names carries a published figure on the pages read
- No month-to-month option is published beside the three-month figure
- Claims laboratory testing on its about page with no certificate reachable
254. Mobile Care Health
$239 — The bottom of A published range — read in the related-products block of the NAD+ page as "Sermorelin $239.00 – $699.00 · Price range: $239.00 through $699.00 — available on subscription". Read on the coenzyme product page, not on a sermorelin product page, and the interval is not named there either
Summary, strengths and trade-offs8 points
Mobile Care sells across three different hosts — a parent site, a treatments subdomain and a storefront on a separate registrable domain — and only the storefront publishes a price.
Strengths
- Publishes an open storefront with a price range on every product
- Prints the compounding disclaimer on the product page and again in its FAQ
- Says the medication is prepared by a state-licensed pharmacy for individual patients
- Marks which products are available on subscription
Trade-offs
- Splits one business across three hosts, only one of which publishes any price
- Publishes ranges with no indication of which option sits at either end
- Names no subscription interval on a product it sells by subscription
- Its parent site's copyright line has an empty year, so nothing there dates the content
255. ARSYNL Rx
$249 — printed as a bare figure beside 'Provided by ARSYNL Rx'; the page states no billing period, no vial count and no supply length
Summary, strengths and trade-offs8 points
ARSYNL Rx publishes a figure against every peptide it sells and a period against none of them — four product pages, four bare numbers, no billing cycle anywhere.
Strengths
- Names its operating company on its own pages rather than leaving a reader to guess
- Publishes a figure on the product page for each peptide it sells
- Keeps each compound on its own listing instead of burying prices in a plan grid
- Prices its nasal and injectable NAD+ separately rather than as one product
Trade-offs
- Attaches no billing period to any peptide figure, so none of them can be compared
- States no supply length or vial count beside a price
- One listed peptide product returns a gone status while the catalog still links it
- Publishes no state list and names no dispensing pharmacy
256. Momentum Health 360
$249 — starting from; the catalog names no billing period
Summary, strengths and trade-offs8 points
Momentum Health 360 carries a June 2026 federal warning letter that names its own website and its FDA establishment identifier, and its NAD+ page renders a price for the two-month plan while the one-month lane prints no figure at all.
Strengths
- Prices five tracked compounds individually on an open catalog with no intake in the way
- States in its own words that its compounded medicines are not FDA-approved
- Prints "Billed monthly" beside the one figure that is a monthly figure
- Offers plan lengths from one to six months on the product page itself
Trade-offs
- Carries a June 2026 federal warning letter naming its own website and establishment identifier
- Its NAD+ one-month lane renders no price at all, so the cheapest term cannot be seen
- The NAD+ product page and the shop catalog print different figures for the same product
- Its catalog floors name no billing period, so four of its five prices are periodless
257. RyzeRx
$249 — the product-page price, printed as "$249 USD" beside "Add to cart" with no billing period, supply length or vial size.
Summary, strengths and trade-offs9 points
RyzeRx prices every product on its own page, from single peptides to vial-by-vial weight-loss strengths, and says on none of them what period or supply the figure buys.
Strengths
- Puts a figure on every product page, from single peptides to each weight-loss vial strength
- Publishes its site in English and Spanish from the same navigation
- Says its medicines come from United States licensed pharmacies
- Offers a free consultation before any commitment
Trade-offs
- No product page says what period or supply its figure buys, though its terms say subscription plans renew automatically
- Its homepage cards still lead with category starting figures that none of the named peptides carries
- Its fifty-state lines are a marketing statistic and a statement about provider licensure, not a coverage statement
- Names no dispensing pharmacy and no certificate of analysis is reachable
- The support phone line in its terms, "(800) 555-0123", has the shape of a placeholder number; the cancellation route the terms actually name is email
258. June Health
$259 — "PEPTIDES / Clinician-favorite / Sermorelin / GHRH analog — natural HGH stimulation / PRICE / $259" — no billing period stated; the page adds "Your card is only charged if a licensed clinician approves your prescription."
Summary, strengths and trade-offs8 points
June Health prices two of the compounds compared here as flat figures with no billing period attached, and puts a weight-loss rate in a banner above every one of those pages that happens to equal one of the two prices exactly.
Strengths
- Prices both compounds as single flat figures with nothing bundled into a plan
- Says plainly that the card is only charged if a clinician approves the prescription
- Renders a distinct not-found document for an unknown product and for an unknown page
- Separates its peptide catalog from its weight-loss catalog in its own navigation
Trade-offs
- States no billing period beside either figure, so neither can be compared to a monthly rate
- Prints a weight-loss rate in the banner above every product that equals one of its own peptide prices
- Titles one product as tablets while its description names two other routes
- Publishes nothing at all in the page itself — the served document has no products in it
259. MintRx
$295 — one-time fill, in the seller's own words, of a kit the same card calls a 28-day supply — twenty-eight days is not a calendar month
Summary, strengths and trade-offs8 points
MintRx publishes the most specific price disclosures in this batch — a strength, a container size and a supply length beside almost every figure — and names no operating company anywhere on its site.
Strengths
- Prints a strength, a container size or a spray count beside almost every figure, which is a more specific disclosure than most sellers here manage
- Names a 28-day supply and a 28-day refill cadence on its sermorelin cards rather than rounding either to a month
- Sells four tracked compounds in both an injectable and a non-injectable form, so the two routes can be compared on price directly
- Publishes a telephone number and a HIPAA notice alongside its terms and privacy policy
Trade-offs
- No operating company is named anywhere on the site — no corporate form, no street address, and no governing-law clause in the terms
- Six of its seven longevity and sexual-health products print their price only on another product's card, so a reader on one product page may see every figure except that product's own
- The same figure covers both PT-141 products on different terms, one described as a 30-day supply and the other as a single prescribed order
- No state coverage list, and the compounding pharmacy that fills an order is never named
260. Celia Rx
$299 — Per item with no period stated — "Sermorelin Injectable $299.00" on the open storefront. The seller prices all three sermorelin routes almost identically: troche $299.00, tablet triturate $299.99. A $55.00 fifteen-minute onboarding consultation is sold as its own line item
Summary, strengths and trade-offs8 points
Celia Rx runs an open storefront where every peptide carries a flat item price and the onboarding consultation is a line item of its own — and where one nasal spray is dearer than a bottle six times its concentration.
Strengths
- Publishes an open storefront with every item priced, rather than putting prices behind an intake
- Prices the onboarding consultation as its own line and states how long it is
- Prices every route of a compound rather than one headline form
- Names its operating company in the opening sentence of its terms
Trade-offs
- No item carries a billing period, so nothing on the storefront is comparable to a monthly rate
- Its oxytocin lines make the smaller bottle cheaper and far more concentrated, which reverses any per-milligram ranking
- Names no dispensing pharmacy, describing it only as "a qualified 503A pharmacy"
- Publishes no state coverage
261. Kin Meds
$349 — printed as "Personalized Sermorelin — In stock — Wellness — Cardio + Strength — Sermorelin — Starts At $349". No period of any kind is attached: not a month, not a supply length, not a plan term. Its template sibling Elara MD prints the identical figure as "$349/month"
Summary, strengths and trade-offs8 points
Kin Meds prints a bare "Starts At" figure with no period attached to it, publishes no operating company of its own, and carries an FDA warning letter issued the same day as one of its template siblings.
Strengths
- Prints, on the product page itself, that it is not a state-licensed pharmacy nor a drug manufacturer and that compounded medications are not FDA-approved
- Marks stock status on the product page
- Publishes more routes than most of its template siblings — an injection, a nasal spray and a troche, each priced
- Says in plain words that the medication is compounded and dispensed by a licensed third-party pharmacy
Trade-offs
- Neither figure carries a period, so nothing on the page says what the money buys
- No operating company is published anywhere on the pages read
- Carries an FDA warning letter for false and misleading claims
- Four other brands on this roster run the same page template, so its numbers are not an independent observation of the market
262. Wellspring Longevity Clinic
$349 — printed as "…Wellspring Longevity Clinic is not a state-licensed pharmacy nor a drug manufacturer. Sermorelin — Starts at $349" — the disclaimer runs immediately above the figure. No period is attached to the figure itself
Summary, strengths and trade-offs8 points
Wellspring Longevity Clinic prints, above its own price on every product page, that it is not a state-licensed pharmacy nor a drug manufacturer — a disclaimer it shares with a brand running the same template.
Strengths
- Puts its own regulatory disclaimer above the price on every product page rather than in a footer
- States that compounded medications are not FDA-approved in the same sentence block as the price
- Says the medication is compounded and dispensed by a licensed third-party pharmacy
- Its figures sit in the middle of its template family rather than at the top
Trade-offs
- Neither figure carries a period, so the disclaimer is clearer than the price
- The disclaimer is shared with at least one sibling brand rather than being this seller's own editorial choice
- Its terms name only the arbitration provider, never an operating company
- No pharmacy named, no certificate of analysis, no state coverage list
263. Vital Harmony Rx
$479 — printed as "Sermorelin — Cardio + Strength — Starts at $479", with no period attached. Three brands running this same template publish $349 for the same product under the same category label
Summary, strengths and trade-offs8 points
Vital Harmony Rx runs the same product template as four other brands on this roster and charges a hundred and thirty dollars more for the growth-hormone peptide than three of them.
Strengths
- Publishes a figure for both peptides on browsable product pages rather than behind an intake
- Uses the same category labels as its siblings, which makes the comparison against them straightforward
- Its requested terms path resolves to a real terms page rather than a soft redirect
- Prints tools — a protein and a carbohydrate calculator — beside the catalog rather than only a checkout
Trade-offs
- The highest figures of the five brands sharing its page template, on identically described products
- Neither figure carries a period, so nothing states what the money buys
- Its terms name only the arbitration provider, never an operating company
- No pharmacy named, no certificate of analysis, no state coverage list
264. Aspire Health
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Aspire says which of its legal entities you contract with depends on where you live and who is licensed to treat you — the most precise entity disclosure in this batch, on a site that publishes no price.
Strengths
- Publishes two legal entities and the rule that decides which one a given patient contracts with
- States that compounded peptides are not FDA-approved in their compounded form, in its own words
- Warns that regulators may change what compounded versions remain available
- Says compounded medication is prepared for an individual patient on a provider's prescription
Trade-offs
- Publishes no price anywhere on the page read
- Its footer copyright is a year out of date
- Names no dispensing pharmacy
- Publishes no state coverage, only a statement that the entity depends on the state
265. AVArx
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
AVArx splits each peptide into an injectable and a sublingual or nasal listing, then prices none of the five — every page sells a provider evaluation instead of a product.
Strengths
- Separates injectable, troche and nasal forms of the same compound into distinct pages
- Names its operating company on two separate legal pages
- Frames each listing as a provider evaluation rather than as an over-the-counter purchase
- Publishes a clean hard error for a path that does not exist, so its pages can be trusted to exist
Trade-offs
- Carries no figure on any of its five treatment pages
- Gives a reader nothing to compare against another seller before intake
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
266. David Borenstein
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
This practice names twelve compounds across offices in two states and publishes no company name at all: its copyright line is a bare year.
Strengths
- Names twelve compounds, seven of them tracked here, on one service page
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Publishes no company name anywhere — the copyright line carries a year and nothing else
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
267. California Trim Clinic
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
California Trim Clinic advertises a monthly starting figure for each weight-loss drug and footnotes it with a three-month requirement, and lists thirteen tracked peptides on a therapy page that carries no price at all.
Strengths
- Says compounded medications are prepared for patient-specific use pursuant to an individual prescription and are not FDA-approved
- Names the city its practice is based in rather than only claiming to be nationwide
- Publishes a starting figure for both weight-loss drugs rather than hiding both behind an intake
- Publishes a free educational guide about what to ask before starting peptide or weight-loss care
Trade-offs
- Advertises a monthly figure whose own footnote attaches a three-month term
- Lists thirteen tracked peptides and prices none of them
- Publishes no state list and names no dispensing pharmacy
- No certificate of analysis is reachable
268. Carolina Health & Wellness
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Carolina Health & Wellness carries eight tracked compounds across a deep site and puts a figure on none of them.
Strengths
- Carries eight tracked compounds including MOTS-c and tesamorelin
- Exposes a deep, followable site rather than a thin landing page
- Keeps its peptide catalog visible without an account
- Returns a clean hard error for a path that does not exist
Trade-offs
- Carries no figure on any of the eight pages read
- Publishes no corporate entity anywhere
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
269. Defy Medical
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Defy Medical names its operating company, names a single state's law as governing, and publishes a vendor-disclosure page — a level of legal disclosure very little else on this roster matches.
Strengths
- Publishes a vendor-information page from its own footer, which almost nothing else here does
- Names the company on the other side of the transaction rather than only a trading name
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Its peptide page names one tracked compound and the per-compound pages are not where the address pattern suggests
- Publishes no figure for any compound on the pages read
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
270. Denver Peptide Clinic
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Denver Peptide Clinic publishes a certification seal and, beside it, the certifier's own lookup pre-filled with its address — a claim a reader can check rather than an image they must trust.
Strengths
- Publishes the certifier's own lookup link, not just a badge image
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Its front page names no compound at all; the three declared here are on its questions page
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
271. Denver Wellness & Aesthetics Center
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
This clinic names eighteen compounds on one page, eleven of them tracked here, and the only company name on its legal page belongs to the agency that built the site.
Strengths
- One of the widest declared lists on this roster, in about five thousand characters
- Declares eleven of the sixteen compounds this site tracks on pages a reader can reach
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Its legal page carries its web agency's company name and none of its own
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
272. Dvida Spa
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Dvida tells readers, on its own peptide page, that two of the compounds it lists there appear on the FDA's bulk drug substances warning list and are not approved for human use.
Strengths
- Names the FDA bulk substances warning list against two compounds on its own menu, on the page selling them
- Answers "are peptides FDA-approved" with the word "No" and then explains
- Names its operating company in the first line of its terms
- Distinguishes compounded GLP-1s from branded products in the same note
Trade-offs
- Publishes no price for anything
- Publishes no state coverage and names no dispensing pharmacy
- Its own product URL carries a spelling error that a reader retyping the address will not reproduce
- The disclosure is strong but the catalog detail behind each compound is thin
273. Embody Her Health
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Embody Her Health's single figure is a first-visit fee that also renders on its legal page, so nothing on its own site prices the compound it sells.
Strengths
- States the first-visit fee and what it includes rather than leaving it to checkout
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Its only figure is a visit fee that also renders on the legal page, so no product price is published
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
274. Executive Medicine of Texas
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Executive Medicine of Texas names eleven tracked compounds in a service page of about six and a half thousand characters, one of the densest declared lists on this roster.
Strengths
- Names eleven tracked compounds in a page short enough to read in full
- Declares eleven of the sixteen compounds this site tracks on pages a reader can reach
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Its own terms page names no company, so the absence rests on the page that should have carried it
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
275. Fit MD
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Fit MD puts three of its four tracked compounds in its own page title and prices none of them; the peptide line sits inside its hormone practice rather than beside it.
Strengths
- Names its compounds in the page title, so a reader searching for one lands on confirmation
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- The page describes the category rather than the products, and carries no figure
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
276. Focal Point Vitality
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Focal Point Vitality carries eleven tracked compounds in its own navigation, including KPV and semax, and no price behind any of them.
Strengths
- Carries eleven tracked compounds in its navigation, including KPV and semax
- Exposes a deep, followable site rather than a single landing page
- Names compounds most local clinics do not stock, such as epitalon and MOTS-c
- Returns a clean hard error for a path that does not exist
Trade-offs
- Carries no figure on any page read
- Publishes no corporate entity anywhere
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
277. Gameday Men's Health
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Gameday is a franchise operator, not a clinic — its terms name the franchising company as the party you contract with, and it refers to its own "Pharmacy Network" without naming a pharmacy in it.
Strengths
- Names the franchising company that actually owns and operates the site, in the terms' opening paragraph
- Publishes a per-compound service page for sermorelin and another for PT-141
- Publishes a notice address a reader can write to
- Distinguishes services it provides from services provided by affiliated practices
Trade-offs
- Publishes no price on any page read
- Refers to its own "Pharmacy Network" without naming a single pharmacy in it
- A franchise network means the clinic a reader visits is not the company they contracted with
- Publishes no state coverage
278. Genesis Lifestyle Medicine
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Genesis Lifestyle Medicine gives sermorelin and NAD+ their own pages inside a clinic menu that also sells branded weight-loss pens, and puts a price on none of it.
Strengths
- Separates the branded weight-loss products it lists by name from the compounded ones
- Gives sermorelin and NAD+ their own pages rather than a single peptide page
- Runs physical locations as well as a telehealth menu
- Groups its hormone offerings under a heading that says what they are for
Trade-offs
- Publishes no price anywhere across the pages read
- Publishes no state list
- Names no dispensing pharmacy
- No certificate of analysis is reachable
279. Glowlight Med Spa
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Glowlight's peptide page carries eight dollar figures and every one of them also renders on its privacy policy, which is what proves none of them prices a peptide.
Strengths
- Names five tracked compounds and keeps its weight-loss program visibly separate from them
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Every figure on the peptide page is a site-wide promotion that also renders on the privacy policy
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
280. Houston Men's Clinic
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Houston Men's Clinic trades under one name and puts a different one in its copyright line, with no corporate form attached to either.
Strengths
- Names four tracked compounds as services on a page a reader can take in at once
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Publishes two trading names that do not match and no registered company behind either
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
281. Hybrid Medical Solution
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Hybrid Medical Solution names ten tracked compounds across goal-based sub-pages, links a storefront that sells supplements, and carries only its web agency's company name on the page.
Strengths
- Splits a ten-compound menu across goal-based sub-pages rather than listing everything at once
- Declares ten of the sixteen compounds this site tracks on pages a reader can reach
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Its linked storefront is open and sells supplements, so no compound on the menu is priced
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
282. Insta RX
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Insta RX publishes two NAD+ figures that differ by $115, and the higher one is conditioned on a twelve-month prepayment stated only in a footnote.
Strengths
- States "same price at every dose" beside its NAD+ figure
- Says plainly that it "does not produce compounded medications"
- Publishes a figure without an intake or an account
- Sells the injection and the nasal spray under one price rather than two
Trade-offs
- Publishes two NAD+ figures $115 apart on two of its own pages
- Hides a twelve-month prepayment condition in an asterisk footnote
- Prints a tirzepatide description underneath its NAD+ heading
- Publishes no operating company, no state list and no named pharmacy
283. Joey Med
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Joey Med publishes a detailed article on what semaglutide costs — every figure in it about the market rather than about itself. Its own plan pages print a four-week price without naming the drug inside, and its NAD+ page prices a three-month supply.
Strengths
- Names MD Telehealth Platform LLC as the company trading as Joey Med, at the head of its own articles
- Distinguishes brand-name, generic and compounded routes in its own explainer rather than blurring them
- Says compounded versions are made by licensed compounding pharmacies and are not FDA-approved
- Dates its articles with both a published and an updated date
Trade-offs
- Its weight-loss plan pages price each plan without naming the drug it contains
- The semaglutide figures in its explainer describe what other companies charge, which is not a price a reader can act on here
- Publishes no state list and names no dispensing pharmacy
- No certificate of analysis is reachable
284. MedSol Rx
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
MedSol Rx publishes a plan ladder whose arithmetic reconciles at every rung, and separately tells readers on its own product pages that the same medicine typically costs two to eight times what it charges.
Strengths
- Every plan total reconciles exactly against its own per-month figure
- Publishes a month-to-month lane beside the prepaid ones instead of only the cheapest
- States in its own words that its compounded medicines are not FDA-evaluated
- Names the clinician network that makes the prescribing decision
Trade-offs
- Its own product pages quote a typical cost several times what it charges
- Declines to publish a NAD+ or sermorelin price, offering a quote on request instead
- Its oral semaglutide plan card lists a tirzepatide injection supply as its contents
- Says only that it serves patients nationwide, with no count and no list
285. MetroMed Health
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
MetroMed names eleven tracked compounds and sells some of them as kits, on a page that is nearly two megabytes of markup wrapped around about eight thousand characters of text.
Strengths
- Names eleven tracked compounds and runs a separate page for the kits it bundles them into
- Declares eleven of the sixteen compounds this site tracks on pages a reader can reach
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- A kit is not a per-compound unit, and no figure is published on either page
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
286. Mojo Vitality
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Mojo Vitality names seven compounds including PT-141 and tesamorelin on a three-page site, and publishes no figure on any of them.
Strengths
- Names seven distinct tracked compounds on a small site
- Names its operating company in the footer of every page served
- Includes PT-141 and tesamorelin rather than only the common growth-hormone peptides
- Returns a clean hard error for a path that does not exist
Trade-offs
- Carries no figure on any page served
- Exposes only three followable pages, so nothing can be cross-checked
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
287. Muse Maven Med Spa
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Muse Maven appears under three different names across its own address, its terms and its footer, and sells three tracked compounds together as packages.
Strengths
- Names its three tracked compounds together in its own navigation rather than burying them
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Publishes three different names for itself and no corporate form for any of them
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
288. R2 Medical Clinic
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
R2 publishes a regulatory-status and evidence-strength table against its own catalog, and tells readers in that table that the clinical evidence for some of what it sells is insufficient.
Strengths
- Publishes a regulatory status and an evidence strength for each peptide it sells, in a table
- States plainly that the human evidence for some of its own catalog is insufficient
- Distinguishes an approved indication from the use it is being sold for, compound by compound
- Says its medications come from compounding pharmacies and that they are not FDA-approved for all indicated uses
Trade-offs
- Publishes no price for anything
- Publishes no corporate entity
- Names no dispensing pharmacy and publishes no state coverage
- Its 404 page is nearly twice the size of its real terms page, so nothing on this host can be judged by weight
289. Ready Med
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Ready Med carries a June 2026 federal warning letter, prints one price in its hero and a different one three times in the body of the same page, and answers its own question about which states it serves with text about something else.
Strengths
- States in its own words that compounded drugs do not undergo pre-market FDA approval
- Prices an oral and an injectable form of semaglutide separately
- Says what the membership covers, including the shipping cadence
- Publishes a street address that matches the one on its federal letter
Trade-offs
- Carries a June 2026 federal warning letter naming its own website
- Two of its product pages each print two different prices for the same product
- Its own FAQ question about state availability is answered with unrelated text
- Names no legal entity, no pharmacy, and gives a personal mail account as its contact
290. The Recovery Project
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
The Recovery Project carries twelve tracked compounds in its navigation, KPV and semax among them, and prices none of them anywhere on the site.
Strengths
- Carries twelve tracked compounds, one of the widest catalogs on this roster
- Stocks KPV and semax, which most sellers here do not name at all
- Exposes a deep followable site rather than a landing stub
- Returns a clean hard error with a tiny body for a path that does not exist
Trade-offs
- Carries no figure on any page read
- Publishes no corporate entity anywhere
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
291. REGENX Health
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
REGENX Health lists four peptides on a dedicated peptides page and puts a figure against none of them.
Strengths
- Runs a dedicated peptides page separate from its hormone lines
- Names four distinct compounds including tesamorelin and PT-141
- Names its operating company in its terms
- Returns a clean hard error for a path that does not exist
Trade-offs
- Carries no figure on any page read, including the peptides page
- Its terms page also carries a second company name that is its web agency, not an operator
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
292. Renew Vitality
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Renew Vitality names its operating company and describes itself as a telemedicine provider in its own terms, and publishes no price on any page this pass could read.
Strengths
- Names its operating company and states what kind of provider it is in the same sentence
- Carries a terms page dated within six months, which most of this batch does not
- Publishes a dedicated sermorelin therapy page under its hormone service
- Says its prescribers build a plan combining approved and compounded medications
Trade-offs
- Publishes no price for anything
- Names no dispensing pharmacy
- Publishes no state coverage
- The peptide pages sit several levels below the hormone service, so the catalog is hard to take in at once
293. Revitalize IV Solutions
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Revitalize lists seventeen peptides on a page with no prices on it, prices two of them on a different page, and publishes the rest of the menu as a downloadable PDF — which does resolve.
Strengths
- Publishes a downloadable peptide menu from its own page, and the file actually resolves
- Prices its IV and injection lines in detail, with the gram options named
- Names seventeen peptides on one page, one of the widest declared catalogs in this batch
- Prices facial, IV, injection and laser lines on one public page
Trade-offs
- The peptide page itself contains no price at all — a reader has to find the pricing page or the PDF
- Only two of the fourteen compounds this site tracks carry a published figure
- Publishes no corporate entity; the footer has a year and no name
- Names no dispensing pharmacy and publishes no state coverage
294. Rewind Anti-Aging of Miami
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Rewind Anti-Aging of Miami gives seven compounds their own service pages and prices none of them — and shares nothing but a brand word with the Rewinding RX already on this roster.
Strengths
- Publishes a service page per compound rather than one combined menu
- Names its operating company consistently on every page read
- Names ten tracked compounds including MOTS-c and tesamorelin
- Keeps its peptide pages separate from its weight-loss line
Trade-offs
- Carries no figure on any of the eight pages read
- Its brand words collide with an unrelated company already on this roster
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
295. SCULPT Aesthetic Center
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
SCULPT promises a certificate of analysis, a third-party test and a purity threshold of ninety-nine percent, and publishes no certificate, no PDF and no link anywhere on the page that says it.
Strengths
- Names ten compounds this site tracks on one service page
- Publishes a per-peptide instruction card with a scannable video guide for reconstitution
- States the grade of peptide it claims to use rather than leaving it implied
- The service page is complete enough to compare against sellers who publish less
Trade-offs
- Promises a certificate of analysis and a ninety-nine percent purity threshold with no document behind either
- Publishes no price for anything
- Publishes no corporate entity
- Publishes no state coverage and names no dispensing pharmacy
296. Serotonin Centers
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Serotonin Centers is a franchised clinic chain that publishes one figure across its whole peptide and NAD+ menu — a monthly NAD+ membership with a stated supply length — and prices nothing else it sells.
Strengths
- Publishes a monthly membership figure with the supply length stated inside it rather than a bare rate
- Says outright that individual session pricing depends on delivery method and plan, instead of implying one exists
- Names its operating company and its trading name in its own terms
- Runs physical clinics, so a buyer who wants an in-person infusion rather than a mailed vial has that option
Trade-offs
- Prices nothing on its peptide menu — sermorelin and PT-141 are described at length with no figure anywhere
- A franchise of independently owned centers, so a corporate-page figure need not be the price at any one clinic
- Publishes no service-state list, only a clinic locator, so mail-order eligibility cannot be checked
- Names no compounding pharmacy anywhere on the peptide or NAD+ pages
297. Sparta TRT
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Sparta TRT publishes a fuller fee schedule than most sellers here — consultation, cancellation and labs, all itemised — and none of those line items is the peptide it sells.
Strengths
- Itemises consultation, cancellation and lab fees separately rather than folding them in
- Discloses that the consultation fee drops once a patient enrols
- Names its operating company on its privacy policy
- States that every plan requires evaluation, labs and a prescription
Trade-offs
- Its peptide page carries no figure, so sermorelin is unpriced
- Every figure on the pricing page is for testosterone or oral hormone therapy
- Publishes no state list and names no dispensing pharmacy
- Charges separately for initial lab testing rather than including it
298. Strong Health
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Strong Health writes the research-use distinction into its own sales copy and puts a page behind each of eleven compounds, then prints no figure on any of them.
Strengths
- States in its own words that it will never supply a research-use vial
- Publishes a page per compound rather than a single undifferentiated peptide menu
- Publishes a comparison table naming the alternatives it is arguing against
- Says baseline and monitoring bloodwork are part of its model
Trade-offs
- Carries no figure on any of the seven compound pages read
- Publishes no corporate entity anywhere on those pages
- Publishes no state list and names no dispensing pharmacy
- Its comparison table describes rivals in categories it defines itself
299. ThinWorks Weight Loss Centers
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
ThinWorks gives each compound its own service page named for a single town, and its only two figures are a discount code that also renders on its terms of service.
Strengths
- Runs a separate service page per compound rather than one undifferentiated menu
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Its two published figures are a site-wide coupon, and its cost article quotes other companies
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
300. VIP Weight Loss & Anti-Aging
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
VIP publishes the same product page five times, once per town, all linked from one document — so anything that crawls this seller sees five candidates unless it notices.
Strengths
- Serves five towns and names eight tracked compounds across its catalog
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Duplicates every product page per town, which makes one seller look like five
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
301. VitalRenew Clinic
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
VitalRenew names nine tracked compounds in about five thousand characters, and only one of them has a page of its own.
Strengths
- A dense declared list on a single page a reader can finish
- Declares nine of the sixteen compounds this site tracks on pages a reader can reach
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Only one compound has any depth behind it; the rest are names on a list
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
302. Apollo Virtual Health
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Apollo Virtual Health names four tracked compounds on a single short page and pads the list with nothing it does not carry.
Strengths
- A short catalog that can be read in full in a couple of minutes
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- No company name, no state list and no figure anywhere on the pages read
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
303. BetterMe Rx
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
BetterMe Rx runs its NAD+ and sermorelin pages in English and Spanish, answers the cost question with a comparison rather than a number, and publishes no figure a reader can act on.
Strengths
- Publishes its NAD+ and sermorelin pages in English and in Spanish
- Says a video or telephone consultation may be required in some states
- Prints dosing instructions for the oral and injectable forms of both weight-loss drugs
- Separates its microdosing treatments from its standard ones by name
Trade-offs
- Answers its own cost question with a comparison instead of a figure
- Publishes no price on any page read, in either language
- Publishes no state list and names no dispensing pharmacy
- Runs a peptide menu of three tracked compounds with nothing priced on any of them
304. Brightmeds
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Brightmeds publishes a price for every product it sells — to search engines. The figures live in the page’s structured data and appear nowhere a reader can see them, so this record credits no published price.
Strengths
- Says compounded medications are not FDA-approved because they are made to an individual prescription
- Publishes dosing instructions for glutathione, NAD+ and sermorelin on their own pages
- Offers a full refund if a prescription is not approved
- Says plainly that it does not directly offer medical or pharmacy care
Trade-offs
- Publishes prices only in the page’s structured data, where no reader will see them
- Names the FDA as a recognizing authority in that markup for products it describes as compounded
- Publishes no state list and names no dispensing pharmacy
- No certificate of analysis is reachable
305. EllieMD
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
EllieMD publishes two company names in one sentence and says which of them does what, which is a fuller answer to who is charging you than almost anything else on this roster gives.
Strengths
- Names both the operating company and the company services are offered on behalf of, in one sentence
- Names the company on the other side of the transaction rather than only a trading name
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- No product price is reachable without completing an intake
- Publishes no figure for any compound on the pages read
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
306. SynergenX Health
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
SynergenX publishes a page on who should not take peptides, which almost no seller here does, and no figure on either of the two peptide pages it runs.
Strengths
- Publishes a dedicated page on who should not take peptides
- Gives sermorelin and PT-141 their own pages rather than one combined menu
- Names its operating company on its privacy policy
- Operates named physical locations rather than a purely virtual front
Trade-offs
- Carries no figure on either peptide page
- The only published figure on the site is for hormone testing, not for a peptide
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in a peptide price, because there is no peptide price
307. telos rx
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
telos rx names its operating company beside its brand in the footer and names sixteen peptides on one page — and publishes no figure on that page for any of them.
Strengths
- Names the operating company beside the brand in its own footer
- States the regulatory position in short, unhedged sentences
- Names twelve compounds this site tracks on a single page
- Publishes editorial about the peptides rather than only product cards
Trade-offs
- No figure appears on the page read, although the page links its own pricing anchor
- The catalog and the checkout live somewhere this pass did not reach
- Names no dispensing pharmacy
- Publishes no state coverage
308. Vea Health
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Vea Health argues at length against gray-market peptide vendors, claims triple testing on its own coenzyme page, and publishes no price for any peptide anywhere this session could reach.
Strengths
- Attaches its third-party-testing claim to the peptide page itself rather than only to its weight-loss lane
- Names the operating company, a holding company and the clinical practice separately, and says which is which
- States plainly that it is a management services organization and not the practice delivering care
- Argues its own position on gray-market vendors in its own words rather than leaving the category unaddressed
Trade-offs
- No peptide figure on any of the three shop pages read — a reader cannot price either product without an intake
- The testing claim is made on the product page and no certificate is reachable from it
- Some shop paths redirect onto a separate funnel subdomain, so a requested URL is not reliably the page served
- No pharmacy named and no state coverage list, despite a strapline claiming fifty-state reach
309. Viking Alternative Medicine
Does not publish a Sermorelin price.
Summary, strengths and trade-offs8 points
Viking runs a pricing page that refuses to price, and says why in words worth quoting — what it publishes instead is what it says its patients typically pay, which is not the same thing.
Strengths
- Says in its own words why it will not publish a flat rate, instead of publishing a rate that is not one
- Publishes what it says most patients actually pay, with the period attached
- Prices its missed-appointment charge, which most of this roster leaves unstated
- Names ten peptides across its own FAQ and dedicated compound pages
Trade-offs
- Publishes no price for any compound — the range on the pricing page describes patients, not products
- Publishes no corporate entity
- Names no dispensing pharmacy and publishes no state coverage
- A reader who takes the bottom of its patient range as a price will be quoting the wrong kind of number
